FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Henriques, DF
   Nunes, JAL
   Anjos, MV
   Melo, JM
   Rosario, WO
   Azevedo, RSS
   Chiang, JO
   Martins, LC
   dos Santos, FB
   Casseb, LMN
   Vasconcelos, PFC
   Rodrigues, SG
AF Henriques, Daniele Freitas
   Nunes, Juliana A. L.
   Anjos, Maura, V
   Melo, Juliana M.
   Rosario, Wallace O.
   Azevedo, Raimunda S. S.
   Chiang, Jannifer O.
   Martins, Livia C.
   dos Santos, Flavia B.
   Casseb, Livia M. N.
   Vasconcelos, Pedro F. C.
   Rodrigues, Sueli G.
TI Evaluation of immunoglobulin M-specific capture enzyme-linked
   immunosorbent assays and commercial tests for flaviviruses diagnosis by
   a National Reference Laboratory
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Flaviviruses; Dengue; Zika; Yellow fever; ELISA; IgM; Commercial tests
ID ZIKA VIRUS-INFECTION; DENGUE; ANTIGEN; IGM
AB Zika and Dengue viruses present considerable immunological cross-reactivity, resulting in a troublesome semdiagnosis due to occurrence of false positive results. Due to Brazil's wide variety of circulating flaviviruses we aimed to access the use of in house serological tests adapted by National Reference Laboratory for Arboviruses in Brazil and evaluate commercial tests available. We evaluated in house IgM ELISAs for the individual detection of anti-ZIKV, -DENV, and -YFV IgM, against a panel of samples positive for dengue, zika, yellow fever, Rocio, Ilheus, Saint Louis encephalitis, West Nile and chikungunya. We also evaluated two commercial kits for dengue and zika IgM detection recommended by the Brazilian Ministry of Health in 2015. The sensitivity and specificity for the in house ZIKV IgM ELISA was 60.0 % and 88.6 % and for the in house DENV IgM ELISA was 100 % and 82.2 %, respectively. The in house YFV IgM ELISA presented 100 % for both sensitivity and specificity. The Novagnost Zika Virus IgM test presented a sensitivity of 47.3 % and specificity of 85.3 % and the Serion ELISA classic Dengue Virus IgM, 92.8 % and 58.9 %, respectively. Overall, both in house ELISAs for ZIKV and DENV adapted and evaluated here, presented better performances than the commercial kits tested.
C1 [Henriques, Daniele Freitas; Nunes, Juliana A. L.; Anjos, Maura, V; Melo, Juliana M.; Rosario, Wallace O.; Azevedo, Raimunda S. S.; Chiang, Jannifer O.; Martins, Livia C.; Casseb, Livia M. N.; Vasconcelos, Pedro F. C.; Rodrigues, Sueli G.] Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, BR-67030000 Ananindeua, Para, Brazil.
   [dos Santos, Flavia B.] Oswaldo Cruz Inst, Viral Immunol Lab, BR-21040900 Rio De Janeiro, RJ, Brazil.
RP Henriques, DF (corresponding author), Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, BR-67030000 Ananindeua, Para, Brazil.
EM danielehenriques@iec.gov.br
OI Santos, Flavia/0000-0002-1309-5366
FU General Coordination of Public Health Laboratories (CGLAB/MS)
FX The authors wish to thank General Coordination of Public Health
   Laboratories (CGLAB/MS) for providin Commercial IgM assays. We also
   thank Dr. Eliana Vieira Pinto da Silva and Ms. Luis Fabio dos Santos
   Gomes.
CR Andries AC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1551-x
   Arrieta G, 2019, ANN CLIN MICROB ANTI, V18, DOI 10.1186/s12941-019-0328-7
   Ayres M, 2007, BIOESTAT VERSAO 5 0
   Basile AJ, 2018, J VIROL METHODS, V260, P26, DOI 10.1016/j.jviromet.2018.06.018
   Beaty B.J., 1995, DIAGNOSTIC PROCEDURE, P189
   Blacksell SD, 2007, CLIN VACCINE IMMUNOL, V14, P1458, DOI 10.1128/CVI.00482-06
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Falconar AKI, 2006, CLIN VACCINE IMMUNOL, V13, P1044, DOI 10.1128/CVI.00105-06
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Groen J, 2000, CLIN DIAGN LAB IMMUN, V7, P867, DOI 10.1128/CDLI.7.6.867-871.2000
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/mmbr.00055-16, 10.1128/MMBR.00055-16]
   Krammer F, 2019, TRENDS IMMUNOL, V40, P467, DOI 10.1016/j.it.2019.04.008
   KUNO G, 1991, J VIROL METHODS, V33, P101, DOI 10.1016/0166-0934(91)90011-N
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lee H, 2019, ANN LAB MED, V39, P566, DOI 10.3343/alm.2019.39.6.566
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Murphy K., 2010, IMUNOBIOLOGIA JANEWA
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Organization P.A.H., 1994, DENG DENG HEM FEV AM
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Scroferneker M., 1998, IMUNOLOGIA BASICA AP
   Silva C.P., 2018, ANALISE CURVA ANTICO
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Van den Bossche D, 2019, EUR J CLIN MICROBIOL, V38, P771, DOI 10.1007/s10096-019-03472-8
   WHO World Health Organization, 2016, ZIK VIR MICR GUILL B
   WHO World Health Organization TDR Special Programme for Research and Trainning in Tropical Diseases, 2009, DENG GUID DIAGN TREA, DOI [10.1176/pn.41.1.0029b, DOI 10.1176/PN.41.1.0029B]
NR 31
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD DEC
PY 2020
VL 286
AR 113976
DI 10.1016/j.jviromet.2020.113976
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA OH4AH
UT WOS:000582512800009
PM 32971183
OA Other Gold
DA 2020-12-09
ER

PT J
AU Chouin-Carneiro, T
   David, MR
   Nogueira, FD
   dos Santos, FB
   Lourenco-de-Oliveira, R
AF Chouin-Carneiro, Thais
   David, Mariana Rocha
   Nogueira, Fernanda de Bruycker
   dos Santos, Flavia Barreto
   Lourenco-de-Oliveira, Ricardo
TI Zika virus transmission by BrazilianAedes aegyptiandAedes albopictusis
   virus dose and temperature-dependent
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; OUTBREAK; AMERICA; COMPETENCE; INFECTION;
   EVOLUTION; REGION; ISLAND; BRAZIL; AREAS
AB Background Zika virus (ZIKV) emerged in the Pacific Ocean and subsequently caused a dramatic Pan-American epidemic after its first appearance in the Northeast region of Brazil in 2015. The virus is transmitted byAedesmosquitoes. We evaluated the role of temperature and infectious doses of ZIKV in vector competence of Brazilian populations of Ae.aegypti and Ae.albopictus. Methodology/Principal findings TwoAe.aegypti(Rio de Janeiro and Natal) and twoAe.albopictus(Rio de Janeiro and Manaus) populations were orally challenged with five viral doses (10(2)to 10(6)PFU / ml) of a ZIKV strain (Asian genotype) isolated in Northeastern Brazil, and incubated for 14 and 21 days in temperatures mimicking the spring-summer (28 degrees C) and winter-autumn (22 degrees C) mean values in Brazil. Detection of viral particles in the body, head and saliva samples was done by plaque assays in cell culture for determining the infection, dissemination and transmission rates, respectively. Compared with 28 degrees C, at 22 degrees C, transmission rates were significantly lower for bothAe.aegyptipopulations, andAe.albopictuswere not able to transmit the virus.Ae.albopictusshowed low transmission rates even when challenged with the highest viral dose, while bothAe.aegyptipopulations presented higher of infection, dissemination and transmission rates thanAe.albopictus.Ae.aegyptishowed higher transmission efficiency when taking virus doses of 10(5)and 10(6)PFU/mL following incubation at 28 degrees C; bothAe.aegyptiandAe.albopictuswere unable to transmit ZIKV with virus doses of 10(2)and 10(3)PFU/mL, regardless the incubation temperature. Conclusions/Significance The ingested viral dose and incubation temperature were significant predictors of the proportion of mosquito's biting becoming infectious.Ae.aegyptiandAe.albopictushave the ability to transmit ZIKV when incubated at 28 degrees C. However Brazilian populations ofAe.aegyptiexhibit a much higher transmission potential for ZIKV thanAe.albopictusregardless the combination of infection dose and incubation temperature.
   Author summary Zika virus is an arbovirus that has become endemic in Brazilian territory and in tropical and subtropical countries of the Americas since 2015. The virus is transmitted byAedesmosquitoes.Aedes aegyptiandAedes albopictusare widespread in Brazil. To evaluated the influence of temperature and the effect of the infectious dose of ZIKV in vector competence, Brazilian populations ofAe.aegyptiandAe.albopictuswere orally exposed to different infectious doses, distributed from 10(2)to 10(6)PFU / ml and incubated at 22 degrees C and 28 degrees C. We experimentally demonstrated that both populations ofAe.aegyptiandAe.albopictushave the ability to transmit ZIKV when incubated at 28 degrees C, however the infectious dose strongly influenced the proportion of mosquitoes that were able to transmit the virus.Ae.albopictuspopulations showed low transmission rates when challenged with the highest viral dose, whileAe.aegyptipopulations are more susceptible, presenting high rates of infection, dissemination and transmission. When incubated at 22 degrees C,Ae.albopictuspopulations were not able to transmit the virus. Combined, the results indicate that Brazilian populations ofAe.aegyptiexhibit a much higher transmission potential for ZIKV thanAe.albopictus.
C1 [Chouin-Carneiro, Thais; David, Mariana Rocha; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Lab Mosquitos Transmissores Hematozoarios, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Chouin-Carneiro, Thais; Nogueira, Fernanda de Bruycker; dos Santos, Flavia Barreto] Fiocruz MS, Lab Imunol Viral, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
RP Chouin-Carneiro, T (corresponding author), Fiocruz MS, Lab Mosquitos Transmissores Hematozoarios, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.; Chouin-Carneiro, T (corresponding author), Fiocruz MS, Lab Imunol Viral, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
EM chouin.carneiro@gmail.com
OI Reis, AlessanRSS/0000-0001-8486-7469; Santos, Flavia/0000-0002-1309-5366
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/202.003/2016, E-26/102.351/2013,
   E-26/201.335/2016]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [302462/2018-0, 309577/2013-6]; CAPES-COFECUBCAPES
   [799/14]; National Instituto of Health (NIH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [1UO1
   AI115595-01]; Financiadora de Estudos e Projetos (FINEP)Ciencia
   Tecnologia e Inovacao (FINEP) [04.16.0058.02]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX This study was supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro FAPERJ to FBS grant number E-26/202.003/2016, to RLO
   grant numbers E-26/102.351/2013 and E-26/201.335/2016, Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPQ) grant numbers
   302462/2018-0 to FBS, to RLO grant number 309577/2013-6, CAPES-COFECUB
   to RLO grant number 799/14, National Instituto of Health (NIH) to RLO
   grant number 1UO1 AI115595-01, Financiadora de Estudos e Projetos
   (FINEP) to RLO grant number 04.16.0058.02, the European Unions Horizon
   2020 Research and Innovation Programme under ZIKAlliance to RLO grant
   number 734548, TCC was supported by fellowships from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and CNPq. The
   funders had no role in the study design, data collection, analysis and
   decision to publish or preparation of the manuscript.
CR Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/s1679-49742017000100002, 10.5123/S1679-49742017000100002]
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2018, AM J TROP MED HYG, V99, P417, DOI 10.4269/ajtmh.18-0097
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FAY R. W., 1966, MOSQUITO NEWS, V26, P531
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hardy JL, 1983, ANN REV ENTOMOLOGY
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Liu ZZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02337
   Mbaika S, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0566-7
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   R Core Team, 2017, R LANG ENV STAT COMP
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsai CH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2493-x
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Woodring J. L. HS, 1996, NATURAL CYCLES VECTO
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 50
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2020
VL 14
IS 9
AR e0008527
DI 10.1371/journal.pntd.0008527
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA NQ6LC
UT WOS:000570982100005
PM 32898136
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Rabelo, K
   de Souza, LJ
   Salomao, NG
   Machado, LN
   Pereira, PG
   Portari, EA
   Basilio-de-Oliveira, R
   dos Santos, FB
   Neves, LD
   Morgade, LF
   Provance, DW
   Higa, LM
   Tanuri, A
   de Carvalho, JJ
   Paes, MV
AF Rabelo, Kissila
   de Souza, Luiz Jose
   Salomao, Natalia Gedeao
   Machado, Lara Nascentes
   Pereira, Priscila Gomes
   Portari, Elyzabeth Avvad
   Basilio-de-Oliveira, Rodrigo
   dos Santos, Flavia Barreto
   Neves, Laura Dias
   Morgade, Luciana Faes
   Provance, David William, Jr.
   Higa, Luiza Mendonca
   Tanuri, Amilcar
   de Carvalho, Jorge Jose
   Paes, Marciano Viana
TI Zika Induces Human Placental Damage and Inflammation
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE immune response; histopathology; ultrastructure; cytokines; flavivirus
ID VIRUS-INFECTION; IMMUNE-SYSTEM; GROWTH-FACTOR; BRAIN; BDNF; BARRIER
AB In Brazil, an epidemic of Zika virus (ZIKV) infections was declared in 2015 that coincided with alarming reports of microcephaly in newborns associated with mother infection. Although the virus has placental tropism, changes in the tissue morphology and immunity of infected patients have not yet been elucidated. Here, we investigated the histopathological and ultrastructural changes along with the immunological profile and the BDNF expression in rare placental material. Tissues were obtained in the 2015-2016 Brazilian epidemic, of ten ZIKV-infected patients during pregnancy, five resulting in cases of fetal microcephaly and five non-microcephaly, compared to five non-infected control placentae. Viral antigens were only detected in samples from the ZIKV infected patients. Infected placentae presented histopathological severe damage, while the ultrastructural evaluation showed abnormal organelles, such as clusters of virus-like particles consistent with the ZIKV dimensions. Increased infiltration of CD68(+)and TCD8(+)cells, expression of MMPs, cytokines (IFN-gamma and TNF-alpha) and other immunological mediators (RANTES/CCL5 and VEGFR-2) confirmed excessive inflammation and vascular permeability dysfunction. An evaluation of BDNF showed a decrease that could modulate neuronal damage in the developing fetus. The placental changes caused by ZIKV are not pathognomonic, however, the data provide evidence that this infection leads to severe placental injury.
C1 [Rabelo, Kissila; Pereira, Priscila Gomes; de Carvalho, Jorge Jose] Univ Estado Rio de Janeiro, Lab Ultraestrutura & Biol Tecidual, Rio De Janeiro, Brazil.
   [de Souza, Luiz Jose; Machado, Lara Nascentes] Fac Med Campos, Rio De Janeiro, Brazil.
   [Salomao, Natalia Gedeao; Provance, David William, Jr.; Paes, Marciano Viana] Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Portari, Elyzabeth Avvad] Inst Fernandes Figueira Fiocruz, Anat Patol, Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, Rodrigo] Univ Fed Estado Rio De Janeiro, Anat Patol, Rio De Janeiro, Brazil.
   [dos Santos, Flavia Barreto] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Neves, Laura Dias; Morgade, Luciana Faes] CEPLIN Uti Neonatal Nicola Albano, Hosp Geral Dr Beda, Rio De Janeiro, Brazil.
   [Provance, David William, Jr.] Fiocruz MS, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, Brazil.
   [Higa, Luiza Mendonca; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Lab Virol Mol, Rio De Janeiro, Brazil.
RP Rabelo, K (corresponding author), Univ Estado Rio de Janeiro, Lab Ultraestrutura & Biol Tecidual, Rio De Janeiro, Brazil.; Paes, MV (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
EM kissilarabelo91@gmail.com; marciano@ioc.fiocruz
RI ; Provance, David/D-5294-2013
OI Rabelo, Kissila/0000-0001-7579-7788; Provance,
   David/0000-0002-9824-0672; Santos, Flavia/0000-0002-1309-5366
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [308780/2015-9]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/110.511/2014,
   E-26/010.001.498/2016, E26/202.003/2016, E-26/202.659/2019]; Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX This work was supported by the CNPq (308780/2015-9) and the FAPERJ
   (E-26/110.511/2014, E-26/010.001.498/2016, E26/202.003/2016, and
   E-26/202.659/2019). To Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) and CNPq for the students fellowships. The
   funders had no role in the study design, data collection, analysis and
   decision to publish, or preparation of the manuscript.
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Beaufrere A, 2019, BRAIN PATHOL, V29, P114, DOI 10.1111/bpa.12644
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Ministry of Health, 2018, EP B INT MON GROWTH
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chiu CF, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00214
   Choudhury RH, 2019, AM J REPROD IMMUNOL, V81, DOI 10.1111/aji.13054
   Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   de Noronha L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02266
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foo SS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124152
   Franczyk M, 2017, PLACENTA, V50, P19, DOI 10.1016/j.placenta.2016.12.014
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hayes JP, 2018, GENES BRAIN BEHAV, V17, P107, DOI 10.1111/gbb.12403
   Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9
   Kawamura K, 2011, ENDOCRINOLOGY, V152, P1090, DOI 10.1210/en.2010-1124
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lima MC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01928
   Lum FM, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1082
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Oefner CM, 2015, PLACENTA, V36, P59, DOI 10.1016/j.placenta.2014.10.012
   Petitt M, 2017, PHYSIOL BEHAV, V176, P139, DOI [10.1016/j.physbeh.2017.03.040, DOI 10.1016/J.PHYSBEH.2017.03.040]
   Pinar H, 2014, OBSTET GYNECOL, V123, P325, DOI 10.1097/AOG.0000000000000100
   Pomar L, 2020, ULTRASOUND OBST GYN, V56, P740, DOI 10.1002/uog.21936
   Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabelo K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01018
   Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Rosenberg A, 2016, COLL AM PATHOL, V1, P1, DOI [10.5858/arpa.2016-0401-OA, DOI 10.5858/ARPA.2016-0401-OA]
   Santos GR, 2020, INT J GYNECOL PATHOL, V39, P157, DOI 10.1097/PGP.0000000000000586
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Strauss JF, 2013, REPROD SCI, V20, P140, DOI 10.1177/1933719111424454
   Tapia-Arancibia L, 2004, FRONT NEUROENDOCRIN, V25, P77, DOI 10.1016/j.yfrne.2004.04.001
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tometten M, 2005, CHEM IMMUNOL ALLERGY, V89, P135, DOI 10.1159/000087962
   Tsatsaris V, 2003, J CLIN ENDOCR METAB, V88, P5555, DOI 10.1210/jc.2003-030528
   Weisblum Y, 2017, J VIROL, V91, DOI [10.1128/jvi.01905-16, 10.1128/JVI.01905-16]
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
   Zulu MZ, 2019, J INNATE IMMUN, V11, P447, DOI 10.1159/000497416
NR 54
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD SEP 1
PY 2020
VL 11
AR 2146
DI 10.3389/fimmu.2020.02146
PG 15
WC Immunology
SC Immunology
GA NQ2BF
UT WOS:000570669900001
PM 32983175
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Cruz, ACR
   Nunes, JP
   da Silva, SP
   da Silva, EVP
   Pereira, GJG
   Santos, MM
   Monteiro, HAD
   dos Santos, FB
   Guimaraes, RJDSE
   Aragao, CF
   Martins, LC
AF Ribeiro Cruz, Ana Cecilia
   Nunes Neto, Joaquim Pinto
   da Silva, Sandro Patroca
   Pinto da Silva, Eliana Vieira
   Galvao Pereira, Glennda Juscely
   Santos, Maissa Maia
   de Oliveira Monteiro, Hamilton Antonio
   dos Santos, Flavia Barreto
   de Paula Souza e Guimaraes, Ricardo Jose
   Aragao, Carine Fortes
   Martins, Livia Caricio
TI Chikungunya Virus Detection inAedes aegyptiandCulex
   quinquefasciatusduring an Outbreak in the Amazon Region
SO VIRUSES-BASEL
LA English
DT Article
DE Chikungunya; Aedes aegypti; Culex quinquefasciatus;
   East-Central-South-Africa genotype; entomological surveillance; Amazon;
   Brazil
ID AEDES-AEGYPTI; CELL; SPREAD
AB Chikungunya virus (CHIKV) was first reported in Brazil in 2014 and, after it spread countrywide, an outbreak of febrile illness with reports of arthralgia happened in the municipality of Xinguara, Para, Brazil in 2017, indicating the virus' circulation. Here, we aimed to investigate CHIKV in mosquito vectors collected during an active surveillance of virus isolation in cell culture by using molecular detection and viral genome sequencing. A total of 492Aedes,CulexandMansoniamosquitoes were collected and separated in 36 pools according to the species and sex, and 22.2% (8/36) were positive. CHIKV was indentified in pools ofAe. aegyptifemales (n= 5), anAe. aegyptimale (n= 1) and inCulex quinquefasciatusfemales (n= 2). However, as the mosquitoes' whole bodies were macerated and used for detection, one cannot suggest the role of the latter in the viral transmission. Despite this, vector competence studies must be carried out in the different species to investigate long-term adaptations. Viral genome sequencing has characterized the East-Central-South-African (ECSA) genotype in all positive pools analyzed, corroborating previous reports for the Amazon region.
C1 [Ribeiro Cruz, Ana Cecilia; Nunes Neto, Joaquim Pinto; da Silva, Sandro Patroca; Pinto da Silva, Eliana Vieira; Galvao Pereira, Glennda Juscely; Santos, Maissa Maia; de Oliveira Monteiro, Hamilton Antonio; de Paula Souza e Guimaraes, Ricardo Jose; Aragao, Carine Fortes; Martins, Livia Caricio] Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrag, Secretaria Vigilancia & Saude, Minist Saude, BR-67030000 Ananindeua, PA, Brazil.
   [Ribeiro Cruz, Ana Cecilia] Univ Estado Para, Dept Patol, BR-66087662 Belem, Para, Brazil.
   [Galvao Pereira, Glennda Juscely; Aragao, Carine Fortes] Inst Evandro Chagas, Programa Posgrad Virol, BR-67030000 Ananindeua, PA, Brazil.
   [dos Santos, Flavia Barreto] Fundacao Oswaldo Cruz, Lab Imunol Viral, BR-21040900 Rio De Janeiro, RJ, Brazil.
RP Nunes, JP (corresponding author), Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrag, Secretaria Vigilancia & Saude, Minist Saude, BR-67030000 Ananindeua, PA, Brazil.
EM anacecilia@iec.gov.br; joaquimneto@iec.gov.br; spatroca@gmail.com;
   elianapinto@iec.gov.br; bioagl2013@gmail.com; maissasantos@iec.gov.br;
   hamiltonmonteiro@iec.gov.br; flaviab@ioc.fiocruz.br;
   ricardoguimaraes@iec.gov.br; carinefaragao@gmail.com;
   liviamartins@iec.gov.br
RI Guimaraes, Ricardo/F-7182-2015
OI Guimaraes, Ricardo/0000-0002-5767-4765; RIBEIRO CRUZ, ANA
   CECILIA/0000-0002-4607-9346; PINTO NUNES NETO,
   JOAQUIM/0000-0001-5981-0065; Fortes Aragao, Carine/0000-0003-2721-6496
FU Instituto Evandro Chagas/Ministerio da Saude; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [302462/2018-0]
FX Instituto Evandro Chagas/Ministerio da Saude and to Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) grant number
   302462/2018-0 to F.B.S.
CR Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263
   Aragao CF, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11121126
   Aragao CF, 2018, ACTA TROP, V186, P1, DOI 10.1016/j.actatropica.2018.06.022
   Beaty B.J., 1995, ARBOVIRUSES DIAGNOST, P1890
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Cardoso FD, 2019, REV INST MED TROP SP, V61, DOI [10.1590/s1678-9946201961057, 10.1590/S1678-9946201961057]
   Cleton NB, 2014, NED TIJDSCHR GENEES, V158, P7918
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   de Jesus JG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226098
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/s1678-9946201860019, 10.1590/S1678-9946201860019]
   Diallo M, 2016, J INFECT DIS, V214, pS459, DOI 10.1093/infdis/jiw397
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Forattini O.P., 1965, ENTOMOLOGIA MED CULI, V2
   Forattini O.P., 1962, ENTOMOLOGIA MED PART, V1
   Forattini O.P., 2002, CULICIDOLOGIA MED U, V2
   Forattini O.P., 1965, ENTOMOLOGIA MED CULI, V3
   Ximenes MDFD, 2020, ACTA TROP, V209, DOI 10.1016/j.actatropica.2020.105538
   GRIFFIN DE, 2013, FIELDS VIROLOGY, P651
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107
   Intayot P, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8030121
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lane J, 1953, NEOTROPICAL CULICIDA, VI
   Lane J, 1953, NEOTROPICAL CULICIDA, VII
   Lessa-Aquino C, 2018, EPIDEMIOL INFECT, V146, P2056, DOI 10.1017/S0950268818002467
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/s1518-8787.2016050006791, 10.1590/S1518-8787.2016050006791]
   Lowy I, 2017, AM J PUBLIC HEALTH, V107, P517, DOI 10.2105/AJPH.2017.303652
   Machado LC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007332
   Menting S, 2011, ADV VIROL, V2011, DOI 10.1155/2011/514681
   Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174
   Ponce-Garcia G, 2018, J AM MOSQUITO CONTR, V34, P147, DOI 10.2987/17-6683.1
   Reinhold JM, 2018, INSECTS, V9, DOI 10.3390/insects9040158
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Souza TML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39406-9
   Souza Thiara Manuele Alves, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Tauro LB, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760180597
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Xavier J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217871
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
NR 50
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD AUG
PY 2020
VL 12
IS 8
AR 853
DI 10.3390/v12080853
PG 11
WC Virology
SC Virology
GA OC0WL
UT WOS:000578884400001
PM 32759878
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Salomao, N
   Rabelo, K
   Basilio-de-Oliveira, C
   Basilio-de-Oliveira, R
   Geraldo, L
   Lima, F
   dos Santos, F
   Nuovo, G
   Oliveira, ERA
   Paes, M
AF Salomao, Natalia
   Rabelo, Kissila
   Basilio-de-Oliveira, Carlos
   Basilio-de-Oliveira, Rodrigo
   Geraldo, Luiz
   Lima, Flavia
   dos Santos, Flavia
   Nuovo, Gerard
   Oliveira, Edson R. A.
   Paes, Marciano
TI Fatal Dengue Cases Reveal Brain Injury and Viral Replication in
   Brain-Resident Cells Associated with the Local Production of
   Pro-Inflammatory Mediators
SO VIRUSES-BASEL
LA English
DT Article
DE dengue; human fatal cases; neuropathogenesis; inflammation; central
   nervous system
ID HEMORRHAGIC-FEVER; CEREBRAL-CORTEX; WHITE-MATTER; NITRIC-OXIDE;
   WEST-NILE; VIRUS; MANIFESTATIONS; INVOLVEMENT; INFECTION; ACTIVATION
AB Dengue is an arboviral disease caused by dengue virus (DENV), which is transmitted to humans byAedes aegyptimosquitoes. Infection by DENV most commonly results in a mild flu-like illness; however, the disease has been increasingly associated with neurological symptomatology. This association draws attention to further investigations on the impact of DENV infection in the host's central nervous system. Here, we analyzed brain samples of three fatal dengue cases that occurred in 2002 during an outbreak in Rio de Janeiro, Brazil. Brain tissues of these cases were marked by histopathological alterations, such as degenerated neurons, demyelination, hemorrhage, edema, and increased numbers of astrocytes and microglial cells. Samples were also characterized by lymphocytic infiltrates mainly composed of CD8 T cells. DENV replication was evidenced in neurons, microglia and endothelial cells through immunohistochemistry and in situ hybridization techniques. Pro-inflammatory cytokines, such as TNF-alpha and IFN-gamma were detected in microglia, while endothelial cells were marked by the expression of RANTES/CCL5. Cytoplasmic HMGB1 and the production of nitric oxide were also found in neurons and microglial cells. This work highlights the possible participation of several local pro-inflammatory mediators in the establishment of dengue neuropathogenesis.
C1 [Salomao, Natalia; Paes, Marciano] Fundacao Oswaldo Cruz, Interdisciplinary Med Res Lab Rio de Janeiro, BR-21040900 Rio De Janeiro, Brazil.
   [Rabelo, Kissila] Univ Estado Rio De Janeiro, Ultrastruct & Tissue Biol Lab Rio de Janeiro, BR-20551030 Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, Carlos; Basilio-de-Oliveira, Rodrigo] Fed Univ State Rio de Janeiro, Gaffree Guinle Univ Hosp Rio de Janeiro, Pathol Anat, BR-20270004 Rio De Janeiro, Brazil.
   [Geraldo, Luiz; Lima, Flavia] Univ Fed Rio de Janeiro, Inst Biomed Sci Rio de Janeiro, Glial Cell Biol Lab, BR-21941590 Rio De Janeiro, Brazil.
   [dos Santos, Flavia] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst Rio de Janeiro, Viral Immunol Lab, BR-21040900 Rio De Janeiro, Brazil.
   [Nuovo, Gerard] Ohio State Univ, Ohio State Univ Fdn, Comprehens Canc Ctr, Columbus, OH 43210 USA.
   [Nuovo, Gerard] Ohio State Univ Fdn, Phylogeny Med Lab Columbus, Columbus, OH 43214 USA.
   [Oliveira, Edson R. A.] Univ Illinois, Dept Microbiol & Immunol Chicago, Chicago, IL 60612 USA.
RP Paes, M (corresponding author), Fundacao Oswaldo Cruz, Interdisciplinary Med Res Lab Rio de Janeiro, BR-21040900 Rio De Janeiro, Brazil.
EM natgsalomao@gmail.com; kissilarabelo91@gmail.com;
   basiliopatologia@br.inter.net; rodrigopboliveira@gmail.com;
   lh_geraldo@hotmail.com; flima@icb.ufrj.br; flaviabarretod@gmail.com;
   jerrynuovo@yahoo.com; edsonrao@gmail.com; marciano@ioc.fiocruz.br
OI Nuovo, Gerard/0000-0002-5351-4721; Oliveira, Edson
   RA/0000-0002-8606-7454; Santos, Flavia/0000-0002-1309-5366; Souza Lima,
   Flavia Regina/0000-0003-0799-9235; Geraldo, Luiz
   Henrique/0000-0003-3318-4697; Rabelo, Kissila/0000-0001-7579-7788
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Riode
   Janeiro [E-26/210.4001/2019]
FX This research was funded by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Riode Janeiro, grant number E-26/210.4001/2019.
CR Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010
   Angibaud G, 2001, J CLIN NEUROSCI, V8, P63, DOI 10.1054/jocn.2000.0735
   Araujo FMC, 2011, J VIROL METHODS, V177, P128, DOI 10.1016/j.jviromet.2011.07.003
   Asiimwe N, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7205747
   Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016
   Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453
   Benarroch EE, 2011, NEUROLOGY, V77, P1568, DOI 10.1212/WNL.0b013e318233b3e4
   BHAMARAP.N, 1967, ANN TROP MED PARASIT, V61, P500, DOI 10.1080/00034983.1967.11686519
   Bhatt RS, 2015, IMMUNOBIOLOGY, V220, P1170, DOI 10.1016/j.imbio.2015.06.002
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boly M, 2017, J NEUROSCI, V37, P9603, DOI 10.1523/JNEUROSCI.3218-16.2017
   Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001
   BUTLER SR, 1971, BRIT MED J, V4, P544, DOI 10.1136/bmj.4.5786.544
   Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848
   Carabali M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1058-x
   Chen JC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-165
   Chimelli L., 1990, CLIN NEUROPATHOL
   Chu JJH, 2003, J GEN VIROL, V84, P3305, DOI 10.1099/vir.0.19447-0
   Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685
   Dalrymple NA, 2012, J VIROL, V86, P6408, DOI 10.1128/JVI.00213-12
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   Dzoljic E, 2015, FUNCT NEUROL, V30, P159
   Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y
   Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001
   Ghouili I, 2018, MOL NEUROBIOL, V55, P4596, DOI 10.1007/s12035-017-0630-3
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222
   Hou JH, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1142492
   Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746
   Kong LQ, 2014, CEREB CORTEX, V24, P773, DOI 10.1093/cercor/bhs359
   Kouretova J, 2017, J ENZYM INHIB MED CH, V32, P712, DOI 10.1080/14756366.2017.1306521
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lim MQ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02225
   Lima DM, 2011, VACCINE, V29, P831, DOI 10.1016/j.vaccine.2010.10.078
   Mamdouh KH, 2013, J GLOB INFECT DIS, V5, P183, DOI 10.4103/0974-777X.122021
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Miner JJ, 2016, CURR OPIN IMMUNOL, V38, P18, DOI 10.1016/j.coi.2015.10.008
   Mustafa YM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00525
   Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008
   Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412
   Nielsen DG, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-211
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Oliveira ERA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16197-5
   Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83
   Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P341
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200
   PATEY O, 1993, AM J TROP MED HYG, V48, P793, DOI 10.4269/ajtmh.1993.48.793
   Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207
   Povoa TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168973
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Puccioni-Sohler M, 2013, ARQ NEURO-PSIQUIAT, V71, P667, DOI 10.1590/0004-282X20130147
   Quallo MM, 2009, P NATL ACAD SCI USA, V106, P18379, DOI 10.1073/pnas.0909751106
   Ramirez R, 2014, VIRUS GENES, V49, P185, DOI 10.1007/s11262-014-1087-3
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   Rathi K R, 2013, Med J Armed Forces India, V69, P254, DOI 10.1016/j.mjafi.2012.08.021
   de Souza KPR, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-267
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Saini L, 2017, NEUROL INDIA, V65, P636, DOI [10.4103/neuroindia.NI_1367_15, 10.4103/neuroindia.ni_1367_15]
   Salomao NG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28137-y
   Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Thisyakorn U, 1999, SE ASIAN J TROP MED
   Thisyakorn Usa, 1994, Journal of the Medical Association of Thailand, V77, P410
   Tjalkens Ronald B, 2017, Adv Neurobiol, V18, P159, DOI 10.1007/978-3-319-60189-2_8
   Tohidpour A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00276
   Trung D.T., 2010, SYSTEMIC VASCULAR LE, P57
   Vilhardt F, 2017, BRIT J PHARMACOL, V174, P1719, DOI 10.1111/bph.13426
NR 71
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUN
PY 2020
VL 12
IS 6
AR 603
DI 10.3390/v12060603
PG 16
WC Virology
SC Virology
GA MP8UG
UT WOS:000552473800001
PM 32486462
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Lima, MDQ
   Chouin-Carneiro, T
   Azeredo, E
   Barbosa, LS
   Souza, TMA
   da Silva, JBC
   Nunes, PCG
   Dal Fabbro, M
   Facco, IHR
   Venancio-Da-Cunha, R
   dos Santos, FB
AF Queiroz Lima, Monique da Rocha
   Chouin-Carneiro, Thais
   Azeredo, Elzinandes
   Barbosa, Luciana Santos
   Alves Souza, Thiara Manuele
   Correa da Silva, Jessica Badolato
   Guerra Nunes, Priscila Conrado
   Dal Fabbro, Marcia
   Romanholi Facco, Izilyanne H.
   Venancio-da-Cunha, Rivaldo
   dos Santos, Flavia Barreto
TI The inability of a dengue NS1 ELISA to detect Zika infections
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CHIKUNGUNYA-VIRUS; CROSS-REACTIVITY; SPECIFICITY; ENHANCEMENT;
   BIOSENSOR; ASSAYS
AB The presence of dengue virus (DENV), Zika virus (ZIKV) and Chikungunya virus (CHIKV) in Brazil, may result in a difficult diagnosis due to the signs and symptoms shared by those. Moreover, as DENV and ZIKV belong to the same family, serological assays may show a high rate of cross-reactivity. Here, we evaluated a Dengue NS1 capture assay for early and differential diagnosis of dengue during the Zika epidemic occurred in Brazil in 2016. Samples (n = 227) from 218 patients included sera, plasma and urine from previously confirmed acute cases of Zika, dengue and Zika/dengue co-infections. Nine of those patients presented two specimens. The Dengue NS1 test was very specific for dengue diagnosis (99.32%), even in the co-circulation with ZIKV, and exhibited a high accuracy in not detecting acute Zika infections (92.43%). Our findings showed that the dengue NS1 capture test analyzed here was not able to recognize the ZIKV NS1 and its potential for cross-reaction.
C1 [Queiroz Lima, Monique da Rocha; Chouin-Carneiro, Thais; Azeredo, Elzinandes; Barbosa, Luciana Santos; Alves Souza, Thiara Manuele; Correa da Silva, Jessica Badolato; Guerra Nunes, Priscila Conrado; dos Santos, Flavia Barreto] Oswaldo Cruz Inst, Viral Immunol Lab, BR-21045360 Rio De Janeiro, Brazil.
   [Dal Fabbro, Marcia; Romanholi Facco, Izilyanne H.; Venancio-da-Cunha, Rivaldo] Univ Fed Mato Grosso do Sul, Med Clin Dept, BR-79070900 Campo Grande, MS, Brazil.
RP Lima, MDQ; dos Santos, FB (corresponding author), Oswaldo Cruz Inst, Viral Immunol Lab, BR-21045360 Rio De Janeiro, Brazil.
EM moniqueq@ioc.fiocruz.br; flaviab@ioc.fiocruz.br
OI Santos, Flavia/0000-0002-1309-5366
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/201.489/2014, E-26/202.003/2016,
   E-26/202.659/2019]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [302462/2018-0, 312707/2018-5]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; CNPqNational
   Council for Scientific and Technological Development (CNPq); FIOCRUZ;
   Financiadora de Estudos e Projetos FINEPCiencia Tecnologia e Inovacao
   (FINEP) [04.16.0058.00]
FX We are grateful to all staff at the Viral Immunology Laboratory for
   technical support. We gratefully thank the voluntarily participation in
   this study of healthy individuals and patients from Walfrido Arruda
   Emergency Care Unit, Coronel Antonino (Mato Grosso do Sul, Brazil). This
   study was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro FAPERJ to ELA grant number E-26/201.489/2014 and to FBS grant
   number E-26/202.003/2016 and E-26/202.659/2019, to Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) grant number
   302462/2018-0 to FBS, and 312707/2018-5 to ELA, to Financiadora de
   Estudos e Projetos FINEP number 04.16.0058.00 to F.B.S., to FIOCRUZ, to
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and
   CNPq for the students fellowships. M.R.Q.L. is a CAPES fellowship
   recipient. The funders had no role in the study design, data collection,
   analysis and decision to publish or preparation of the manuscript.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   Azeredo Elzinandes Leal, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brito CAA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005583
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   da Costa VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094655
   Darwish NT, 2018, J PHARMACEUT BIOMED, V149, P591, DOI 10.1016/j.jpba.2017.11.064
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   FDA, 2016, ZIK VIR EM US AUTH
   Gelanew T, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0925-7
   Gomez EJ, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000862
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/jcm.00580-17, 10.1128/JCM.00580-17]
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Omarjee R, 2013, EUROSURVEILLANCE, P19, DOI DOI 10.2807/1560-
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Lima MDQ, 2014, J VIROL METHODS, V204, P105, DOI 10.1016/j.jviromet.2014.02.031
   Lima MDQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001147
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Samanta J, 2015, WORLD J CLIN CASES, V3, P125, DOI 10.12998/wjcc.v3.i2.125
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tyson J, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01464-18
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Xu X, 2016, PLOS CURR, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
NR 42
TC 3
Z9 3
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 9
PY 2019
VL 9
AR 18596
DI 10.1038/s41598-019-55160-4
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JU5YU
UT WOS:000501753000007
PM 31819129
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Pauvolid-Correa, A
   Dias, HG
   Maia, LMS
   Porfirio, G
   Morgado, TO
   Sabino-Santos, G
   Santa Rita, PH
   Barreto, WTG
   de Macedo, GC
   Torres, JM
   Nantes, WAG
   Santos, FM
   de Assis, WO
   Rucco, AC
   Yui, RMD
   Campos, JBV
   Silva, RRLE
   Ferreira, RD
   Neves, NAD
   Costa, MCD
   Martins, LR
   de Souza, EM
   Carvalho, MD
   Lima, MG
   Alves, FDG
   Riquelme, LHG
   Figueiro, LLB
   de Santana, MFG
   Santos, LGRO
   Medeiros, SS
   Seino, LL
   Miranda, EH
   Linhares, JHR
   Santos, VD
   da Silva, SA
   Lucio, KA
   Gomes, VS
   Oliveira, AD
   Silva, JD
   Marques, WD
   Marques, MS
   de Barros, JF
   Campos, L
   Couto-Lima, D
   Netto, CC
   Strussmann, C
   Panella, N
   Hannon, E
   de Macedo, BC
   de Almeida, JR
   Ribeiro, KR
   de Castro, MCB
   Campos, LP
   dos Santos, APR
   de Souza, IM
   Bianchini, MD
   Correa, SHR
   Luz, ROB
   Vieira, AD
   Pinto, LMD
   Azeredo, E
   Figueiredo, LTM
   Alencar, JAF
   de Lima, SMB
   Herrera, HM
   Shlessarenko, RD
   dos Santos, FB
   de Filippis, AMB
   Salyer, S
   Montgomery, J
   Komar, N
AF Pauvolid-Correa, Alex
   Dias, Helver Goncalves
   Siqueira Maia, Laura Marina
   Porfirio, Grasiela
   Morgado, Thais Oliveira
   Sabino-Santos, Gilberto
   Santa Rita, Paula Helena
   Gomes Barreto, Wanessa Teixeira
   de Macedo, Gabriel Carvalho
   Torres, Jaire Marinho
   Gimenes Nantes, Wesley Arruda
   Santos, Filipe Martins
   de Assis, William Oliveira
   Rucco, Andreza Castro
   dos Santos Yui, Rafael Mamoru
   Vilela Campos, Joao Bosco
   Leandro e Silva, Renato Rodrigues
   Ferreira, Raquel da Silva
   da Silva Neves, Nilvanei Aparecido
   de Souza Costa, Michell Charlles
   Martins, Leticia Ramos
   de Souza, Emerson Marques
   dos Santos Carvalho, Michellen
   Lima, Marina Goncalves
   Goncalves Alves, Fernanda de Cassia
   Guimaraes Riquelme-Junior, Luiz Humberto
   Batista Figueiro, Luan Luiz
   Gomes de Santana, Matheus Fernandes
   Rodrigues Oliveira Santos, Luiz Gustavo
   Medeiros, Samara Serra
   Seino, Larissa Lopes
   Miranda, Emily Hime
   Rezende Linhares, Jose Henrique
   Santos, Vanessa de Oliveira
   da Silva, Stephanie Almeida
   Lucio, Kelly Araujo
   Gomes, Viviane Silva
   Oliveira, Alexandre de Araujo
   Silva, Julia dos Santos
   Marques, William de Almeida
   Marques, Marcio Schafer
   Franca de Barros, Jose Junior
   Campos, Leticia
   Couto-Lima, Dinair
   Netto, Claudia Coutinho
   Strussmann, Christine
   Panella, Nicholas
   Hannon, Emily
   de Macedo, Barbara Cristina
   de Almeida, Julia Ramos
   Ribeiro, Karen Ramos
   Barros de Castro, Maria Carolina
   Campos, Larissa Pratta
   Rosa dos Santos, Ana Paula
   de Souza, Isabelle Marino
   Bianchini, Mateus de Assis
   Ramiro Correa, Sandra Helena
   Baptista Luz, Renato Ordones
   Vieira, Ananda dos Santos
   de Oliveira Pinto, Luzia Maria
   Azeredo, Elzinandes
   Moraes Figueiredo, Luiz Tadeu
   Fonseca Alencar, Jeronimo Augusto
   Barbosa de Lima, Sheila Maria
   Herrera, Heitor Miraglia
   Shlessarenko, Renata Dezengrini
   dos Santos, Flavia Barreto
   Bispo de Filippis, Ana Maria
   Salyer, Stephanie
   Montgomery, Joel
   Komar, Nicholas
TI Zika Virus Surveillance at the Human-Animal Interface in West-Central
   Brazil, 2017-2018
SO VIRUSES-BASEL
LA English
DT Article
DE Zika; enzootic cycle; Brazil; zoonotic; plaque reduction neutralization
   test (PRNT)
ID IDENTIFICATION; TRANSMISSION; ARBOVIRUSES; GUIDELINES; INFECTION;
   EMERGENCE; MOSQUITOS; VECTORS
AB Zika virus (ZIKV) was first discovered in 1947 in Uganda but was not considered a public health threat until 2007 when it found to be the source of epidemic activity in Asia. Epidemic activity spread to Brazil in 2014 and continued to spread throughout the tropical and subtropical regions of the Americas. Despite ZIKV being zoonotic in origin, information about transmission, or even exposure of non-human vertebrates and mosquitoes to ZIKV in the Americas, is lacking. Accordingly, from February 2017 to March 2018, we sought evidence of sylvatic ZIKV transmission by sampling whole blood from approximately 2000 domestic and wild vertebrates of over 100 species in West-Central Brazil within the active human ZIKV transmission area. In addition, we collected over 24,300 mosquitoes of at least 17 genera and 62 species. We screened whole blood samples and mosquito pools for ZIKV RNA using pan-flavivirus primers in a real-time reverse-transcription polymerase chain reaction (RT-PCR) in a SYBR Green platform. Positives were confirmed using ZIKV-specific envelope gene real-time RT-PCR and nucleotide sequencing. Of the 2068 vertebrates tested, none were ZIKV positive. Of the 23,315 non-engorged mosquitoes consolidated into 1503 pools tested, 22 (1.5%) with full data available showed some degree of homology to insect-specific flaviviruses. To identify previous exposure to ZIKV, 1498 plasma samples representing 62 species of domestic and sylvatic vertebrates were tested for ZIKV-neutralizing antibodies by plaque reduction neutralization test (PRNT90). From these, 23 (1.5%) of seven species were seropositive for ZIKV and negative for dengue virus serotype 2, yellow fever virus, and West Nile virus, suggesting potential monotypic reaction for ZIKV. Results presented here suggest no active transmission of ZIKV in non-human vertebrate populations or in alternative vector candidates, but suggest that vertebrates around human populations have indeed been exposed to ZIKV in West-Central Brazil.
C1 [Pauvolid-Correa, Alex; Bispo de Filippis, Ana Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
   [Dias, Helver Goncalves; de Oliveira Pinto, Luzia Maria; Azeredo, Elzinandes; dos Santos, Flavia Barreto] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunol Viral, BR-21040900 Rio De Janeiro, Brazil.
   [Siqueira Maia, Laura Marina; Ferreira, Raquel da Silva; da Silva Neves, Nilvanei Aparecido; de Souza Costa, Michell Charlles; Martins, Leticia Ramos; de Souza, Emerson Marques; dos Santos Carvalho, Michellen; Shlessarenko, Renata Dezengrini] Univ Fed Mato Grosso, Fac Med, Lab Virol, BR-78060900 Cuiaba, Brazil.
   [Porfirio, Grasiela; de Macedo, Gabriel Carvalho; Torres, Jaire Marinho; Gimenes Nantes, Wesley Arruda; Santos, Filipe Martins; de Assis, William Oliveira; Rucco, Andreza Castro; dos Santos Yui, Rafael Mamoru; Vilela Campos, Joao Bosco; Leandro e Silva, Renato Rodrigues; Herrera, Heitor Miraglia] Univ Catolica Dom Bosco, Lab Biol Parasitaria, Programa Posgrad Ciencias Ambientais & Sustentabi, BR-79117010 Campo Grande, MS, Brazil.
   [Morgado, Thais Oliveira; Bianchini, Mateus de Assis; Ramiro Correa, Sandra Helena; Baptista Luz, Renato Ordones; Vieira, Ananda dos Santos] Univ Fed Mato Grosso, Hosp Vet, BR-78060900 Cuiaba, Brazil.
   [Sabino-Santos, Gilberto; Marques, Marcio Schafer; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Fac Med, Ctr Pesquisa Virol, BR-14025099 Ribeirao Preto, Brazil.
   [Santa Rita, Paula Helena; Lima, Marina Goncalves; Goncalves Alves, Fernanda de Cassia; Guimaraes Riquelme-Junior, Luiz Humberto; Batista Figueiro, Luan Luiz; Gomes de Santana, Matheus Fernandes] Univ Catolica Dom Bosco, Bioterio, BR-79117010 Campo Grande, MS, Brazil.
   [Gomes Barreto, Wanessa Teixeira; Rodrigues Oliveira Santos, Luiz Gustavo; Medeiros, Samara Serra; Seino, Larissa Lopes] Univ Fed Mato Grosso do Sul UFMS, Lab Ecol Populacoes & Movimento, Programa Ecol & Conservacao, BR-79070900 Campo Grande, MS, Brazil.
   [Miranda, Emily Hime; Rezende Linhares, Jose Henrique; Santos, Vanessa de Oliveira; da Silva, Stephanie Almeida; Lucio, Kelly Araujo; Gomes, Viviane Silva; Barbosa de Lima, Sheila Maria] Fiocruz MS, Biomanguinhos, Lab Tecnol Virol, BR-21040900 Rio De Janeiro, Brazil.
   [Oliveira, Alexandre de Araujo; Silva, Julia dos Santos; Marques, William de Almeida; Fonseca Alencar, Jeronimo Augusto] Fiocruz MS, Inst Oswaldo Cruz, Lab Diptera, BR-21040900 Rio De Janeiro, Brazil.
   [Franca de Barros, Jose Junior; Campos, Leticia] Fiocruz MS, Inst Oswaldo Cruz, Lab Virol Mol, BR-21040900 Rio De Janeiro, Brazil.
   [Couto-Lima, Dinair] Fiocruz MS, Lab Transmissores Hematozoarios, Inst Oswaldo Cruz, BR-21040900 Rio De Janeiro, Brazil.
   [Netto, Claudia Coutinho] CRAS, BR-79037109 Campo Grande, MS, Brazil.
   [Strussmann, Christine; de Almeida, Julia Ramos; Ribeiro, Karen Ramos; Barros de Castro, Maria Carolina; Campos, Larissa Pratta; Rosa dos Santos, Ana Paula; de Souza, Isabelle Marino] Univ Fed Mato Grosso, Fac Med Vet, BR-78060900 Cuiaba, Brazil.
   [Panella, Nicholas; Hannon, Emily; Komar, Nicholas] US Ctr Dis Control & Prevent CDC, Arboviral Dis Branch, Lab Arbovirus Ecol, Ft Collins, CO 80521 USA.
   [de Macedo, Barbara Cristina] Univ Cuiaba UNIC, Fac Med Vet, BR-78065900 Cuiaba, Brazil.
   [Salyer, Stephanie; Montgomery, Joel] CDC, Global Epidemiol Lab, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA.
   [Salyer, Stephanie; Montgomery, Joel] CDC, Surveillance Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA.
RP Pauvolid-Correa, A (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.; Komar, N (corresponding author), US Ctr Dis Control & Prevent CDC, Arboviral Dis Branch, Lab Arbovirus Ecol, Ft Collins, CO 80521 USA.
EM pauvolid@gmail.com; helvergd@gmail.com; lauramsmaia@gmail.com;
   grasi_porfirio@hotmail.com; thaismorgado@gmail.com; sabinogsj@usp.br;
   paulabiovet@ucdb.br; wanessatgbarreto@gmail.com;
   carvalhodemacedo@gmail.com; jairemarinho@hotmail.com;
   wesley_anantes@hotmail.com; filipemsantos@outlook.com;
   william.oliveira.assis@gmail.com; drezacastro.rucco@hotmail.com;
   rafayui99@gmail.com; bjoaocampos@gmail.com; renatorleandro@gmail.com;
   rah.kell_@hotmail.com; nilvanei@hotmail.com;
   michellcharlles2021@gmail.com; le_ramos@hotmail.com;
   emersonesem@gmail.com; michellengalex@gmail.com;
   marina-lima94@outlook.com; fdecassia.alves@gmail.com;
   bioriquelme@gmail.com; llb.figueiro@gmail.com;
   matheussantana_21@hotmail.com; gu_tapirus@hotmail.com;
   samarabio2013@gmail.com; larissalopesseino@hotmail.com;
   emily@bio.fiocruz.br; jose.henrique@bio.fiocruz.br;
   vanessa.oliveira@bio.fiocruz.br; stephanie.silva@bio.fiocruz.br;
   kelly.araujo@bio.fiocruz.br; viviane.gomes@bio.fiocruz.br;
   alexandre.bio.br@gmail.com; juliass@ioc.fiocruz.br;
   wmarques.bio@gmail.com; marcioschafer@msn.com; barros@ioc.fiocruz.br;
   leticia_bonfim1998@hotmail.com; dcouto@ioc.fiocruz.br;
   ccoutinhonetto@gmail.com; christrussmann@gmail.com; nap4@cdc.gov;
   hannon.emily.r@gmail.com; barbara_cm02macedo@hotmail.com;
   juh.ramos97@gmail.com; ramosrkaren@gmail.com; m.carolinac@outlook.com;
   larissapratta@gmail.com; anapaula.santosrosa@hotmail.com;
   isamarinodesouza@gmail.com; assisbianchini@gmail.com;
   correasandrahelena@gmail.com; renato.ordones@outlook.com;
   ananda.asv@gmail.com; lmopnogueira@gmail.com; naideazeredo@gmail.com;
   ltmfigue@fmrp.usp.br; jafalencar@gmail.com; smaria@bio.fiocruz.br;
   herrera@ucdb.br; renatadezengrini@yahoo.com.br; flaviab@ioc.fiocruz.br;
   abispo@ioc.fiocruz.br; wig9@cdc.gov; ztq9@cdc.gov; nck6@cdc.gov
RI Nantes, Wesley/AAQ-7412-2020; Torres, Jaire M/W-3898-2017;
   Oliveira-Santos, Luiz Gustavo Rodrigu G R/F-9562-2012; G, Sabino-Santos
   Jr/Q-5164-2019; Porfirio, Grasiela/F-3353-2019; Pauvolid-Correa,
   Alex/D-3643-2017; Herrera, Heitor/K-3759-2012; Strussmann,
   Christine/D-5971-2013; Martins Santos, Filipe/P-2156-2014
OI Nantes, Wesley/0000-0002-3454-4714; Torres, Jaire M/0000-0001-6228-6161;
   Oliveira-Santos, Luiz Gustavo Rodrigu G R/0000-0001-9632-5173; G,
   Sabino-Santos Jr/0000-0002-5462-5386; da S. Ferreira,
   Raquel/0000-0002-0969-1392; Barbosa de Lima, Sheila
   Maria/0000-0001-9234-1678; Slhessarenko, Renata/0000-0002-3246-899X;
   Porfirio, Grasiela/0000-0003-0837-7489; Salyer,
   Stephanie/0000-0001-7679-2006; Barros, Jose/0000-0002-4288-8680; Dias,
   Helver/0000-0001-5181-7078; de Araujo Oliveira,
   Alexandre/0000-0003-1289-8172; Pauvolid-Correa,
   Alex/0000-0002-6924-157X; Herrera, Heitor/0000-0003-2404-8765; Santos,
   Flavia/0000-0002-1309-5366; Strussmann, Christine/0000-0001-9880-9489;
   Martins Santos, Filipe/0000-0003-2032-8129
FU Office of Infectious Disease, Bureau for Global Health, U.S. Agency for
   International Development (USAID)United States Agency for International
   Development (USAID); USAIDUnited States Agency for International
   Development (USAID); Health Surveillance and Reference Laboratories
   (CVSLR) of Fiocruz
FX This research was funded by the Office of Infectious Disease, Bureau for
   Global Health, U.S. Agency for International Development (USAID), and
   the APC was funded by USAID and the Health Surveillance and Reference
   Laboratories (CVSLR) of Fiocruz.
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Beaty B.J., 1995, DIAGNOSTIC PROCEDURE, P189
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto SR, 2019, ECOHEALTH, V16, P61, DOI 10.1007/s10393-019-01394-7
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Forattini OP., 2002, CULICIDOLOGIA MED, P860
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Iwashita H, 2018, TROP MED HEALTH, V46, DOI 10.1186/s41182-018-0095-8
   Johnson BW, 2009, CLIN VACCINE IMMUNOL, V16, P1052, DOI 10.1128/CVI.00095-09
   Karabatsos N., 1985, INT CATALOGUE ARBOVI, P1147
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lane J., 1953, NEOTROPICAL CULICIDA, V2, P1660
   LVOV DK, 2014, VOP VIRUSOL, V59, P18
   Machado NG, 2017, NATIVA, V5, P320, DOI 10.5935/2318-7670.v05n05a04
   Ferreira CMM, 2010, BIOTA NEOTROP, V10, P155, DOI 10.1590/S1676-06032010000300017
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MILLS JN, 1995, J MAMMAL, V76, P716, DOI 10.2307/1382742
   Ministry of Health (Ministerio da Saude), 2018, B EPIDEMIOLOGICO, V2
   Ministry of Health (Ministerio da Saude), 2019, B EPIDEMIOLOGICO, V4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Figueiredo LTM, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00259
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00523-17, 10.1128/msphere.00523-17]
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Pauvolid-Correa A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006014
   Pauvolid-Correa A, 2015, ARCH VIROL, V160, P21, DOI 10.1007/s00705-014-2219-8
   Pauvolid-Correa A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002706
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
NR 41
TC 3
Z9 3
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2019
VL 11
IS 12
AR 1164
DI 10.3390/v11121164
PG 18
WC Virology
SC Virology
GA KC0RH
UT WOS:000506894800036
PM 31888285
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Nunes, PCG
   Rioja, LD
   Coelho, JMCD
   Salomao, NG
   Rabelo, K
   Jose, CC
   Rodrigues, FDD
   de Azeredo, EL
   Basilio-de-Oliveira, CA
   Basilio-de-Oliveira, R
   Nogueira, RMR
   Sanchez-Arcila, JC
   dos Santos, FB
   Paes, MV
AF Guerra Nunes, Priscila Conrado
   Rioja, Lilimar da Silveira
   Chicarino de Oliveira Coelho, Janice Mery
   Salomao, Natalia Gedeao
   Rabelo, Kissila
   Jose, Carollina Ceia
   de Carvalho Rodrigues, Francisco das Chagas
   de Azeredo, Elzinandes Leal
   Basilio-de-Oliveira, Carlos Alberto
   Basilio-de-Oliveira, Rodrigo
   Ribeiro Nogueira, Rita Maria
   Sanchez-Arcila, Juan Camilo
   dos Santos, Flavia Barreto
   Paes, Marciano Viana
TI Renal Injury in DENV-4 Fatal Cases: Viremia, Immune Response and
   Cytokine Profile
SO PATHOGENS
LA English
DT Article
DE dengue 4; fatal case; viremia; histopathology; cytokines; inflammatory
   mediators
ID ACUTE KIDNEY INJURY; DENGUE HEMORRHAGIC-FEVER; ACUTE TUBULAR-NECROSIS;
   VIRUS; FAILURE; RHABDOMYOLYSIS; HYALINOSIS; PATIENT; PROTEIN; IMPACT
AB Dengue virus (DENV) infections may result in asymptomatic cases or evolve into a severe disease, which involves multiple organ failure. Renal involvement in dengue can be potentially related to an increased mortality. Aiming to better understand the role of DENV in renal injury observed in human fatal cases, post-mortem investigations were performed in four DENV-4 renal autopsies during dengue epidemics in Brazil. Tissues were submitted to histopathology, immunohistochemistry, viral quantification, and characterization of cytokines and inflammatory mediators. Probably due the high viral load, several lesions were observed in the renal tissue, such as diffuse mononuclear infiltration around the glomerulus in the cortical region and in the medullary vessels, hyalinosis arteriolar, lymphocytic infiltrate, increased capsular fibrosis, proximal convoluted tubule (PCT) damage, edema, PCT debris formation, and thickening of the basal vessel membrane. These changes were associated with DENV-4 infection, as confirmed by the presence of DENV-specific NS3 protein, indicative of viral replication. The exacerbated presence of mononuclear cells at several renal tissue sites culminated in the secretion of proinflammatory cytokines and chemokines. Moreover, it can be suggested that the renal tissue injury observed here may have been due to the combination of both high viral load and exacerbated host immune response.
C1 [Guerra Nunes, Priscila Conrado; de Azeredo, Elzinandes Leal; dos Santos, Flavia Barreto] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunol Viral, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Rioja, Lilimar da Silveira] Univ Estado Rio De Janeiro, Dept Patol & Lab, BR-20550170 Rio De Janeiro, RJ, Brazil.
   [Chicarino de Oliveira Coelho, Janice Mery; de Carvalho Rodrigues, Francisco das Chagas] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Nacl Infectol, Lab Anat Patol, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Salomao, Natalia Gedeao; Jose, Carollina Ceia; Paes, Marciano Viana] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Rabelo, Kissila] Univ Estado Rio De Janeiro, Lab Ultraestrutura & Biol Tecidual, BR-20550170 Rio De Janeiro, RJ, Brazil.
   [Basilio-de-Oliveira, Carlos Alberto; Basilio-de-Oliveira, Rodrigo] Univ Fed Estado Rio De Janeiro, Anat Patol, BR-20270004 Rio De Janeiro, RJ, Brazil.
   [Ribeiro Nogueira, Rita Maria] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Sanchez-Arcila, Juan Camilo] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA.
RP Nunes, PCG (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunol Viral, BR-21040900 Rio De Janeiro, RJ, Brazil.; Paes, MV (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM pricgn@ioc.fiocruz.br; lilimar.rioja@gmail.com;
   janice.coelho@ini.fiocruz.br; natgsalomao@gmail.com;
   kissilarabelo91@gmail.com; carollina.ceia@gmail.com;
   francisco.rodrigues@ini.fiocruz.br; elzinandes@ioc.fiocruz.br;
   basiliopatologia@br.inter.net; rodrigopboliveira@gmail.com;
   ritanog72@gmail.com; juancamilos@gmail.com; flaviab@ioc.fiocruz.br;
   marciano@ioc.fiocruz.br
OI Santos, Flavia/0000-0002-1309-5366; Paes, Marciano/0000-0002-2266-2801;
   Rabelo, Kissila/0000-0001-7579-7788; Sanchez-Arcila, Juan
   Camilo/0000-0002-6879-4439; Nunes, Priscila/0000-0002-4841-9308
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/202.003/2016]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [302462/2018-0];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); NATIONAL EYE INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R01EY026202, R01EY026202, R01EY026202,
   R01EY026202, R01EY026202] Funding Source: NIH RePORTER
FX This study was supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro FAPERJ to F.B.S., grant number E-26/202.003/2016; to
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   grant number 302462/2018-0 to F.B.S.; and to Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and CNPq for the
   students fellowship. The funders had no role in the study design, data
   collection, analysis, and decision to publish or preparation of the
   manuscript.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   [Anonymous], 2015, MINIST SAUDE SECR VI
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Basílio-de-Oliveira C.A., 2005, Braz J Infect Dis, V9, P341, DOI 10.1590/S1413-86702005000400012
   Basu G, 2011, NEPHROL DIAL TRANSPL, V26, P524, DOI 10.1093/ndt/gfq477
   BOONPUCKNAVIG V, 1976, ARCH PATHOL LAB MED, V100, P206
   Chapman J, 2006, NAT CLIN PRACT NEPHR, V2, P622, DOI 10.1038/ncpneph0322
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Faria NRD, 2017, AM J TROP MED HYG, V97, P137, DOI 10.4269/ajtmh.16-0227
   Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507
   GLASSOCK RJ, 1991, KIDNEY INT, V40, pS5
   Nunes PCG, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3255-x
   Guzman M G, 1999, Int J Infect Dis, V3, P130, DOI 10.1016/S1201-9712(99)90033-4
   Heringer M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2488-4
   Hommel D, 1999, NEPHRON, V83, P183, DOI 10.1159/000045506
   Huang SY, 2015, AM J TROP MED HYG, V92, P75, DOI 10.4269/ajtmh.14-0343
   Hunley Tracy E, 2010, Curr Opin Nephrol Hypertens, V19, P227, DOI 10.1097/MNH.0b013e3283374c09
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kabra SK, 1998, NATL MED J INDIA, V11, P59
   Khalil MAM, 2012, CLIN KIDNEY J, V5, P390, DOI 10.1093/ckj/sfs117
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kularatne S. A. M., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P686
   Kuo MC, 2008, CLIN J AM SOC NEPHRO, V3, P1350, DOI 10.2215/CJN.00020108
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Laoprasopwattana K, 2010, J PEDIATR-US, V157, P303, DOI 10.1016/j.jpeds.2010.02.008
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Lizarraga KJ, 2015, CLIN NEPHROL, V83, P104, DOI 10.5414/CN108217
   Malavige G N, 2007, Indian J Med Microbiol, V25, P143
   Mallhi TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138465
   Mehra N, 2012, TROP DOCT, V42, P160, DOI 10.1258/td.2012.120023
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mohsin N, 2009, RENAL FAILURE, V31, P736, DOI 10.3109/08860220903003404
   Nejat M, 2012, KIDNEY INT, V81, P1254, DOI 10.1038/ki.2012.23
   OLSON JL, 1985, LAB INVEST, V52, P387
   Pagliari C, 2016, J CLIN VIROL, V75, P16, DOI 10.1016/j.jcv.2015.12.005
   PAHO, OPAS OMS BRAS MIN SA
   Pancharoen C, 2002, J MED ASS THAI S1, V85, P298
   Oliveira JFP, 2015, CLIN KIDNEY J, V8, P681, DOI 10.1093/ckj/sfv106
   Povoa TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168973
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   R Core Team, 2011, R LANG ENV STAT COMP
   Repizo LP, 2014, REV INST MED TROP SP, V56, P85, DOI 10.1590/S0036-46652014000100014
   Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Upadhaya BK, 2010, SAUDI J KIDNEY DIS T, V21, P521
   Vasanwala FF, 2009, SINGAP MED J, V50, pE253
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Wiersinga WJ, 2006, CLIN INFECT DIS, V43, P800, DOI 10.1086/507111
   Wiwanitkit V, 2005, RENAL FAILURE, V27, P647, DOI 10.1080/08860220500200916
   WORLD HEALTH ORGANIZATION (WHO); Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
NR 51
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD DEC
PY 2019
VL 8
IS 4
AR 223
DI 10.3390/pathogens8040223
PG 11
WC Microbiology
SC Microbiology
GA KB7DX
UT WOS:000506652300066
PM 31703246
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Nunes, PCG
   Sanchez-Arcila, JC
   Nogueira, RMR
   Lima, MRQ
   dos Santos, FBS
AF Nunes, P. C. G.
   Sanchez-Arcila, J. C.
   Nogueira, R. M. R.
   Lima, M. R. Q.
   dos Santos, F. B. S.
TI 30 YEARS OF DENGUE FATAL DENGUE CASES IN BRAZIL
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Nunes, P. C. G.; Sanchez-Arcila, J. C.; Lima, M. R. Q.; dos Santos, F. B. S.] Fiocruz MS, Oswaldo Cruz Inst, LIV, Rio De Janeiro, Brazil.
   [Nogueira, R. M. R.] Fiocruz MS, Oswaldo Cruz Inst, Flavivirus Lab LABFLA, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD SEP
PY 2019
VL 113
SU 1
SI SI
MA A048
BP S264
EP S264
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JH9CH
UT WOS:000493064400652
DA 2020-12-09
ER

PT J
AU Salomao, N
   Souza, LJ
   Rabelo, K
   Lima, M
   Nunes, P
   Sales, AP
   Portari, E
   dos Santos, F
   Paes, M
AF Salomao, Natalia
   Souza, Luiz Jose
   Rabelo, Kissila
   Lima, Monique
   Nunes, Priscila
   Sales, Anna Paula
   Portari, Elyzabeth
   dos Santos, Flavia
   Paes, Marciano
TI PLACENTAL INJURY OF A PREGNANT WOMAN INFECTED WITH CHIKUNGUNYA IN THE
   THIRD TRIMESTER OF GESTATION
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 21-24, 2018
CL Tokyo, JAPAN
SP Int Federat Placenta Assoc
C1 [Salomao, Natalia; Lima, Monique; Nunes, Priscila; dos Santos, Flavia; Paes, Marciano] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Souza, Luiz Jose; Sales, Anna Paula] Hosp Plantadores Cana CRDI, Campos Dos Goytacazes, Brazil.
   [Rabelo, Kissila] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
   [Portari, Elyzabeth] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
OI Paes, Marciano/0000-0002-2266-2801; Rabelo, Kissila/0000-0001-7579-7788
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2019
VL 83
MA P2.74
BP E90
EP E90
DI 10.1016/j.placenta.2019.06.286
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA IV0WE
UT WOS:000483998500284
DA 2020-12-09
ER

PT J
AU Nunes, P
   Nogueira, R
   Coelho, J
   Rodrigues, F
   Salomao, N
   Jose, C
   de Carvalho, J
   Rabelo, K
   de Azeredo, E
   Basilio-de-Oliveira, R
   Basilio-de-Oliveira, C
   dos Santos, F
   Paes, M
AF Nunes, Priscila
   Nogueira, Rita
   Coelho, Janice
   Rodrigues, Francisco
   Salomao, Natalia
   Jose, Carollina
   de Carvalho, Jorge
   Rabelo, Kissila
   de Azeredo, Elzinandes
   Basilio-de-Oliveira, Rodrigo
   Basilio-de-Oliveira, Carlos
   dos Santos, Flavia
   Paes, Marciano
TI A Stillborn Multiple Organs' Investigation from a Maternal DENV-4
   Infection: Histopathological and Inflammatory Mediators Characterization
SO VIRUSES-BASEL
LA English
DT Article
DE dengue 4; pregnancy; fetal death; cytokines; inflammatory mediators
ID DENGUE VIRUS-INFECTIONS; T-CELL RESPONSES; RIO-DE-JANEIRO;
   HEMORRHAGIC-FEVER; INTERFERON-GAMMA; PREGNANCY; ANTIBODIES; BRAZIL;
   KINETICS; PLACENTA
AB Dengue virus (DENV) is an emerging virus involved in outbreaks in Brazil. The association between the virus and vertical transmission, with disorders in the placenta, has raised a worldwide concern. On the 29th gestational week, a pregnant woman presented severe complications due to a DENV infection leading to maternal and fetus death. Postmortem analysis of fetal organs demonstrated the presence of DENV using reverse transcriptase polymerase chain reaction (RT-PCR) in the fetal brain and DENV non-structural protein 3 (NS3) staining in placenta and several peripheral fetal tissues, such as the brain, liver, lungs, and spleen. Histological analysis of the placenta and fetal organs revealed different types of tissue abnormalities, which included inflammation, hemorrhage, edema, and necrosis in placenta and tissue disorganization in the fetus, such as spongiform parenchyma, microglial inflammation, steatosis, hyalinose arteriolar, inflammatory cells in the alveolar septa, and disorganization of the lymphoid follicle. Increased cellularity (macrophage, Hofbauer cells and TCD8+ lymphocytes) and up-regulation of inflammatory mediators such as IFN-, TNF-, RANTES/CCL5, MCP1/CCL2, and VEGF/R2 were detected in the liver, lung, spleen, brain, and placenta, supporting placental and fetus peripheral tissues inflammation. Maternal infection leading to the production of those vascular mediators may alter the vascular permeability, facilitating the virus entry and tissue and barrier dysfunction.
C1 [Nunes, Priscila; de Azeredo, Elzinandes; dos Santos, Flavia] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunol Viral, BR-21040900 Rio De Janeiro, Brazil.
   [Nogueira, Rita] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
   [Coelho, Janice; Rodrigues, Francisco] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Nacl Infectol, Lab Anat Patol, BR-21040900 Rio De Janeiro, Brazil.
   [Salomao, Natalia; Jose, Carollina; Paes, Marciano] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21040900 Rio De Janeiro, Brazil.
   [de Carvalho, Jorge; Rabelo, Kissila] Univ Estado Rio De Janeiro, Lab Ultraestrutura & Biol Tecidual, BR-20551030 Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, Rodrigo; Basilio-de-Oliveira, Carlos] Univ Fed Estado Rio De Janeiro, Anat Patol, BR-20270901 Rio De Janeiro, Brazil.
RP Paes, M (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21040900 Rio De Janeiro, Brazil.
EM pricgn@ioc.fiocruz.br; ritanog72@gmail.com;
   janice.coelho@ini.fiocruz.br; francisco.rodrigues@ini.fiocruz.br;
   natgsalomao@gmail.com; carollina.ceia@gmail.com; jjcarv@gmail.com;
   kissilarabelo91@gmail.com; elzinandes@ioc.fiocruz.br;
   rodrigopboliveira@gmail.com; basiliopatologia@br.inter.net;
   flaviab@ioc.fiocruz.br; marciano@ioc.fiocruz.br
OI Paes, Marciano/0000-0002-2266-2801; Rabelo, Kissila/0000-0001-7579-7788;
   Santos, Flavia/0000-0002-1309-5366; Nunes, Priscila/0000-0002-4841-9308;
   Carvalho, Jorge/0000-0002-9426-6381
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPqNational Council for Scientific and Technological
   Development (CNPq) [303822/2015-5, 155798/2014-6]; Programa Estrategico
   de Pesquisa em Saude/PAPES VI-FIOCRUZ [407690/2012-3]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.003/2016]; Brazilian Ministry of Health; FIOCRUZ; NATIONAL EYE
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R01EY026202, R01EY026202, R01EY026202] Funding Source: NIH RePORTER
FX To Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq
   [grant number 303822/2015-5 and 155798/2014-6] and Programa Estrategico
   de Pesquisa em Saude/PAPES VI-FIOCRUZ [grant number 407690/2012-3], to
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), to
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ to FBS
   grant number E-26/202.003/2016, to FIOCRUZ, and Brazilian Ministry of
   Health.
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Agarwal K, 2017, INT J GYNECOL OBSTET, V139, P4, DOI 10.1002/ijgo.12245
   Ahsan J, 2018, JCPSP-J COLL PHYSICI, V28, pS137, DOI 10.29271/jcpsp.2018.06.S137
   Aldinucci D, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/292376
   [Anonymous], PAHO WHO DAT ENG CAS
   Argolo AFLT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-254
   Basílio-de-Oliveira C.A., 2005, Braz J Infect Dis, V9, P341, DOI 10.1590/S1413-86702005000400012
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   BHAMARAP.N, 1967, ANN TROP MED PARASIT, V61, P500, DOI 10.1080/00034983.1967.11686519
   Bhaskar E, 2012, J INFECT DEV COUNTR, V6, P369
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Brasil P, 2017, LANCET INFECT DIS, V17, P885, DOI 10.1016/S1473-3099(17)30298-0
   BURKE T, 1968, T ROY SOC TROP MED H, V62, P682, DOI 10.1016/0035-9203(68)90120-X
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Feitoza HAC, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311x00178915, 10.1590/0102-311X00178915]
   Chansamouth V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004577
   Coyne CB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005515
   de-Oliveira-Pinto LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038527
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   do Nascimento LB, 2017, EPIDEMIOL SERV SAUDE, V26, P433, DOI [10.5123/S1679-49742017000300002, 10.5123/s1679-49742017000300002]
   Gagnon SJ, 1999, J VIROL, V73, P3623, DOI 10.1128/JVI.73.5.3623-3629.1999
   Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200
   Goldenberg RL, 2017, LANCET INFECT DIS, V17, P886, DOI 10.1016/S1473-3099(17)30455-3
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Nunes PCG, 2016, J MED VIROL, V88, P1448, DOI 10.1002/jmv.24479
   Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012
   Heringer M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2488-4
   Huerre MR, 2001, VIRCHOWS ARCH, V438, P107
   Kariyawasam S, 2010, J INFECT DEV COUNTR, V4, P767, DOI 10.3855/jidc.908
   Kubelka CF, 2010, J INFECTION, V61, P501, DOI 10.1016/j.jinf.2010.09.020
   KURANE I, 1989, J CLIN INVEST, V83, P506, DOI 10.1172/JCI113911
   Kurane Ichiro, 2011, Trop Med Health, V39, P45, DOI 10.2149/tmh.2011-S09
   La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee YH, 2016, J GEN VIROL, V97, P3103, DOI 10.1099/jgv.0.000637
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/j.jcv.2014.02.009, 10.1016/J.JCV.2014.02.009]
   Leon-Juarez Moises, 2017, Pathog Dis, V75, DOI 10.1093/femspd/ftx093
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Salgado DM, 2010, PEDIATR INFECT DIS J, V29, P238, DOI 10.1097/INF.0b013e3181bc3c5b
   McClure EM, 2009, SEMIN FETAL NEONAT M, V14, P182, DOI 10.1016/j.siny.2009.02.003
   Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774
   MS, 2016, DENG DIAGN MAN CLIN
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Paixao ES, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28387-w
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Povoa TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168973
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704
   Rao Sachin, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2012-008229
   Ribeiro CF, 2017, INT J INFECT DIS, V55, P109, DOI 10.1016/j.ijid.2017.01.002
   Ribeiro CF, 2016, REV INST MED TROP SP, V58, DOI 10.1590/S1678-9946201658008
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   SES/SINAN Boletim Epidemiologico, 2013, SES SINAN B EPIDEMIO
   Setlik RF, 2004, SOUTH MED J, V97, P688, DOI 10.1097/00007611-200407000-00015
   Sharma Swati, 2016, Infect Dis Obstet Gynecol, V2016, P5046091, DOI 10.1155/2016/5046091
   Srikiatkhachorn A, 2007, J VIROL, V81, P1592, DOI 10.1128/JVI.01642-06
   Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
   Dat TT, 2018, NAGOYA J MED SCI, V80, P241, DOI [10.18999/nagims.80.2.241, 10.18999/nagjms.80.2.241]
   Tseng CS, 2005, FEMS IMMUNOL MED MIC, V43, P99, DOI 10.1016/j.femsim.2004.10.004
   Wakimoto MD, 2015, EXPERT REV ANTI-INFE, V13, P1441, DOI 10.1586/14787210.2015.1100534
   WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D
   World Health Organization (WHO), DENG SEV DENG
   WORLD HEALTH ORGANIZATION (WHO); Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
   Yamada M, 2003, ARTERIOSCL THROM VAS, V23, P1996, DOI 10.1161/01.ATV.0000096208.80992.63
NR 71
TC 4
Z9 4
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2019
VL 11
IS 4
AR 319
DI 10.3390/v11040319
PG 14
WC Virology
SC Virology
GA HX3RS
UT WOS:000467310600016
PM 30986974
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Carvalho, FR
   Medeiros, T
   Vianna, RAD
   Douglass-Jaimes, G
   Nunes, PCG
   Quintans, MDS
   Souza, CF
   Cavalcanti, SMB
   dos Santos, FB
   de Oliveira, SA
   Cardoso, CAA
   Silva, AA
AF Carvalho, Fabiana Rabe
   Medeiros, Thalia
   de Oliveira Vianna, Renata Artimos
   Douglass-Jaimes, Guillermo
   Guerra Nunes, Priscila Conrado
   Salgado Quintans, Maria Dolores
   Souza, Cintia Fernandes
   Baeta Cavalcanti, Silvia Maria
   dos Santos, Flavia Barreto
   de Oliveira, Solange Artimos
   Araujo Cardoso, Claudete Aparecida
   Silva, Andrea Alice
TI Simultaneous circulation of arboviruses and other congenital infections
   in pregnant women in Rio de Janeiro, Brazil
SO ACTA TROPICA
LA English
DT Article
DE Arboviruses; Vertical transmission of infectious disease; Pregnancy
ID CHIKUNGUNYA VIRUS-INFECTION; ANTIBODY KINETICS; EPIDEMIC; DENGUE
AB Background: Arboviruses (Zika, dengue and chikungunya) represent a major risk for pregnant women, especially because their vertical transmission can lead to neurological damage in newborns. Early diagnosis can be difficult due to similar clinical presentation with other congenital infections that are associated with congenital abnormalities.
   Objectives: To investigate the circulation of arboviruses and other pathogens responsible for congenital infections, reporting clinical aspects and geographic distribution of maternal rash in a metropolitan region of Rio de Janeiro (Brazil).
   Methods: Cross-sectional study with pregnant women presenting rash attended at the Exanthematic Diseases Unit (Niteroi, Rio de Janeiro) from 2015 to 2018. Diagnosis of arboviruses was performed by real-time PCR (RT-qPCR) and laboratorial screening for syphilis, toxoplasmosis, rubella, cytomegalovirus and HIV was assessed. Demographic data was used for georeferencing analysis.
   Findings: We included 121 pregnant women, of whom Zika virus was detected in 45 cases (37.2%), chikungunya in 33 (27.3%) and dengue in one (0.8%). Five patients presented syphilis, and we observed one case each of listeria, cytomegalovirus, and a syphilis-toxoplasmosis case. Similarity of clinical symptoms was observed in all groups; however, 84.8% of patients with chikungunya presented arthralgia. Following the decline of Zika cases, chikungunya infection was mostly observed during 2017-2018. Considering pregnant women infected with arboviruses and other infections, 41% resided in urban slums, mostly in Niteroi.
   Main conclusions: Simultaneous circulation of arboviruses and other agents responsible for congenital infections were observed; however, we did not identify co-infections between arboviruses. In this scenario, we emphasize the importance of adequate prenatal care to provide an accurate diagnosis of maternal rash.
C1 [Carvalho, Fabiana Rabe; Medeiros, Thalia; de Oliveira Vianna, Renata Artimos; Souza, Cintia Fernandes; Araujo Cardoso, Claudete Aparecida; Silva, Andrea Alice] Univ Fed Fluminense, Fac Med, Lab Multiusuario Apoio Pesquisa Nefrol & Ciencias, Niteroi, RJ, Brazil.
   [Douglass-Jaimes, Guillermo] Pomona Coll, Environm Anal Program, Claremont, CA 91711 USA.
   [Guerra Nunes, Priscila Conrado; dos Santos, Flavia Barreto] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Salgado Quintans, Maria Dolores; Araujo Cardoso, Claudete Aparecida] Univ Fed Fluminense, Fac Med, Dept Maternoinfantil, Niteroi, RJ, Brazil.
   [Baeta Cavalcanti, Silvia Maria] Univ Fed Fluminense, Inst Biomed, Dept Microbiol & Parasitol, Niteroi, RJ, Brazil.
   [de Oliveira, Solange Artimos] Univ Fed Fluminense, Fac Med, Dept Med Clin, Niteroi, RJ, Brazil.
   [Silva, Andrea Alice] Univ Fed Fluminense, Fac Med, Dept Patol, Niteroi, RJ, Brazil.
RP Silva, AA (corresponding author), Hosp Univ Antonio Pedro, Dept Patol, Lab Multiusuario Apoio Pesquisa Nefrol & Ciencias, Marques Parana 303, BR-24033900 Niteroi, RJ, Brazil.
EM fabianarc@id.uff.br; thaliamedeiros@id.uff.br; renatavianna03@gmail.com;
   guillermo.douglass-jaimes@pomona.edu; pricgn@ioc.fiocruz.br;
   mdsquintans@id.uff.br; cinttiafs@yahoo.com.br;
   silviacavalcanti67@gmail.com; flaviab@ioc.fiocniz.br;
   sartimos@id.uff.br; claudetecardoso@id.uff.br; aasilva@id.uff.br
RI Medeiros, Thalia/F-4007-2018; Silva, Andrea Alice/J-6729-2012; amsalu,
   ribka/G-8780-2019
OI Medeiros, Thalia/0000-0002-5642-4027; Silva, Andrea
   Alice/0000-0001-5856-6128; Santos, Flavia/0000-0002-1309-5366; Souza,
   Cintia/0000-0001-6068-5097
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPESCAPES
   [D035.117.001/ D035.117.003/D014.216.001]; Pro-reitoria de Pos-graduacao
   Pesquisa e Inovacao from the Universidade Federal Fluminense
   (Proppi/UFF)
FX This work was supported by the Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior - CAPES (D035.117.001/ D035.117.003/D014.216.001) and
   by the Pro-reitoria de Pos-graduacao Pesquisa e Inovacao from the
   Universidade Federal Fluminense (Proppi/UFF).
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brazil: Ministry of Health, 2018, EP B SYPH, V48
   Brazil: Ministry of Health, 2007, 1 SEM PART MAN FOR M
   Brazil: Ministry of Health, 2017, INT GUID SURV HLTH C
   Contopoulos-Ioannidis D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006510
   Dotters-Katz SK, 2015, OBSTET GYNECOL SURV, V70, P453, DOI 10.1097/OGX.0000000000000184
   Escobar M, 2017, EMERG INFECT DIS, V23, P1777, DOI 10.3201/eid2311.170480
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Ingall D, 2006, INFECT DIS FETUS NEW, P643
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   da Silva DAL, 2016, J FOOD PROTECT, V79, P628, DOI 10.4315/0362-028X.JFP-15-482
   Lovero K., 2017, SUPER SPECIAL MOMS G
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Oliveira RG, 2018, BMC INFECT DIS, V18, P1
   Paixao ES, 2018, EMERG INFECT DIS, V24, P1748, DOI 10.3201/eid2409.170361
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Ramful D, 2014, J INFECT DIS, V209, P1726, DOI 10.1093/infdis/jit814
   Andaki ACR, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00105317, 10.1590/0102-311x00105317]
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Snyder RE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005287
   Domingues RMSM, 2012, CAD SAUDE PUBLICA, V28, P425, DOI 10.1590/S0102-311X2012000300003
   Van der Linden V., 2016, MMWR-MORBID MORTAL W, P1
   Watanaveeradej V, 2006, EMERG INFECT DIS, V12, P1770, DOI 10.3201/eid1211.051560
NR 29
TC 4
Z9 4
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD APR
PY 2019
VL 192
BP 49
EP 54
DI 10.1016/j.actatropica.2019.01.020
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HO9GE
UT WOS:000461268800006
PM 30685232
DA 2020-12-09
ER

PT J
AU Nunes, PCG
   Daumas, RP
   Sanchez-Arcila, JC
   Nogueira, RMR
   Horta, MAP
   dos Santos, FB
AF Guerra Nunes, Priscila Conrado
   Daumas, Regina Paiva
   Sanchez-Arcila, Juan Camilo
   Ribeiro Nogueira, Rita Maria
   Pereira Horta, Marco Aurelio
   dos Santos, Flavia Barreto
TI 30 years of fatal dengue cases in Brazil
SO BMC PUBLIC HEALTH
LA English
DT Review
DE Dengue mortality; Surveillance; 30 years; Brazil
ID RIO-DE-JANEIRO; HEMORRHAGIC-FEVER; EPIDEMIOLOGIC SURVEILLANCE; CASE
   CLASSIFICATION; DISEASE SEVERITY; CO-CIRCULATION; SHOCK SYNDROME; VIRUS
   TYPE-2; VIRAL LOAD; GENOTYPE-V
AB Background: Over the last 30 years, extensive dengue epidemics have occurred in Brazil, characterized by emergences and re-emergences of different serotypes, a change in the epidemiological profile and an increase in the number of severe and fatal cases. Here, we present a review on the dengue fatal cases that occurred in Brazil in 30 years (1986-2015).
   Methods: We performed an ecological study by using secondary data on dengue fatal cases obtained in the National System of Reported Diseases (Sistema de Informacao de Agravos de Notificacao -SINAN) and in the Mortality Information System (SIM), both maintained by the Brazilian Ministry of Health. Cases were analyzed by region, demographic variables, clinical classification and complications based on the data available.
   Results: In 30 years (1986-2015), the Southeast region reported 43% (n = 2225) of all dengue deaths in the country. The Midwest region was responsible for 18% of the fatal cases. After 2000, deaths occurred in almost all states, with the exception of Santa Catarina and Rio Grande do Sul, South region. From 2006 to 2010, the number of deaths increased, with higher rates of mortality, especially in Goias and Mato Grosso. From 2011 to 2015, Goias became the state with the highest mortality rate in the country, and Rio Grande do Sul reported its first dengue deaths. In 30 years, a total of 2682 dengue deaths occurred in males and 2455 in females, and an equal distribution between the sexes was observed. From 1986 to 2006, dengue deaths occurred predominantly in individuals over 15 years old, but this scenario changed in 2007-2008. After 2009, fatal cases on individuals above 15 years old became more frequent, with peaks in the years of 2010, 2013 and 2015.
   Conclusions: The Brazil is experiencing a hyperendemic scenario, which has resulted in the co-circulation of the four DENV serotypes and with the increasing occurrence of severe and fatal cases. The disease surveillance and studies characterizing what has been reported overtime, are still important tools to better understand the factors involved in the disease outcome.
C1 [Guerra Nunes, Priscila Conrado; Sanchez-Arcila, Juan Camilo; dos Santos, Flavia Barreto] Fiocruz MS, Oswaldo Cruz Fdn, Viral Immunol Lab, Oswaldo Cruz Inst,IOC, Ave Brasil 4365, Manguinho, RJ, Brazil.
   [Daumas, Regina Paiva] Fiocruz MS, Evandro Chagas Clin Res Inst, Clin Epidemiol Lab, Ave Brasil 4365, Manguinho, RJ, Brazil.
   [Ribeiro Nogueira, Rita Maria; Pereira Horta, Marco Aurelio] Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab LABFLA, Ave Brasil 4365, Manguinho, RJ, Brazil.
RP dos Santos, FB (corresponding author), Fiocruz MS, Oswaldo Cruz Fdn, Viral Immunol Lab, Oswaldo Cruz Inst,IOC, Ave Brasil 4365, Manguinho, RJ, Brazil.
EM flaviab@ioc.fiocruz.br
OI Santos, Flavia/0000-0002-1309-5366; Sanchez-Arcila, Juan
   Camilo/0000-0002-6879-4439
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPqNational Council for Scientific and Technological
   Development (CNPq) [302462/2018-0]; Priscila's Nunes fellowship
FX To Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq
   [grant number 302462/2018-0] and Priscila's Nunes fellowship. The funder
   had no role on the study design, data collection and analysis, data
   interpretation and in the decision to publish.
CR Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x
   Amancio FF, 2014, REV INST MED TROP SP, V56, P267, DOI 10.1590/S0036-46652014000300014
   Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476
   [Anonymous], 2005, GUIA DE VIGILANCIA E, pA15
   Araujo FMC, 2012, NEUROLOGY, V78, P736, DOI 10.1212/WNL.0b013e31824b94e9
   Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x
   Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106
   Barreto ML, 2008, LANCET, V372, P205, DOI 10.1016/S0140-6736(08)61069-7
   Basuki PS, 2010, SE ASIAN J TROP MED, V41, P1088
   Braga DNdeM, 2014, ASPECTOS LAB ANATOMO
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Cunha RV, 1999, T ROY SOC TROP MED H, V93, P247, DOI 10.1016/S0035-9203(99)90008-1
   Faria NRD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002095
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   Cavalcanti LPD, 2017, MEM I OSWALDO CRUZ, V112, P583, DOI 10.1590/0074-02760160537
   Cavalcanti LPD, 2016, AM J TROP MED HYG, V94, P187, DOI 10.4269/ajtmh.15-0392
   Cavalcanti LPD, 2014, MEM I OSWALDO CRUZ, V109, P93, DOI 10.1590/0074-0276140384
   Dettogni RS, 2015, HUM IMMUNOL, V76, P717, DOI 10.1016/j.humimm.2015.09.026
   Diaz-Quijano FA, 2015, TROP MED INT HEALTH, V20, P1403, DOI 10.1111/tmi.12542
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Figueiredo MAA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000699
   de Araujo JMG, 2009, J VIROL METHODS, V155, P34, DOI 10.1016/j.jviromet.2008.09.023
   Garcia G, 2011, INT J INFECT DIS, V15, pE38, DOI 10.1016/j.ijid.2010.09.008
   Nunes PCG, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3255-x
   Nunes PCG, 2016, J MED VIROL, V88, P1130, DOI 10.1002/jmv.24464
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   Horstick O, 2012, PATHOG GLOB HEALTH, V106, P94, DOI 10.1179/2047773212Y.0000000017
   Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676
   Khursheed M, 2013, J PAK MED ASSOC, V63, P670
   Lee Min-Sheng, 2006, Journal of Microbiology Immunology and Infection, V39, P121
   Leo YS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-123
   Macedo GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096314
   MARIANO Francisco, 1917, Arch. Brasileiros de Med., V7, P272
   Martinez-Vega RA, 2006, REV MED CHILE, V134, P1153, DOI 10.4067/S0034-98872006000900010
   Melo MA, 2018, RAU UEG REV ADM UEG, V9, P25
   Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774
   Morra ME, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1979
   MS (Ministerio da Saude), 2011, SAUD BRAS 2010 AN SI
   MS-Ministerio da Saude, 2009, DIR NAC PREV CONTR E
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nogueira MB, 2008, MEM I OSWALDO CRUZ, V103, P483, DOI 10.1590/S0074-02762008000500013
   Nogueira R. M. R., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P68
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   PAHO PAHO, 2017, REP CAS DENG FEV TH
   Paixao ES, 2015, REV SOC BRAS MED TRO, V48, P399, DOI 10.1590/0037-8682-0145-2015
   Pinto RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161884
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Thomas L, 2008, AM J TROP MED HYG, V78, P990
   Vasconcelos PFC, 1998, REV SAUDE PUBL, V32, P447, DOI 10.1590/S0034-89101998000500007
   Machado AAV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003104
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   World Health Organization, 2016, DENG SEV DENG FACT S
   WORLD HEALTH ORGANIZATION (WHO); Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
NR 66
TC 8
Z9 9
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAR 21
PY 2019
VL 19
AR 329
DI 10.1186/s12889-019-6641-4
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HQ2QC
UT WOS:000462245600001
PM 30898104
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU de Bruycker-Nogueira, F
   Souza, TMA
   Chouin-Carneiro, T
   Faria, NRD
   Santos, JB
   Torres, MC
   Ramalho, ILC
   de Aguiar, SF
   Nogueira, RMR
   de Filippis, AMB
   dos Santos, FB
AF de Bruycker-Nogueira, Fernanda
   Alves Souza, Thiara Manuele
   Chouin-Carneiro, Thais
   da Costa Faria, Nieli Rodrigues
   Santos, Jaqueline Bastos
   Torres, Maria Celeste
   Cavalcante Ramalho, Izabel Leticia
   de Aguiar, Shirlei Ferreira
   Ribeiro Nogueira, Rita Maria
   Bispo de Filippis, Ana Maria
   dos Santos, Flavia Barreto
TI DENV-1 Genotype V in Brazil: Spatiotemporal dispersion pattern reveals
   continuous co-circulation of distinct lineages until 2016
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DENGUE VIRUS 1; POPULATION-DYNAMICS; SURVEILLANCE; ALGORITHMS
AB In Brazil, DENV-1 introduced in the 80's, remained the prevalent serotype from 2012 to 2016. After its re-emergence in the country in 2009, the co-circulation of different viral lineages was identified, however, its transmission dynamics afterwards, was not fully characterized. In this study, we performed the continuous molecular surveillance after the reemergence period (2012 to 2016), covering the 30 years of circulation of DENV-1 in Brazil. Phylogenetic analysis allowed confirmation of the continued presence of genotype V, as well as three distinct co-circulating lineages. The molecular characterization of the E gene presented two new amino acid substitutions previously unidentified in the country. Phylogeographic analysis has shown that a large flow of migrations has occurred between Brazil and Argentina in the last 10 years.
C1 [de Bruycker-Nogueira, Fernanda; Alves Souza, Thiara Manuele; Chouin-Carneiro, Thais; dos Santos, Flavia Barreto] Oswaldo Cruz Inst FIOCRUZ, Viral Immunol Lab, Rio De Janeiro, Brazil.
   [da Costa Faria, Nieli Rodrigues; Santos, Jaqueline Bastos; Torres, Maria Celeste; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Oswaldo Cruz Inst FIOCRUZ, Flavivirus Lab, Rio De Janeiro, Brazil.
   [Cavalcante Ramalho, Izabel Leticia] Cent Lab Publ Hlth Ceara LACEN CE, Fortaleza, Ceara, Brazil.
   [de Aguiar, Shirlei Ferreira] Cent Lab Publ Hlth Rio de Janeiro LACEN RJ, Rio De Janeiro, Brazil.
RP de Bruycker-Nogueira, F; dos Santos, FB (corresponding author), Oswaldo Cruz Inst FIOCRUZ, Viral Immunol Lab, Rio De Janeiro, Brazil.
EM nandanog@ioc.fiocruz.br; flaviab@ioc.fiocruz.br
OI Santos, Flavia/0000-0002-1309-5366
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/202.003/2016]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [30382202015-5];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); NATIONAL EYE INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R01EY026202, R01EY026202] Funding Source:
   NIH RePORTER
FX To Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ to
   FBS grant number E-26/202.003/2016, to Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) grant number
   30382202015-5 to FBS, to Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) and CNPq for the students fellowships.
CR Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016
   Cunha MD, 2016, INFECT GENET EVOL, V43, P130, DOI 10.1016/j.meegid.2016.05.021
   de Bruycker-Nogueira F, 2016, INFECT GENET EVOL, V45, P454, DOI 10.1016/j.meegid.2016.09.025
   de Bruycker-Nogueira F, 2015, INFECT GENET EVOL, V34, P126, DOI 10.1016/j.meegid.2015.07.007
   dos Santos FB, 2013, DENGUE B, V37, P61
   dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Dutra KR, 2017, J MED VIROL, V89, P966, DOI 10.1002/jmv.24729
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226
   Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04
   Piersen TC, 2013, FIELDS VIROLOGY, P747
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rambaut A., 2012, FIGTREE 1 4 0
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   SVS, 2016, B EP MON CAS DENG FE, V16
   SVS/MS, 2018, SVS MS B EP
   SVS/MS, 2017, B EP MON CAS DENG FE, V52
   SVS/MS, 2015, B EP MON CAS DENG FE, V52
   SVS/MS, 2016, DENG SIT EP DAD
   Tittarelli E, 2017, EMERG INFECT DIS, V23, P1684, DOI 10.3201/eid2310.161718
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
NR 33
TC 2
Z9 2
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 21
PY 2018
VL 8
AR 17160
DI 10.1038/s41598-018-35622-x
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HB1FO
UT WOS:000450766300018
PM 30464188
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU de Souza, TMA
   Ribeiro, ED
   Correa, VCE
   Damasco, PV
   Santos, CC
   de Bruycker-Nogueira, F
   Chouin-Carneiro, T
   Faria, NRD
   Nunes, PCG
   Heringer, M
   Lima, MDQ
   Badolato-Correa, J
   Cipitelli, MD
   de Azeredo, EL
   Nogueira, RMR
   dos Santos, FB
AF Alves de Souza, Thiara Manuele
   Ribeiro, Edcelha D'Athaide
   Correa e Correa, Valmir
   Damasco, Paulo Vieira
   Santos, Carla Cunha
   de Bruycker-Nogueira, Fernanda
   Chouin-Carneiro, Thais
   da Costa Faria, Nieli Rodrigues
   Guerra Nunes, Priscila Conrado
   Heringer, Manoela
   Queiroz Lima, Monique da Rocha
   Badolato-Correa, Jessica
   Cipitelli, Marcio da Costa
   de Azeredo, Elzinandes Leal
   Ribeiro Nogueira, Rita Maria
   dos Santos, Flavia Barreto
TI Following in the Footsteps of the Chikungunya Virus in Brazil: The First
   Autochthonous Cases in Amapa in 2014 and Its Emergence in Rio de Janeiro
   during 2016
SO VIRUSES-BASEL
LA English
DT Article
DE chikungunya virus; surveillance; co-infection; ECSA genotype; Asian
   genotype; Brazil
ID PHYLOGENETIC ANALYSES; STRUCTURAL PROTEINS; DENGUE VIRUSES;
   INDIAN-OCEAN; INFECTION; EPIDEMIC; ARTHRALGIA; TRAVELERS; ZIKA;
   TRANSMISSION
AB Currently, Brazil lives a triple arboviruses epidemic (DENV, ZIKV and CHIKV) making the differential diagnosis difficult for health professionals. Here, we aimed to investigate chikungunya cases and the possible occurrence of co-infections during the epidemic in Amapa (AP) that started in 2014 when the first autochthonous cases were reported and in Rio de Janeiro (RJ) in 2016. We further performed molecular characterization and genotyping of representative strains. In AP, 51.4% of the suspected cases were confirmed for CHIKV, 71.0% (76/107). Of those, 24 co-infections by CHIKV/DENV, two by CHIKV/DENV-1, and two by CHIKV/DENV-4 were observed. In RJ, 76.9% of the suspected cases were confirmed for CHIKV and co-infections by CHIKV/DENV (n = 8) and by CHIKV/ZIKV (n = 17) were observed. Overall, fever, arthralgia, myalgia, prostration, edema, exanthema, conjunctival hyperemia, lower back pain, dizziness, nausea, retroorbital pain, and anorexia were the predominating chikungunya clinical symptoms described. All strains analyzed from AP belonged to the Asian genotype and no amino acid changes were observed. In RJ, the East-Central-South-African genotype (ECSA) circulation was demonstrated and no E1-A226V mutation was observed. Despite this, an E1-V156A substitution was characterized in two samples and for the first time, the E1-K211T mutation was reported in all samples analyzed.
C1 [Alves de Souza, Thiara Manuele; de Bruycker-Nogueira, Fernanda; Chouin-Carneiro, Thais; da Costa Faria, Nieli Rodrigues; Guerra Nunes, Priscila Conrado; Heringer, Manoela; Queiroz Lima, Monique da Rocha; Badolato-Correa, Jessica; Cipitelli, Marcio da Costa; de Azeredo, Elzinandes Leal; dos Santos, Flavia Barreto] Oswaldo Cruz Inst, Viral Immunol Lab, BR-21040360 Rio De Janeiro, Brazil.
   [Ribeiro, Edcelha D'Athaide] Lab Cent Amapa LACEN AP, BR-68908530 Macapa, Brazil.
   [Correa e Correa, Valmir] Lab Fronteira LAFRON, BR-69980000 Oiapoque, Amapa, Brazil.
   [Damasco, Paulo Vieira; Santos, Carla Cunha] Rio Laranjeiras Hosp, BR-22240000 Rio De Janeiro, Brazil.
   [Damasco, Paulo Vieira] Fed Univ State Rio de Janeiro, Gaffree Guinle Univ Hosp, BR-20270003 Rio De Janeiro, Brazil.
   [Damasco, Paulo Vieira] Univ Estado Rio De Janeiro, Pedro Ernesto Univ Hosp, BR-20551030 Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria] Oswaldo Cruz Inst, Flavivirus Lab, BR-21040360 Rio De Janeiro, Brazil.
RP dos Santos, FB (corresponding author), Oswaldo Cruz Inst, Viral Immunol Lab, BR-21040360 Rio De Janeiro, Brazil.
EM thiara.biomed@gmail.com; edcelhamanu@hotmail.com;
   paulovieiradamasco@gmail.com; ccih@fblo.com.br; nandanog@ioc.fiocruz.br;
   tatachouin@gmail.com; nielircf@ioc.fiocruz.br; pricgn@ioc.fiocruz.br;
   manoelaheringer@yahoo.com.br; moniqueq@ioc.fiocruz.br;
   jessica.badolato@ioc.fiocruz.br; marcio_cipitelli@ioc.fiocruz.br;
   elzinandes@ioc.fiocruz.br; rita@ioc.fiocruz.br; flaviab@ioc.fiocruz.br
RI /AAD-2097-2020
OI Santos, Flavia/0000-0002-1309-5366; Nunes, Priscila/0000-0002-4841-9308;
   Lima, Monique/0000-0001-9630-8736
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/110.843/2013, E-26/202.003/2016]; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [30382202015-5]; Financiadora de Estudos e Projetos FINEPCiencia
   Tecnologia e Inovacao (FINEP) [04.16.0058.00]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX This study was supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro FAPERJ to ELA grant number E-26/110.843/2013 and to FBS
   grant number E-26/202.003/2016, to Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) grant number 30382202015-5 to FBS, to
   Financiadora de Estudos e Projetos FINEP number 04.16.0058.00 to FBS, to
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and
   CNPq for the students fellowships. The funders had no role in the study
   design, data collection, analysis and decision to publish or preparation
   of the manuscript.
CR Agarwal A, 2016, VIROLOGY, V497, P59, DOI 10.1016/j.virol.2016.06.025
   Alla SAO, 2011, BEST PRACT RES CL RH, V25, P337, DOI 10.1016/j.berh.2011.03.005
   [Anonymous], SVS MS MONITORAMENTO
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Azeredo Elzinandes Leal, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   Bandyopadhyay D, 2008, INT J DERMATOL, V47, P1148, DOI 10.1111/j.1365-4632.2008.03817.x
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Chopra A, 2012, EPIDEMIOL INFECT, V140, P842, DOI 10.1017/S0950268811001300
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Collao X, 2010, AM J TROP MED HYG, V82, P505, DOI 10.4269/ajtmh.2010.09-0435
   Conteville LC, 2016, MEM I OSWALDO CRUZ, V111, P347, DOI 10.1590/0074-02760160004
   Correia JC, 2012, REV SAUDE PUBL, V46, P935, DOI 10.1590/S0034-89102013005000010
   Couturier E, 2012, RHEUMATOLOGY, V51, P1315, DOI 10.1093/rheumatology/kes015
   de Andrade DC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-31
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Essackjee K, 2013, POSTGRAD MED J, V89, P440, DOI 10.1136/postgradmedj-2012-131477
   FOURIE ED, 1979, S AFR MED J, V56, P130
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   GILOTRA SK, 1967, AM J EPIDEMIOL, V86, P379, DOI 10.1093/oxfordjournals.aje.a120748
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kucharz EJ, 2012, EUR J INTERN MED, V23, P325, DOI 10.1016/j.ejim.2012.01.009
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Larrieu S, 2010, J CLIN VIROL, V47, P85, DOI 10.1016/j.jcv.2009.11.014
   Lee VJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001786
   Lo Presti A, 2016, INFECT GENET EVOL, V41, P270, DOI 10.1016/j.meegid.2016.04.006
   Lum FM, 2015, ANTIVIR RES, V120, P165, DOI 10.1016/j.antiviral.2015.06.009
   Malvy D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-200
   Mohan Alladi, 2010, Indian J Dermatol, V55, P54, DOI 10.4103/0019-5154.60355
   MS (Ministerio da Saude), 2015, FEBRE DE CHIKUNGUNYA
   MS (Ministerio da Saude), 2014, PREP RESP INTR VIR C
   Mulyatno KC, 2012, JPN J INFECT DIS, V65, P92
   Niyas KP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-189
   Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0
   Parreira R., 2014, Eurosurveillance, V19, P20730, DOI 10.2807/1560-7917.ES2014.19.10.20730
   Phommanivong Viengvaly, 2016, Trop Med Health, V44, P24, DOI 10.1186/s41182-016-0020-y
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Riswari SF, 2016, J CLIN VIROL, V74, P61, DOI 10.1016/j.jcv.2015.11.017
   Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032
   Sam IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050476
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   SIMIZU B, 1984, J VIROL, V51, P254, DOI 10.1128/JVI.51.1.254-258.1984
   Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Souza Thiara Manuele Alves, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Sumathy K, 2012, J MED VIROL, V84, P462, DOI 10.1002/jmv.23187
   SVS/MS Boletim Epidemiologico, 2015, SECR VIGILANCIA EM S, V46
   SVS Secretaria de Vigilancia em SaudeMinisterio da Saude, 2017, MON CAS DENG FEBR CH, P52
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   White SK, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.00148-17, 10.1128/genomea.00148-17]
   Yaseen HM, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-249
NR 71
TC 1
Z9 1
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2018
VL 10
IS 11
AR 623
DI 10.3390/v10110623
PG 17
WC Virology
SC Virology
GA HC2UO
UT WOS:000451657600046
PM 30424530
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU de Bruycker-Nogueira, F
   Faria, NRD
   Nunes, PCG
   Nogueira, RMR
   de Filippis, AMB
   dos Santos, FB
AF de Bruycker-Nogueira, Fernanda
   da Costa Faria, Nieli Rodrigues
   Guerra Nunes, Priscila Conrado
   Ribeiro Nogueira, Rita Maria
   Bispo de Filippis, Ana Maria
   dos Santos, Flavia Barreto
TI First detection and molecular characterization of a DENV-1/DENV-4
   co-infection during an epidemic in Rio de Janeiro, Brazil
SO CLINICAL CASE REPORTS
LA English
DT Article
DE co-infection; dengue virus 1; dengue virus 4; genotype II; genotype V
ID CLINICAL PRESENTATION; DENGUE VIRUSES; ZIKA
AB In the 80s, dengue viruses type 1 and 4 (DENV-1 and 4) were isolated in North region of Brazil. However, it was only after the DENV-1 introduction in the state of Rio de Janeiro (RJ) in mid-1980s, that dengue became a nationwide public health problem. In 2009, this serotype re-emerged causing an explosive epidemic in the country. DENV-4 was first detected in RJ in 2011 and in 2012, and DENV-1 and 4 were co-circulating and responsible for a high number of cases notifications. Here, we describe the detection and molecular characterization of a DENV-1/4 co-infection in sample of 2012 in RJ.
C1 [de Bruycker-Nogueira, Fernanda; Guerra Nunes, Priscila Conrado; dos Santos, Flavia Barreto] Fiocruz MS, Oswaldo Cruz Inst, Viral Immunol Lab, Av Brasil 4365,Pavilhao Helio & Peggy Pereira, BR-21040360 Manguinho, RJ, Brazil.
   [da Costa Faria, Nieli Rodrigues; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Fiocruz MS, Oswaldo Cruz Inst, Flavivirus Lab, Rio De Janeiro, Brazil.
RP dos Santos, FB (corresponding author), Fiocruz MS, Oswaldo Cruz Inst, Viral Immunol Lab, Av Brasil 4365,Pavilhao Helio & Peggy Pereira, BR-21040360 Manguinho, RJ, Brazil.
EM flaviab@ioc.fiocruz.br
OI Santos, Flavia/0000-0002-1309-5366
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPqNational Council for Scientific and Technological
   Development (CNPq) [303822/2015-5]; Programa Estrategico de Pesquisa em
   Saude/PAPES VI-FIOCRUZ [407690/2012-3]; Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro/FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.003/2016]; Brazilian Ministry of Health
FX To Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq
   [grant number 303822/2015-5] and Programa Estrategico de Pesquisa em
   Saude/PAPES VI-FIOCRUZ [grant number 407690/2012-3], to Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), to Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ to FBS grant number
   E-26/202.003/2016, to FIOCRUZ, and Brazilian Ministry of Health.
CR Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   [Anonymous], 2016, DENGUE SITUACAO EPID
   [Anonymous], 2018, B EPIDEMIOLOGICO 20, V20
   [Anonymous], 2012, B EPIDEMIOLOGICO DEN
   Azeredo EL, 2018, PLOS CURR
   Chaves BA, 2018, J INFECT DIS, V218, P563, DOI 10.1093/infdis/jiy196
   Colombo TE, 2013, REV INST MED TROP SP, V55, P275, DOI 10.1590/S0036-46652013000400009
   dos Santos FB, 2013, DENGUE B, V37, P61
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Martins Vdo C, 2014, PLOS ONE, V9
   Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
NR 19
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2050-0904
J9 CLIN CASE REP
JI Clin. Case Rep.
PD NOV
PY 2018
VL 6
IS 11
BP 2075
EP 2080
DI 10.1002/ccr3.1750
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA GZ7KA
UT WOS:000449656700011
PM 30455894
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Nunes, PCG
   de Filippis, AMB
   Lima, MQD
   Faria, NRD
   de Bruycker-Nogueira, F
   Santos, JB
   Heringer, M
   Chouin-Carneiro, T
   Couto-Lima, D
   Goncalves, BD
   Sampaio, SA
   de Araujo, ESM
   Sanchez-Arcila, JC
   dos Santos, FB
   Nogueira, RMR
AF Guerra Nunes, Priscila Conrado
   Bispo de Filippis, Ana Maria
   da Rocha Lima, Monique Queiroz
   da Costa Faria, Nieli Rodrigues
   de Bruycker-Nogueira, Fernanda
   Santos, Jaqueline Bastos
   Heringer, Manoela
   Chouin-Carneiro, Thais
   Couto-Lima, Dinair
   Goncalves, Bianca de Santis
   Sampaio, Simone Alves
   Machado de Araujo, Eliane Saraiva
   Sanchez-Arcila, Juan Camilo
   dos Santos, Flavia Barreto
   Ribeiro Nogueira, Rita Maria
TI 30 years of dengue fatal cases in Brazil: a laboratorial-based
   investigation of 1047 cases
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Fatal cases; Epidemiology; Laboratorial diagnosis; Brazil
ID RIO-DE-JANEIRO; HEMORRHAGIC-FEVER; RISK-FACTORS; SHOCK SYNDROME; VIRUS
   TYPE-2; AGE PATTERN; VIRAL LOAD; EPIDEMIC; PATHOGENESIS; SEROTYPE
AB Background: Dengue viruses (DENV) have emerged and reemerged in Brazil in the past 30 years causing explosive epidemics. The disease may range from clinically asymptomatic infections to severe and fatal outcomes. We aimed to describe the epidemiological, clinical and laboratorial aspects of the dengue fatal cases received by a Regional Reference Laboratory, Brazil in 30 years.
   Methods: A total of 1047 suspected fatal dengue cases were received from 1986 to 2015 and analyzed in the Laboratory of Flavivirus, FIOCRUZ. Suspected cases were submitted to viral detection, serological and molecular methods for cases confirmation. Influence of gender, age, serotype and type of infection (primary/secondary) on death outcome, as well the interactions between serotype and age or infection and age and type of infection were also studied.
   Results: A total of 359 cases (34.2%) were confirmed and DENV-1 (11.1%), DENV-2 (43.9%), DENV-3 (32.8%) and DENV-4 (13.7%) were detected. Overall, fatal cases occurred more often in primary infections (59.3%, p = 0.001). However, in 2008, fatal cases were mainly associated to secondary infections (p = 0.003). In 2008 and 2011, deaths were more frequent on children and those infected by DENV-2 presented a higher risk for fatal outcome. Moreover, children with secondary infections had a 4-fold higher risk for death.
   Conclusions: Dengue is a multifactorial disease and, factors such as viral strain/serotype, occurrence of secondary infections and co-morbidities may lead to a severe outcome. However, the high dengue incidence and transmission during epidemics, such as those observed in Brazil may overwhelm and collapse the public health services, potentially impacting on increased disease severity and mortality.
C1 [Guerra Nunes, Priscila Conrado; da Rocha Lima, Monique Queiroz; de Bruycker-Nogueira, Fernanda; Heringer, Manoela; Chouin-Carneiro, Thais; Sanchez-Arcila, Juan Camilo; dos Santos, Flavia Barreto] Fiocruz MS, Inst Oswaldo Cruz, Viral Immunol Lab LIV, IOC, Ave Brasil,4365 Manguinhos, Rio De Janeiro, Brazil.
   [Guerra Nunes, Priscila Conrado; Bispo de Filippis, Ana Maria; da Costa Faria, Nieli Rodrigues; Santos, Jaqueline Bastos; Goncalves, Bianca de Santis; Sampaio, Simone Alves; Machado de Araujo, Eliane Saraiva; Ribeiro Nogueira, Rita Maria] Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab LABFLA, Ave Brasil,4365 Manguinhos, Rio De Janeiro, Brazil.
   [Chouin-Carneiro, Thais; Couto-Lima, Dinair] Fiocruz MS, Inst Oswaldo Cruz, Hematozoa Transmittors Mosquitoes Lab, Ave Brasil,4365 Manguinhos, Rio De Janeiro, Brazil.
RP dos Santos, FB (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Viral Immunol Lab LIV, IOC, Ave Brasil,4365 Manguinhos, Rio De Janeiro, Brazil.
EM flaviab@ioc.fiocruz.br
OI Santos, Flavia/0000-0002-1309-5366; Sanchez-Arcila, Juan
   Camilo/0000-0002-6879-4439
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPqNational Council for Scientific and Technological
   Development (CNPq) [303822/2015-5]; Programa Estrategico de Pesquisa em
   Saude/PAPES VI-FIOCRUZ [407690/2012-3]; Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro /FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.003/2016]; FIOCRUZ; Brazilian Ministry of Health; NATIONAL EYE
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R01EY026202, R01EY026202, R01EY026202, R01EY026202] Funding Source: NIH
   RePORTER
FX To Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq
   [grant number 303822/2015-5] and Programa Estrategico de Pesquisa em
   Saude/PAPES VI-FIOCRUZ [grant number 407690/2012-3], to Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), to Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro /FAPERJ to FBS grant
   number E-26/202.003/2016, to FIOCRUZ, and Brazilian Ministry of Health.
CR Ahmed S, 2013, JCPSP-J COLL PHYSICI, V23, P463, DOI 07.2013/JCPSP.463467
   Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476
   Araujo FMC, 2012, NEUROLOGY, V78, P736, DOI 10.1212/WNL.0b013e31824b94e9
   Barbosa da Silva Jarbas Jr, 2002, Epidemiol Bull, V23, P3
   Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carabali M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1058-x
   Cavalcanti LP, 2011, EMERG INFECT DIS, V17, P132, DOI 10.3201/eid1701.100321
   Changal KH, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2053-6
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Pontes FSC, 2014, QUINTESSENCE INT, V45, P151, DOI 10.3290/j.qi.a30992
   Faria NRD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002095
   de Araujo JMG, 2009, T ROY SOC TROP MED H, V103, P952, DOI 10.1016/j.trstmh.2009.01.025
   Cavalcanti LPD, 2016, AM J TROP MED HYG, V94, P187, DOI 10.4269/ajtmh.15-0392
   Dhanoa A, 2017, PLATELETS, P1
   Dos Santos FB, 2013, BRAZIL DENGUE B, P61
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   de Araujo JMG, 2009, J VIROL METHODS, V155, P34, DOI 10.1016/j.jviromet.2008.09.023
   de Araujo JMG, 2009, MEM I OSWALDO CRUZ, V104, P526, DOI 10.1590/S0074-02762009000300021
   García-Rivera Enid J., 2003, Rev Panam Salud Publica, V13, P362, DOI 10.1590/S1020-49892003000500004
   Gautam Sachidanand, 2016, Surg Neurol Int, V7, pS935, DOI 10.4103/2152-7806.195229
   Gonzalez D, 2005, INT J INFECT DIS, V9, P280, DOI 10.1016/j.ijid.2004.07.012
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Nunes PCG, 2016, J MED VIROL, V88, P1130, DOI 10.1002/jmv.24464
   Guzman M G, 1999, Int J Infect Dis, V3, P130, DOI 10.1016/S1201-9712(99)90033-4
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Leo YS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-123
   Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248
   Ligon B Lee, 2005, Semin Pediatr Infect Dis, V16, P60, DOI 10.1053/j.spid.2004.09.013
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996
   Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012
   Pang JX, 2017, SCI REP-UK, V7, DOI 10.1038/srep39872
   Pang JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001641
   Pawitan Jeanne A, 2011, Acta Med Indones, V43, P129
   Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594
   R Development Core Team, 2011, R LANG ENV STAT COMP
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Rigau-Perez JG, 2002, AM J TROP MED HYG, V67, P355, DOI 10.4269/ajtmh.2002.67.355
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   ROSEN L, 1977, AM J TROP MED HYG, V26, P337, DOI 10.4269/ajtmh.1977.26.337
   Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Schatzmayr HG, 1996, VIRUS REV RES, V1, P17
   SES/SINAN, 2016, OB DENG
   Sharp TM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002159
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Silva Jr J., 2013, DENGUE SITUACAO PERS
   SIM, SIST INF MORT
   Singla M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004497
   Siqueira Jr JB, 2011, DENGUE BRASIL TENDEN
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   SVS, 2010, MIN SAUD
   SVS/MS, 2015, DENG MON ATE SEM EP
   SVS/MS, 2009, DIR PREV CONTR EP DE
   Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566
   Thomas L, 2008, AM J TROP MED HYG, V78, P990
   Tomashek KM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001614
   Wang CC, 2009, T ROY SOC TROP MED H, V103, P871, DOI 10.1016/j.trstmh.2009.04.024
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   WORLD HEALTH ORGANIZATION (WHO); Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
NR 80
TC 7
Z9 6
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUL 27
PY 2018
VL 18
AR 346
DI 10.1186/s12879-018-3255-x
PG 13
WC Infectious Diseases
SC Infectious Diseases
GA GO5AV
UT WOS:000440031000001
PM 30053833
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Salomao, NG
   Rabelo, K
   Povoa, TF
   Alves, AMB
   da Costa, SM
   Goncalves, AJS
   Amorim, JF
   Azevedo, AS
   Nunes, PCG
   Basilio-de-Oliveira, CA
   Basilio-de-Oliveira, RP
   Geraldo, LHM
   Fonseca, CG
   Lima, FRS
   Mohana-Borges, R
   Silva, EM
   dos Santos, FB
   Oliveira, ERA
   Paes, MV
AF Salomao, Natalia G.
   Rabelo, Kissila
   Povoa, Tiago F.
   Alves, Ada M. B.
   da Costa, Simone M.
   Goncalves, Antonio J. S.
   Amorim, Juliana F.
   Azevedo, Adriana S.
   Nunes, Priscilla C. G.
   Basilio-de-Oliveira, Carlos A.
   Basilio-de-Oliveira, Rodrigo P.
   Geraldo, Luiz H. M.
   Fonseca, Celina G.
   Lima, Flavia R. S.
   Mohana-Borges, Ronaldo
   Silva, Emiliana M.
   dos Santos, Flavia B.
   Oliveira, Edson R. A.
   Paes, Marciano V.
TI BALB/c mice infected with DENV-2 strain 66985 by the intravenous route
   display injury in the central nervous system
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DENGUE VIRUS-INFECTION; RIO-DE-JANEIRO; NEUROLOGICAL COMPLICATIONS;
   ELECTRON MICROSCOPY; MULTIPLE-SCLEROSIS; CELL-DEATH; MICROGLIA; FEVER;
   BRAIN; APOPTOSIS
AB Dengue is a mild flu-like arboviral illness caused by dengue virus (DENV) that occurs in tropical and subtropical countries. An increasing number of reports have been indicating that dengue is also associated to neurological manifestations, however, little is known regarding the neuropathogenesis of the disease. Here, using BALB/c mice intravenously infected with DENV-2 strain 66985, we demonstrated that the virus is capable of invading and damaging the host's central nervous system (CNS). Brain and cerebellum of infected animals revealed histological alterations such as the presence of inflammatory infiltrates, thickening of pia matter and disorganization of white matter. Additionally, it was also seen that infection lead to altered morphology of neuroglial cells and apoptotic cell death. Such observations highlighted possible alterations that DENV may promote in the host's CNS during a natural infection, hence, helping us to better understand the neuropathological component of the disease.
C1 [Salomao, Natalia G.; Goncalves, Antonio J. S.; Paes, Marciano V.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Rabelo, Kissila] Univ Estado Rio de Janeiro, Lab Ultraestrutura & Biol Tecidual, Rio De Janeiro, Brazil.
   [Povoa, Tiago F.] Inst Criminalist, Tocantins, Brazil.
   [Alves, Ada M. B.; da Costa, Simone M.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.
   [Amorim, Juliana F.; Azevedo, Adriana S.] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Lab Tecnol Virol, Rio De Janeiro, Brazil.
   [Nunes, Priscilla C. G.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, Carlos A.; Basilio-de-Oliveira, Rodrigo P.] Univ Fed Estado Rio de Janeiro, Hosp Gaffree Guinle, Anat Patol, Rio De Janeiro, Brazil.
   [Geraldo, Luiz H. M.; Fonseca, Celina G.; Lima, Flavia R. S.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Biol Celulas Gliais, Rio De Janeiro, Brazil.
   [Mohana-Borges, Ronaldo; Silva, Emiliana M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
   [dos Santos, Flavia B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Oliveira, Edson R. A.] Univ Fed Rio de Janeiro, Inst Quim Organ, Lab Modelagem Mol, Rio De Janeiro, Brazil.
RP Paes, MV (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.; Oliveira, ERA (corresponding author), Univ Fed Rio de Janeiro, Inst Quim Organ, Lab Modelagem Mol, Rio De Janeiro, Brazil.
EM edsonrao@gmail.com; marciano@ioc.fiocruz.br
RI Borges, Ronaldo S Mohana/C-5575-2013
OI Oliveira, Edson RA/0000-0002-8606-7454; Rabelo,
   Kissila/0000-0001-7579-7788; Paes, Marciano/0000-0002-2266-2801; Santos,
   Flavia/0000-0002-1309-5366; Souza Lima, Flavia
   Regina/0000-0003-0799-9235; Geraldo, Luiz Henrique/0000-0003-3318-4697
FU Brazilian foundation FAPERJ [E-26/110.511/2014, E-26/202.003/2016];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [30382202015-5]
FX We thank the Brazilian foundation FAPERJ (grant number:
   E-26/110.511/2014 and E-26/202.003/2016) and CNPq (grant number:
   30382202015-5) for the financial support and Geraldo C. Wagner from
   Universidade Federal do Estado do Rio de Janeiro (UNIRIO) for the help
   with slides production. We also acknowledge the Laboratory of
   Flaviviruses, Fiocruz, Rio de Janeiro, Brazil, for kindly providing us
   the DENV-2 samples isolated from patient.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Angibaud G, 2001, J CLIN NEUROSCI, V8, P63, DOI 10.1054/jocn.2000.0735
   Araujo FMC, 2011, J VIROL METHODS, V177, P128, DOI 10.1016/j.jviromet.2011.07.003
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011
   Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848
   Castellanos JE, 2016, BIOMEDICA, V36, P156, DOI 10.7705/biomedica.v36i0.2984
   Chatterjee D, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/510396
   Chen HC, 2004, J MED VIROL, V73, P419, DOI 10.1002/jmv.20108
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Courageot MP, 2003, ADV VIRUS RES, V60, P157, DOI 10.1016/S0065-3527(03)60005-9
   Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000
   Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003
   ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390
   Everett H, 2001, VIROLOGY, V288, P1, DOI 10.1006/viro.2001.1081
   Garcia-Rivera EJ, 2002, LANCET, V360, P261, DOI 10.1016/S0140-6736(02)09481-3
   Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621
   Giovannoni G, 1998, MULT SCLER J, V4, P212, DOI 10.1177/135245859800400323
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Nunes PCG, 2016, J MED VIROL, V88, P1130, DOI 10.1002/jmv.24464
   HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jensen CJ, 2013, J NEUROIMMUNE PHARM, V8, P824, DOI 10.1007/s11481-013-9480-6
   Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010
   Lima DM, 2011, VACCINE, V29, P831, DOI 10.1016/j.vaccine.2010.10.078
   Liu Y, 2014, VIROLOGY, V448, P15, DOI 10.1016/j.virol.2013.09.016
   Mamdouh KH, 2013, J GLOB INFECT DIS, V5, P183, DOI 10.4103/0974-777X.122021
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   MCGEER PL, 1988, ANN NEUROL, V24, P574, DOI 10.1002/ana.410240415
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Miagostovich MP, 1997, MEM I OSWALDO CRUZ, V92, P595, DOI 10.1590/S0074-02761997000500006
   Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Murthy JMK, 2010, NEUROL INDIA, V58, P581, DOI 10.4103/0028-3886.68654
   Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240
   Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6
   Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Oliveira ERA, 2016, VIROLOGY, V489, P95, DOI 10.1016/j.virol.2015.12.006
   Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83
   Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042
   Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P341
   PATEY O, 1993, AM J TROP MED HYG, V48, P793, DOI 10.4269/ajtmh.1993.48.793
   Piccoli C, 2006, BBA-BIOENERGETICS, V1757, P1429, DOI 10.1016/j.bbabio.2006.05.018
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4
   Sahu R, 2014, NEUROLOGY, V83, P1601, DOI 10.1212/WNL.0000000000000935
   Saini L, 2017, NEUROL INDIA, V65, P636, DOI [10.4103/neuroindia.NI_1367_15, 10.4103/neuroindia.ni_1367_15]
   Sanguansermsri T., 1976, BANGKOK SEAMEO TROPM, P10
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Thisyakorn Usa, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P504
   Thisyakorn Usa, 1994, Journal of the Medical Association of Thailand, V77, P410
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Torrentes-Carvalho A, 2009, MEM I OSWALDO CRUZ, V104, P1091, DOI 10.1590/S0074-02762009000800005
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
   WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475
   WHO, 2009, WHO LIB CAT IN PUBL
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
NR 76
TC 6
Z9 8
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 27
PY 2018
VL 8
AR 9754
DI 10.1038/s41598-018-28137-y
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK7OQ
UT WOS:000436397000003
PM 29950590
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Nunes, PCG
   Nogueira, RMR
   Heringer, M
   Chouin-Carneiro, T
   Rodrigues, CDD
   de Filippis, AMB
   Lima, MDQ
   dos Santos, FB
AF Guerra Nunes, Priscila Conrado
   Ribeiro Nogueira, Rita Maria
   Heringer, Manoela
   Chouin-Carneiro, Thais
   dos Santos Rodrigues, Cintia Damasceno
   Bispo de Filippis, Ana Maria
   Queiroz Lima, Monique da Rocha
   dos Santos, Flavia Barreto
TI NS1 Antigenemia and Viraemia Load: Potential Markers of Progression to
   Dengue Fatal Outcome?
SO VIRUSES-BASEL
LA English
DT Article
DE dengue; fatal cases; NS1 antigenemia; viraemia load
ID RIO-DE-JANEIRO; DISEASE SEVERITY; VIRUS-INFECTION; PROTEIN NS1; VIRAL
   LOAD; SEROTYPE; BRAZIL; MAGNITUDE; EPIDEMIC; OUTBREAK
AB Dengue is a worldwide problem characterized by a multifactorial pathogenesis. Considering the viral components, it is known that high viremia or high levels of the secreted nonstructural protein 1 (NS1) may be associated with a more severe disease. We aimed to characterize the NS1 antigenemia and viremia in dengue fatal and non-fatal cases, as potential markers of progression to a fatal outcome. NS1 antigenemia and viremia were determined in Brazilian dengue fatal cases (n = 40) and non-fatal cases (n = 40), representative of the four dengue virus (DENV) serotypes. Overall, the fatal cases presented higher NS1 levels and viremia. Moreover, the fatal cases from secondary infections showed significantly higher NS1 levels than the non-fatal ones. Here, irrespective of the disease outcome, DENV-1 cases presented higher NS1 levels than the other serotypes. However, DENV-2 and DENV-4 fatal cases had higher NS1 antigenemia than the non-fatal cases with the same serotype. The viremia in the fatal cases was higher than in the non-fatal ones, with DENV-3 and DENV-4 presenting higher viral loads. Viral components, such as NS1 and viral RNA, may be factors influencing the disease outcome. However, the host immune status, comorbidities, and access to adequate medical support cannot be ruled out as interfering in the disease outcome.
C1 [Guerra Nunes, Priscila Conrado; Heringer, Manoela; Chouin-Carneiro, Thais; Queiroz Lima, Monique da Rocha; dos Santos, Flavia Barreto] Oswaldo Cruz Inst FIOCRUZ, Viral Immunol Lab LIV, Ave Brasil,4365, BR-21040360 Rio De Janeiro, Brazil.
   [Guerra Nunes, Priscila Conrado; Ribeiro Nogueira, Rita Maria; dos Santos Rodrigues, Cintia Damasceno; Bispo de Filippis, Ana Maria] Oswaldo Cruz Inst FIOCRUZ, Flavivirus Lab LABFLA, Ave Brasil,4365, BR-21040360 Rio De Janeiro, Brazil.
   [Chouin-Carneiro, Thais] Inst Oswaldo Cruz, Hematozoa Transmittors Mosquitoes Lab, BR-21040360 Rio De Janeiro, Brazil.
RP dos Santos, FB (corresponding author), Oswaldo Cruz Inst FIOCRUZ, Viral Immunol Lab LIV, Ave Brasil,4365, BR-21040360 Rio De Janeiro, Brazil.
EM pricgn@ioc.fiocruz.br; rita@ioc.fiocruz.br;
   manoela.heringer@ioc.fiocruz.br; tatachouin@gmail.com;
   cintia.damasceno@ioc.fiocruz.br; abispo@ioc.fiocruz.br;
   moniqueq@ioc.fiocruz.br; flaviab@ioc.fiocruz.br
OI Nunes, Priscila/0000-0002-4841-9308; Santos, Flavia/0000-0002-1309-5366
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPqNational Council for Scientific and Technological
   Development (CNPq) [303822/2015-5]; Programa Estrategico de Pesquisa em
   Saude/PAPES VI-FIOCRUZ [407690/2012-3]; Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [26/202.003/2016]; FIOCRUZ; Brazilian Ministry of Health
FX To Eliane Saraiva de Araujo, Simone Alves Sampaio, Jose Farias, and Leda
   Maria for technical support. This work was supported by the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq [grant number
   303822/2015-5]; Programa Estrategico de Pesquisa em Saude/PAPES
   VI-FIOCRUZ [grant number 407690/2012-3]; Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ) [grant number 26/202.003/2016];
   FIOCRUZ; Brazilian Ministry of Health.
CR Adikari TN, 2016, CLIN EXP IMMUNOL, V184, P90, DOI 10.1111/cei.12747
   Allonso D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113634
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Chen RF, 2005, FEMS IMMUNOL MED MIC, V44, P43, DOI 10.1016/j.femsim.2004.11.012
   Hernandez SID, 2013, J CLIN VIROL, V58, P258, DOI 10.1016/j.jcv.2013.06.016
   dos Santos FB, 2013, DENGUE B, V37, P61
   Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244
   Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014
   Erra EO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065900
   Fox A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000967
   de Araujo JMG, 2009, MEM I OSWALDO CRUZ, V104, P526, DOI 10.1590/S0074-02762009000300021
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Nunes PCG, 2016, J MED VIROL, V88, P1130, DOI 10.1002/jmv.24464
   Heringer M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2488-4
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Malavige GN, 2017, IMMUNOLOGY, V151, P261, DOI 10.1111/imm.12748
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Moi ML, 2013, J TRAVEL MED, V20, P185, DOI 10.1111/jtm.12018
   Murgue B, 2000, J MED VIROL, V60, P432, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;432::AID-JMV11&gt;3.0.CO;2-7
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Pan American Health Organization (PAHO), 2017, REP CAS DENG FEV AM
   Paranavitane SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0570-8
   Perdomo-Celis F, 2017, ACTA TROP, V167, P1, DOI 10.1016/j.actatropica.2016.12.011
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Rigau-Perez JG, 2002, AM J TROP MED HYG, V67, P355, DOI 10.4269/ajtmh.2002.67.355
   Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Singla Mohit, 2016, PLoS Negl Trop Dis, V10, pe0004642, DOI 10.1371/journal.pntd.0004642
   Sudiro TM, 2001, J MED VIROL, V63, P29, DOI 10.1002/1096-9071(200101)63:1&lt;29::AID-JMV1004&gt;3.0.CO;2-S
   Thomas SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad1255
   Tran NBC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000657
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   WORLD HEALTH ORGANIZATION (WHO); Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
   Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06
NR 47
TC 8
Z9 8
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUN
PY 2018
VL 10
IS 6
AR 326
DI 10.3390/v10060326
PG 11
WC Virology
SC Virology
GA GK4QE
UT WOS:000436146700049
PM 29903980
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Ramalho, ILC
   Araujo, FMD
   Cavalcanti, LPD
   Braga, DNM
   Perdigao, ACB
   dos Santos, FB
   Nogueira, FD
   da Escossia, KNF
   Guedes, MIF
AF Cavalcante Ramalho, Izabel Leticia
   de Carvalho Araujo, Fernanda Montenegro
   de Goes Cavalcanti, Luciano Pamplona
   Melo Braga, Deborah Nunes
   Bezerra Perdigao, Anne Carolinne
   dos Santos, Flavia Barreto
   Nogueira, Fernanda de Bruycker
   Farias da Escossia, Kiliana Nogueira
   Florindo Guedes, Maria Izabel
TI Dengue 4 in Ceara, Brazil: characterisation of epidemiological and
   laboratorial aspects and causes of death during the first epidemic in
   the state
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue 4; epidemiology; deaths; genotyping; Ceara/Brazil
ID VIRUS SEROTYPE 4; SURVEILLANCE; SAMPLES; TYPE-4
AB BACKGROUND The first dengue cases in Brazil with laboratory confirmation occurred in the northern region of the country, with the isolation of two serotypes, dengue virus 1 (DENV-1) and DEN V-4. In Ceara, the introduction of DENV-4 was reported during a DENV-1 epidemic in 2011, with only two isolations.
   OBJECTIVES The aim of this study was to characterise the first DENV-4 epidemic in the state of Ceara, Brazil.
   METHODS The study population was composed of patients with suspected dengue that were reported to health care units from January to December 2012. The laboratory confirmation of infection was made by viral isolation, reverse transcription polymerase chain reaction (RT-PCR), AgNS1, immunohistochemistry and IgM enzyme-linked immunosorbent assay (ELISA).
   MAIN CONCLUSIONS In the study year, 72,211 suspected dengue cases were reported and 51,865 of these cases (71.8%) were confirmed to be positive. Co-circulation of three serotypes, DENV-1, DENV-3 and DENV-4, was detected with a predominance of DEN V-4 (95.3%). Most cases were not severe, but there were 44 fatal outcomes. DENV-4 Genotype II was identified for the first time in Ceara.
C1 [Cavalcante Ramalho, Izabel Leticia; de Carvalho Araujo, Fernanda Montenegro] Lab Cent Saude Publ, Setor Virol, Fortaleza, Ceara, Brazil.
   [Cavalcante Ramalho, Izabel Leticia; Florindo Guedes, Maria Izabel] Univ Estadual Ceara, Rede Nordeste Biotecnol, Fortaleza, Ceara, Brazil.
   [de Carvalho Araujo, Fernanda Montenegro; Bezerra Perdigao, Anne Carolinne] Ctr Univ Christus, Fortaleza, Ceara, Brazil.
   [de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Dept Saude Comunitaria, Fortaleza, Ceara, Brazil.
   [Melo Braga, Deborah Nunes] Inst Prevencao Canc, Fortaleza, Ceara, Brazil.
   [dos Santos, Flavia Barreto; Nogueira, Fernanda de Bruycker] Inst Oswaldo Cruz, Lab Imunol Viral, Fiocruz, Rio De Janeiro, RJ, Brazil.
   [Farias da Escossia, Kiliana Nogueira] Secretaria Saude Estado Ceara, Nucleo Vigilancia Epidemiol, Fortaleza, Ceara, Brazil.
RP Araujo, FMD (corresponding author), Lab Cent Saude Publ, Setor Virol, Fortaleza, Ceara, Brazil.; Araujo, FMD (corresponding author), Ctr Univ Christus, Fortaleza, Ceara, Brazil.
EM fenanda.montenegro@lacen.ce.gov.br
RI ; Cavalcanti, Luciano/N-4391-2015
OI Santos, Flavia/0000-0002-1309-5366; Cavalcanti,
   Luciano/0000-0002-3440-1182
CR Araujo FMC, 2012, NEUROLOGY, V78, P736, DOI 10.1212/WNL.0b013e31824b94e9
   Araujo FMC, 2011, J VIROL METHODS, V177, P128, DOI 10.1016/j.jviromet.2011.07.003
   Basílio-de-Oliveira C.A., 2005, Braz J Infect Dis, V9, P341, DOI 10.1590/S1413-86702005000400012
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Cunha PEL, 2008, REV BRAS MED FAM COM, V7, P247
   Cavalcanti LPD, 2016, AM J TROP MED HYG, V94, P187, DOI 10.4269/ajtmh.15-0392
   do Nascimento LB, 2015, EPIDEMIOL SERV SAUDE, V24, P475, DOI 10.5123/S1679-49742015000300013
   FONSECA I. S. S., 2014, CIENCIAS BIOL SAUDE, V2, P69
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Leo YS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-123
   Miagostovich MP, 2006, MEM I OSWALDO CRUZ, V101, P307, DOI 10.1590/S0074-02762006000300015
   MS/SAS -Ministerio da Saude/Secretaria de Atencao a Saude, 2013, DIR ORG SERV AT SAUD
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Travassos Cláudia, 2002, Rev Panam Salud Publica, V11, P365, DOI 10.1590/S1020-49892002000500011
   Viana DV, 2013, REV BRAS EPIDEMIOL, V16, P2401
   Vicente CR, 2018, EPIDEMIOL INFECT, V146, P100, DOI 10.1017/S0950268817002618
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
NR 28
TC 0
Z9 0
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2018
VL 113
IS 11
AR e180320
DI 10.1590/0074-02760180320
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GY8KU
UT WOS:000448876500001
PM 30365646
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Rasinhas, AD
   da Silva, MAN
   Caldas, GC
   Jacome, FC
   Leonardo, R
   dos Santos, FB
   Nunes, PCG
   Barth, OM
   Barreto-Vieira, DF
AF Rasinhas, Arthur da Costa
   Nunes da Silva, Marcos Alexandre
   Caldas, Gabriela Cardoso
   Jacome, Fernanda Cunha
   Leonardo, Raphael
   dos Santos, Flavia Barreto
   Guerra Nunes, Priscila Conrado
   Barth, Ortrud Monika
   Barreto-Vieira, Debora Ferreira
TI First detection of dengue virus in the saliva of immunocompetent murine
   model
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue 4; saliva; BALB/c mice; immunocompetent murine model
ID ANTIBODIES; DIAGNOSIS
AB The lack of an experimental animal model for the study of dengue pathogenesis is a limiting factor for the development of vaccines and drugs. In previous studies, our group demonstrated the susceptibility of BALB/c mice to infection by dengue virus (DENV) 1 and 2, and the virus was successfully isolated in several organs. In this study, BALB/c mice were experimentally infected intravenously with DENV-4, and samples of their saliva were collected. Viral RNA extracted from the saliva samples was subjected to qRT-PCR, with a detection limit of 0.002 PFU/mL. The presence of DENV-4 viral RNA was detected in the saliva of two mice, presenting viral titers of 109 RNA/mL. The detection of DENV RNA via saliva sampling is not a common practice in dengue diagnosis, due to the lower detection rates in human patients. However, the results observed in this study seem to indicate that, as in humans, detection rates of DENV RNA in mouse saliva are also low, correlating the infection in both cases. This study reports the first DENV detection in the saliva of BALB/c immunocompetent mice experimentally infected with non-neuroadapted DENV-4.
C1 [Rasinhas, Arthur da Costa; Nunes da Silva, Marcos Alexandre; Caldas, Gabriela Cardoso; Jacome, Fernanda Cunha; Leonardo, Raphael; Barth, Ortrud Monika; Barreto-Vieira, Debora Ferreira] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Morfol & Morfogenese Viral, Rio De Janeiro, RJ, Brazil.
   [dos Santos, Flavia Barreto; Guerra Nunes, Priscila Conrado] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, RJ, Brazil.
RP Rasinhas, AD (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Morfol & Morfogenese Viral, Rio De Janeiro, RJ, Brazil.
EM arthur.rasinhas@ioc.fiocruz.br
OI Santos, Flavia/0000-0002-1309-5366
FU CNPq, IOC
FX CNPq, IOC
CR Anders KL, 2012, AM J TROP MED HYG, V87, P165, DOI 10.4269/ajtmh.2012.11-0713
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Balmaseda A, 2003, CLIN DIAGN LAB IMMUN, V10, P317, DOI 10.1128/CDLI.10.2.317-322.2003
   Barreto DF, 2007, MEM I OSWALDO CRUZ, V102, P175, DOI 10.1590/S0074-02762007005000007
   Barreto-Vieira DF, 2015, INDIAN J APPL RES, V5, P44
   Barth OM, 2010, ATLAS DENGUE VIRUSES
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Clark KB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00305
   Cuzzubbo AJ, 1998, J CLIN MICROBIOL, V36, P3737, DOI 10.1128/JCM.36.12.3737-3739.1998
   Oliveira RAD, 2016, MEM I OSWALDO CRUZ, V111, P378, DOI 10.1590/0074-02760150453
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Jacome FC, 2015, INT J RES STUD BIOSC, V3, P101
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Sarathy VV, 2015, VACCINE, V33, P7051, DOI 10.1016/j.vaccine.2015.09.112
   WHO, 2016, DENG VACC WHO POS PA
   Yamashita A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00875
   Yap G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001046
NR 22
TC 1
Z9 1
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2018
VL 113
IS 4
AR e170208
DI 10.1590/0074-02760170208
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GA9WM
UT WOS:000428692100003
PM 29412340
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Rabelo, K
   Fernandes, RCDC
   de Souza, LJ
   de Souza, TL
   dos Santos, FB
   Nunes, PCG
   de Azeredo, EL
   Salomao, NG
   Trindade, GF
   Basilio-de-Oliveira, CA
   de Carvalho, JJ
   Medina-Acosta, E
   Paes, MV
AF Rabelo, Kissila
   de Souza Campos Fernandes, Regina Celia
   de Souza, Luiz Jose
   de Souza, Thais Louvain
   dos Santos, Flavia Barreto
   Guerra Nunes, Priscila Conrado
   de Azeredo, Elzinandes Leal
   Salomao, Natalia Gedeao
   Trindade, Gisela Freitas
   Basilio-de-Oliveira, Carlos A.
   de Carvalho, Jorge Jose
   Medina-Acosta, Enrique
   Paes, Marciano Viana
TI Placental Histopathology and Clinical Presentation of Severe Congenital
   Zika Syndrome in a Human Immunodeficiency Virus-Exposed Uninfected
   Infant
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Zika virus; placenta; congenital Zika syndrome; histopathology;
   microcephaly; human immunodeficiency virus
ID DENGUE VIRUS; INFECTION; PATHOLOGY; CELLS; TRANSMISSION; ANTIBODIES;
   FETUSES; REPAIR; BRAZIL; BRAIN
AB In the large Zika virus (ZIKV) epidemic that occurred in Brazil in 2015, the intrauterine fetal exposure to ZIKV was associated with a significant risk of developing microcephaly and neurological disorders in the infected infants. ZIKV-associated disease has since been reported in 24 countries in the Americas. At present, definitive evidence is lacking regarding the intrauterine co-exposure to ZIKV and other viral infections and whether the coinfection impacts the risk of acquiring either infection or disease severity. Here, we provide evidence of intrauterine exposure to both ZIKV and human immunodeficiency virus (HIV) infections, causing congenital Zika syndrome in an HIV-exposed uninfected infant. Clinical, imaging and laboratory examinations of the pregnant woman and the newborn were performed. Histopathology, ZIKV/HIV-specific immunoassays, and ultrastructural evaluation of the placenta were performed. The Zika-asymptomatic, HIV-positive pregnant woman underwent ultrasounds revealing fetal cerebral ventriculomegaly, microcephaly, and brain atrophy. Her baby girl was born small for gestational age and with the neurological sequelae of congenital Zika syndrome. The evaluation of the abnormally large term placenta revealed severe damage to the maternal decidua and chorionic villi, cells positive for ZIKV-specific antigens but not for HIV antigens, and intracellular membranous clusters of virus-like particles approximately 25 nm in diameter. The rapid progression and severity of the congenital Zika syndrome may be related to the uncontrolled HIV disease in the mother. The poor inflammatory response observed in the placenta may have reduced the inherent risk of mother-to-child transmission of HIV.
C1 [Rabelo, Kissila; de Carvalho, Jorge Jose] Univ Estado Rio de Janeiro, Lab Ultraestrut & Biol Tecidual, Rio De Janeiro, Brazil.
   [de Souza Campos Fernandes, Regina Celia; de Souza, Luiz Jose; de Souza, Thais Louvain] Fac Med Campos, Campos Dos Goytacazes, Brazil.
   [de Souza Campos Fernandes, Regina Celia; de Souza, Thais Louvain; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Lab Biotechnol, Campos Dos Goytacazes, Brazil.
   [dos Santos, Flavia Barreto; Guerra Nunes, Priscila Conrado; de Azeredo, Elzinandes Leal] Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Salomao, Natalia Gedeao; Paes, Marciano Viana] Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Trindade, Gisela Freitas] Biomanguinhos, Lab Tecnol Virol, Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, Carlos A.] Univ Fed Estado Rio De Janeiro, Anat Patol, Rio De Janeiro, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Lab Biotechnol, Campos Dos Goytacazes, Brazil.; Paes, MV (corresponding author), Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
EM quique@uenf.br; marciano@ioc.fiocruz.br
RI Medina-Acosta, Enrique/G-3041-2010; Trindade, Gustavo
   Ferraz/O-9107-2016; amsalu, ribka/G-8780-2019
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Trindade, Gustavo
   Ferraz/0000-0001-6998-814X; Carvalho, Jorge/0000-0002-9426-6381; Paes,
   Marciano/0000-0002-2266-2801; Santos, Flavia/0000-0002-1309-5366;
   Rabelo, Kissila/0000-0001-7579-7788; Trindade,
   Gisela/0000-0002-1630-4143
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [308780/2015-9]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/110.511/2014,
   E-26/010.001.498/2016, E26/202.003/2016]
FX The authors thank the Hospital Plantadores de Cana for the care of the
   patient and the assistance with sample collection, and the Platform of
   Confocal and Electron Microscopy at the State University of Rio de
   Janeiro and the Platform of Electron Microscopy in Fiocruz. This work
   was supported by the CNPq (308780/2015-9) and the FAPERJ
   (E-26/110.511/2014, E-26/010.001.498/2016 and E26/202.003/2016).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eaton JW, 2014, AIDS, V28, pS507, DOI 10.1097/QAD.0000000000000412
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fu D, 2015, DNA REPAIR, V35, P13, DOI 10.1016/j.dnarep.2015.09.008
   Goff SP, 2001, FIELDS VIROLOGY, P1871
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Inoue A, 2014, J BIOL CHEM, V289, P7109, DOI 10.1074/jbc.M113.520429
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Joao Esau Custodio, 2017, Pediatr Infect Dis J, V36, P500, DOI 10.1097/INF.0000000000001482
   Johnson EL, 2016, CURR OPIN INFECT DIS, V29, P248, DOI 10.1097/QCO.0000000000000267
   Kalk E, 2017, TROP MED INT HEALTH, V22, P604, DOI 10.1111/tmi.12858
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Schonenberger F, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0618-9
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Torrentes-Carvalho A, 2016, CLIN IMMUNOL, V164, P95, DOI 10.1016/j.clim.2016.01.005
NR 28
TC 11
Z9 11
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD DEC 7
PY 2017
VL 8
AR 1704
DI 10.3389/fimmu.2017.01704
PG 8
WC Immunology
SC Immunology
GA FO9XH
UT WOS:000417251200001
PM 29270171
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU dos Santos, TP
   Cruz, OG
   da Silva, KAB
   de Castro, MG
   de Brito, AF
   Maspero, RC
   de Alcantra, R
   dos Santos, FB
   Honorio, NA
   Lourenco-de-Oliveira, R
AF dos Santos, Taissa Pereira
   Cruz, Oswaldo Gonsalvez
   Barbosa da Silva, Keli Antunes
   de Castro, Marcia Goncalves
   de Brito, Anielly Ferreira
   Maspero, Renato Cesar
   de Alcantra, Rosilene
   dos Santos, Flavia Barreto
   Honorio, Nildimar A.
   Lourenco-de-Oliveira, Ricardo
TI Dengue serotype circulation in natural populations of Aedes aegypti
SO ACTA TROPICA
LA English
DT Article
DE Dengue serotypes; Arbovirus detection; Infected mosquitoes
ID RIO-DE-JANEIRO; VIRUS TYPE-4; BRAZIL; SURVEILLANCE; CHIKUNGUNYA;
   INFECTION
AB Ae. aegypti is the main vector of dengue (DENV), Zika (ZIKV), and chikungunya (CHIKV) viruses. The transmission dynamics of these arboviruses, especially the arboviral circulation in the mosquito population during low and high transmission seasons in endemic areas are still poorly understood. We conducted an entomological survey to determine dengue infection rates in Ae. aegypti and Aedes albopictus. These collections were performed in 2012-2013 during a Rio de Janeiro epidemic, just before the introduction and spread of ZIKV and CHIKV in the city. MosquiTrap and BG-Sentinel traps were installed in three fixed and seven itinerant neighborhoods each month over ten months. Mosquitoes were in supernatants pools tested and individually confirmed for DENV infection using RT-PCR. A total of 3053 Aedes mosquitos were captured and Ae. aegypti was much more frequent (92.9%) than Ae. albopictus (6.8%). Ae. aegypti females accounted for 71.8% of captured mosquitoes by MosquitTrap (c) and were the only species found naturally infected with DENV (infection rate = 0.81%). Only one Ae. aegypti male, collected by BG-sentinel, was also tested positive for DENV. The peak of DENV-positive mosquitoes coincided the season of the highest incidence of human cases. The most common serotypes detected in mosquitoes were DENV-3 (24%) and DENV-1 (24%), followed by DENV-4 (20%), DENV-2 (8%) and DENV-1 plus DENV4 (4%), while 95% of laboratory-confirmed human infections in the period were due to DENV-4. These contrasting results suggest silent maintenance of DENV serotypes during the epidemics, reinforcing the importance of entomological and viral surveillance in endemic areas.
C1 [dos Santos, Taissa Pereira; Barbosa da Silva, Keli Antunes; de Castro, Marcia Goncalves; de Brito, Anielly Ferreira; Honorio, Nildimar A.; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Cruz, Oswaldo Gonsalvez] Fundacao Oswaldo Cruz, Programa Computacao Cientif PROCC, Rio De Janeiro, RJ, Brazil.
   [Cruz, Oswaldo Gonsalvez; Maspero, Renato Cesar; de Alcantra, Rosilene] Secretaria Municipal Saude, Prefeiticra Municipal Rio De Janeiro, Rio De Janeiro, RJ, Brazil.
   [dos Santos, Flavia Barreto] Fiocruz MS, Nucleo Operat Sentinela Mosquitos Vetores Nosmov, Rio De Janeiro, RJ, Brazil.
   [Honorio, Nildimar A.] Fundacao Oswaldo Cruz, Lab Biol Mol Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
RP dos Santos, TP (corresponding author), Malad Infectieuses & Vecteurs Ecol Genet Evolut &, Montpellier, France.
EM tayssadnz@gmail.com
OI Santos, Flavia/0000-0002-1309-5366
FU CAPESCAPES; CSF/CNPq; FIOCRUZ/IOC; FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ); SMS/RJ
FX We thank the Cecilia Nicolai, Marcos Nunes Ferreira, Marcos Pinheiro,
   Claudia Codeco, Bruno Oliveira Mariano, Andiaria Ramos, Maycon Neves,
   Marcelo Celestino, Renato Carvalho, Marcelo Quintela for support. This
   work were financed by CAPES, CSF/CNPq, FIOCRUZ/IOC, FAPERJ, and SMS/RJ.
CR Bangs MJ, 2007, J MED ENTOMOL, V44, P163, DOI 10.1603/0022-2585(2007)44[163:PODVRI]2.0.CO;2
   Brasil P., 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004636
   Consoli RAGB, 1994, PRINCIPALS MOSQUITOS
   Conteville LC, 2016, MEM I OSWALDO CRUZ, V111, P347, DOI 10.1590/0074-02760160004
   de Castro MG, 2012, MEM I OSWALDO CRUZ, V107, P940, DOI 10.1590/S0074-02762012000700017
   de la Mora-Covarrubias A, 2010, SALUD PUBLICA MEXICO, V52, P127, DOI 10.1590/s0036-36342010000200004
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Lambrechts L, 2012, MEM I OSWALDO CRUZ, V107, P1080, DOI 10.1590/S0074-02762012000800022
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009
   Ministerio da Saiide, 2011, REL SIT RIO JAN
   Nogueira R. M. R., 1990, MEM I O CRUZ
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Pena-Garcia V. H., 2016, INT J ENV RES PUB HE, V13, P1
   Perez-Castro R, 2016, MEM I OSWALDO CRUZ, V111, P233, DOI 10.1590/0074-02760150363
   Pessanha José Eduardo Marques, 2011, Rev. Soc. Bras. Med. Trop., V44, P103, DOI 10.1590/S0037-86822011000100023
NR 22
TC 5
Z9 5
U1 0
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD DEC
PY 2017
VL 176
BP 140
EP 143
DI 10.1016/j.actatropica.2017.07.014
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FK6IH
UT WOS:000413606800019
PM 28743449
OA Bronze
DA 2020-12-09
ER

PT J
AU Couto-Lima, D
   Madec, Y
   Bersot, MI
   Campos, SS
   Motta, MD
   dos Santos, FB
   Vazeille, M
   Vasconcelos, PFD
   Lourenco-de-Oliveira, R
   Failloux, AB
AF Couto-Lima, Dinair
   Madec, Yoann
   Bersot, Maria Ignez
   Campos, Stephanie Silva
   Motta, Monique De Albuquerque
   dos Santos, Flavia Barreto
   Vazeille, Marie
   da Costa Vasconcelos, Pedro Fernando
   Lourenco-de-Oliveira, Ricardo
   Failloux, Anna-Bella
TI Potential risk of re-emergence of urban transmission of Yellow Fever
   virus in Brazil facilitated by competent Aedes populations
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RIO-DE-JANEIRO; ATLANTIC FOREST; MOSQUITOS; DENGUE; AEGYPTI; ALBOPICTUS;
   INFECTION; OUTBREAK; VECTORS; ANGOLA
AB Yellow fever virus (YFV) causing a deadly viral disease is transmitted by the bite of infected mosquitoes. In Brazil, YFV is restricted to a forest cycle maintained between non-human primates and forest-canopy mosquitoes, where humans can be tangentially infected. Since late 2016, a growing number of human cases have been reported in Southeastern Brazil at the gates of the most populated areas of South America, the Atlantic coast, with Rio de Janeiro state hosting nearly 16 million people. We showed that the anthropophilic mosquitoes Aedes aegypti and Aedes albopictus as well as the YFV-enzootic mosquitoes Haemagogus leucocelaenus and Sabethes albiprivus from the YFV-free region of the Atlantic coast were highly susceptible to American and African YFV strains. Therefore, the risk of reemergence of urban YFV epidemics in South America is major with a virus introduced either from a forest cycle or by a traveler returning from the YFV-endemic region of Africa.
C1 [Couto-Lima, Dinair; Bersot, Maria Ignez; Campos, Stephanie Silva; Motta, Monique De Albuquerque; dos Santos, Flavia Barreto; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Couto-Lima, Dinair; Vazeille, Marie; Failloux, Anna-Bella] Inst Pasteur Arboviruses & Insect Vectors, Paris, France.
   [Madec, Yoann] Inst Pasteur Epidemiol Infect Dis, Paris, France.
   [da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas, Belem, Para, Brazil.
RP Lourenco-de-Oliveira, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.; Failloux, AB (corresponding author), Inst Pasteur Arboviruses & Insect Vectors, Paris, France.
EM lourenco@ioc.fiocruz.br; anna-bella.failloux@pasteur.fr
RI Vasconcelos, Pedro/AAH-3142-2019; Vasconcelos, Pedro/G-1514-2012
OI Vasconcelos, Pedro/0000-0002-6603-5527; Santos,
   Flavia/0000-0002-1309-5366; Madec, Yoann/0000-0002-6201-1261
FU Institut Pasteur; French Government's Investissement. d'Avenir program,
   Laboratoire d'Excellence "Integrative Biology of Emerging Infectious
   Diseases"French National Research Agency (ANR) [ANR-10-LABX-62-IBEID];
   PTR [528]; CAPES-COFECUBCAPES [799-14]; FAPERJ- Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/102.351/2013-CNE]
FX This study was funded by the Institut Pasteur, the French Government's
   Investissement. d'Avenir program, Laboratoire d'Excellence "Integrative
   Biology of Emerging Infectious Diseases" (grant no ANR-10-LABX-62-IBEID)
   and the PTR (grant no 528), the CAPES-COFECUB (grant 799-14), and the
   FAPERJ- Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro (grant E-26/102.351/2013-CNE). We are grateful to Andre
   Yebakima as well as to Tacilaine Divina Cardoso, Paulo Leite, Marcelo
   Santalucia, Tayssa Pereira dos Santos, Jose Bento Lima, Alessandro
   Romano and Cristiano Fernandes for their help in collecting mosquitoes
   in Congo and Brazil, respectively. We also thank Thais Chouin-Carneiro
   and Rosilainy S. Fernandes for their assistance in the experiments, and
   Heloisa Dinis, Leonidas Leite and Roberta Carvalho for their help in
   making the maps.
CR Alencar J, 2016, REV SOC BRAS MED TRO, V49, P351, DOI 10.1590/0037-8682-0438-2015
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Camara FP, 2011, REV SOC BRAS MED TRO, V44, P297, DOI [10.1590/S0037-86822011005000024, 10.1590/s0037-86822011005000024]
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Consoli RAGB, 1994, EDITORA FIOCRUZ, P228
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   de Filippis AMB, 2002, J MED VIROL, V68, P620, DOI 10.1002/jmv.10226
   de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105
   de Souza RP, 2010, J MED VIROL, V82, P175, DOI 10.1002/jmv.21606
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Gerberg EJ, 1970, AM MOSQ CONTROL ASS, V5, P109
   Goenaga S, 2012, VECTOR-BORNE ZOONOT, V12, P986, DOI 10.1089/vbz.2011.0730
   Health B. M. O., 2017, MINISTERIO SAUDE DIV
   Health B. M. O., 2015, B EPIDEMIOLOGICO, V46, P1
   HOVANITZ W, 1946, PHYSIOL ZOOL, V19, P35, DOI 10.1086/physzool.19.1.30151878
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Ling Y, 2016, EMERG INFECT DIS, V22, P1317, DOI 10.3201/eid2207.160469
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P437, DOI 10.1590/S0074-02762002000300031
   Maciel-De-Freitas R, 2006, J MED ENTOMOL, V43, P1112, DOI 10.1603/0022-2585(2006)43[1112:MODVBT]2.0.CO;2
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   MILLER BR, 1988, T ROY SOC TROP MED H, V82, P476, DOI 10.1016/0035-9203(88)90168-X
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   Oliveira LC, 2012, TROP CONSERV SCI, V5, P112, DOI 10.1177/194008291200500110
   RODHAIN F, 1979, B SOC PATHOL EXOT, V72, P411
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960
   Teixeira B, 2015, WILDLIFE RES, V42, P579, DOI 10.1071/WR14148
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Vazeille M, 2013, VECTOR-BORNE ZOONOT, V13, P37, DOI 10.1089/vbz.2012.0982
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Woodall JP, 2016, INT J INFECT DIS, V48, P96, DOI 10.1016/j.ijid.2016.05.001
NR 40
TC 88
Z9 89
U1 0
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 7
PY 2017
VL 7
AR 4848
DI 10.1038/s41598-017-05186-3
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EZ8JI
UT WOS:000404970900010
PM 28687779
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Heringer, M
   Souza, TMA
   Lima, MDQ
   Nunes, PCG
   Faria, NRD
   de Bruycker-Nogueira, F
   Chouin-Carneiro, T
   Nogueira, RMR
   dos Santos, FB
AF Heringer, Manoela
   Souza, Thiara Manuele A.
   Lima, Monique da Rocha Q.
   Nunes, Priscila Conrado G.
   Faria, Nieli Rodrigues da C.
   de Bruycker-Nogueira, Fernanda
   Chouin-Carneiro, Thais
   Nogueira, Rita Maria R.
   dos Santos, Flavia Barreto
TI Dengue type 4 in Rio de Janeiro, Brazil: case characterization following
   its introduction in an endemic region
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue virus type 4; Laboratorial diagnosis; Phylogeny; Endemic; Rio de
   Janeiro; Brazil
ID VIRUS SEROTYPE 4; VIREMIA; STATE; NS1; SENSITIVITY; DISEASE; PATTERN;
   ELISA
AB Background: Due to the populations' susceptibility, DENV-4 introduction in 2010 led to the occurrence of explosive epidemics in the following years in Brazil. In 2011, DENV-4 was identified in Rio de Janeiro (RJ) and it was prevalent in 2012 and 2013. Here, we aimed to characterize clinical, epidemiological and laboratorial aspects of DENV-4 cases after this serotype introduction in an endemic scenario.
   Methods: Dengue suspected cases (n= 3727) were received and analyzed from January 2011 to December 2013, during outbreaks occurred in RJ, Brazil. Samples were submitted to virological, serological and molecular methods for case confirmation. DENV-4 cases (n = 705) were characterized according to the type of infection, disease severity and, viremia levels and NS1 antigenemia were accessed. Representative strains were partial sequenced for genotyping.
   Results: DENV-4 was identified in 44.2% (705/1593) of dengue positive cases, virus isolated in 48.7% of the cases. Anti-DENV IgM was detected in 39.4% of the cases, however an increased detection was observed in cases with = 4 days of symptoms (57.0%). NS1 antigen was identified in 41.5% of DENV-4 cases however, after immune complexes dissociation, the detection significantly increased (87.6%). Females were more affected than males, so did children aged 11-15 years old. Primary cases were more frequently observed than secondary ones and most of them were classified as dengue. No differences on NS1 antigenemia and viraemia within the groups were observed. Despite the higher frequency of severe disease on individuals > 65 years old, no differences were observed among the groups and type of infection. However, DENV-4 fatal cases were more frequent on secondary infections (57.1%). DENV-4 Genotype II was identified with a probable origin from Venezuela and Colombia.
   Conclusions: It has been shown that laboratorial diagnosis is still a reliable tool for the disease surveillance, detecting and confirming emerging epidemics. Despite the occurrence of secondary infections, most DENV-4 cases presented a mild disease. As RJ is endemic for dengue, high rates of secondary infections would be expected. Despite the existence of two genotypes, only Genotype II was identified in our study.
C1 [Heringer, Manoela; Souza, Thiara Manuele A.; Lima, Monique da Rocha Q.; Nunes, Priscila Conrado G.; Faria, Nieli Rodrigues da C.; de Bruycker-Nogueira, Fernanda; Chouin-Carneiro, Thais; dos Santos, Flavia Barreto] Fiocruz MS, Oswaldo Cruz Inst, Viral Immunol Lab, Av Brasil 4365, BR-21045360 Rio De Janeiro, RJ, Brazil.
   [Nogueira, Rita Maria R.] Oswaldo Cruz Inst, Flavivirus Lab, Rio De Janeiro, Brazil.
RP dos Santos, FB (corresponding author), Fiocruz MS, Oswaldo Cruz Inst, Viral Immunol Lab, Av Brasil 4365, BR-21045360 Rio De Janeiro, RJ, Brazil.
EM flaviab@ioc.fiocruz.br
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPqNational Council for Scientific and Technological
   Development (CNPq) [303822/2015-5]; Programa Estrategico de Pesquisa em
   Saude/PAPES VI-FIOCRUZ [407690/2012-3]; Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro/FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [210.026/2014];
   FIOCRUZ; Brazilian Ministry of Health
FX To Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq
   [grant number 303822/2015-5] and Programa Estrategico de Pesquisa em
   Saude/PAPES VI-FIOCRUZ [grant number 407690/2012-3], to Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), to Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ [grant number
   210.026/2014 to RMR], to FIOCRUZ, and Brazilian Ministry of Health.
CR Amancio FF, 2014, J INFECT PUBLIC HEAL, V7, P547, DOI 10.1016/j.jiph.2014.07.016
   Acosta POA, 2011, EMERG INFECT DIS, V17, P1979, DOI 10.3201/eid1710.110776
   Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   Campos RD, 2013, J CLIN VIROL, V56, P86, DOI 10.1016/j.jcv.2012.10.006
   Claro Lenita Barreto Lorena, 2004, Cad. Saúde Pública, V20, P1447, DOI 10.1590/S0102-311X2004000600002
   de Araujo JMG, 2009, T ROY SOC TROP MED H, V103, P952, DOI 10.1016/j.trstmh.2009.01.025
   dos Santos FB, 2013, DENGUE B, V37, P61
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Figueiredo LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104516
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Huang C. C., 2012, J MICROBIOLOGY IMMUN, p1e5
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lindenbach BD, 2001, FIELDS VIROLOGY, VII, P991, DOI DOI 10.1016/J.JMB.2013.11.024
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   Miagostovich MP, 1997, MEM I OSWALDO CRUZ, V92, P595, DOI 10.1590/S0074-02761997000500006
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Lima MDQ, 2014, J VIROL METHODS, V204, P105, DOI 10.1016/j.jviromet.2014.02.031
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Secretaria de Estado de Saude e Defesa Civil do Rio de Janeiro (SESDEC-RJ), 2009, REL CAS DENG
   Secretaria de Vigilancia em Saude Ministerio da Saude., 2009, INF EP DENG SEM 1 52
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2008, B SEM
   Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Word Health Organization, 2013, SUST DRIV OV GLOB IM, P25
   Word Health Organization, 2009, DENG GUID DIAGN TREA
NR 41
TC 10
Z9 10
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUN 9
PY 2017
VL 17
AR 410
DI 10.1186/s12879-017-2488-4
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA EX2IM
UT WOS:000403049600001
PM 28599640
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Buonora, SN
   dos Santos, FB
   Daumas, RP
   Passos, SRL
   da Silva, MH
   de Lima, MR
   Nogueira, RMR
AF Buonora, Sibelle Nogueira
   dos Santos, Flavia Barreto
   Daumas, Regina Paiva
   Lambert Passos, Sonia Regina
   da Silva, Manoela Heringer
   de Lima, Monique Rocha
   Ribeiro Nogueira, Rita Maria
TI Increased sensitivity of NS1 ELISA by heat dissociation in acute dengue
   4 cases
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE NS1 ELISA; Accuracy; Dengue diagnosis; Immune complex dissociation;
   DENV-4
ID VIRUS-INFECTIONS; ANTIGEN; DIAGNOSIS; GLYCOPROTEIN; BRAZIL; ASSAY
AB Background: Dengue is an acute febrile illness considered the major arboviral disease in terms of morbidity, mortality, economic impact and dissemination worldwide. Brazil accounts for the highest notification rate, with circulation of all four dengue serotypes. The NS1 antigen is a dengue highly conserved specific soluble glycoprotein essential for viral replication and viability that can be detected 0 to 18 days from the onset of fever (peak first 3 days). It induces a strong humoral response and is known as a complement-fixing antigen. Lower NS1 test sensitivity occurs in secondary dengue infections probably due to immune complex formation impairing antigen detection by ELISA.
   Methods: We compared the sensitivity of NS1 ELISA in heat dissociated and non-dissociated samples from 156 RT-PCR confirmed acute dengue-4 cases from 362 prospectively enrolled patients.
   Results: Secondary infections accounted for 83.3% of cases. NS1 ELISA was positive in 42.5% and indeterminate in 10. 2% of dengue-4 cases. After heat dissociation, 7 negative and 16 indeterminate samples turned positive, increasing the overall test sensitivity to 57.7%.
   Conclusions: Although it is time consuming and requires the use of specific laboratory equipment, NS1 ELISA combined with heat dissociation could be a slightly better alternative for triage in suspected dengue cases.
C1 [Buonora, Sibelle Nogueira; Lambert Passos, Sonia Regina] Fundacao Oswaldo Cruz, Lab Clin Epidemiol, Natl Inst Infect Dis Evandro Chagas, Ave Brasil,4036 Sala 201 A Manguinhos, BR-21040361 Rio De Janeiro, Brazil.
   [dos Santos, Flavia Barreto; da Silva, Manoela Heringer; de Lima, Monique Rocha; Ribeiro Nogueira, Rita Maria] Fundacao Oswaldo Cruz, Flavivirus Lab, Oswaldo Cruz Inst, Inst Oswaldo Cruz Pavilhao Helio & Peggy Pereira, Ave Brasil,4365, BR-21040900 Rio De Janeiro, Brazil.
   [Daumas, Regina Paiva] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Germano Sinval Faria Teaching Primary Care Ctr, Rua Leopoldo Bulhoes,1480 Bonsucesso, BR-21041210 Rio De Janeiro, Brazil.
RP Buonora, SN (corresponding author), Fundacao Oswaldo Cruz, Lab Clin Epidemiol, Natl Inst Infect Dis Evandro Chagas, Ave Brasil,4036 Sala 201 A Manguinhos, BR-21040361 Rio De Janeiro, Brazil.
EM sibellebuonora@gmail.com
RI DAUMAS, REGINA/M-9387-2013
OI DAUMAS, REGINA/0000-0002-8923-7711; Passos, Sonia/0000-0001-9947-2291;
   Buonora, Sibelle/0000-0002-0843-1783; Santos, Flavia/0000-0002-1309-5366
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico- CNPq
   through CNPq/PROEP [402068/2012-2]; CNPq/REBRATS [401366/2013];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [311414/2013-3]
FX This study was funded by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico- CNPq through CNPq/PROEP 402068/2012-2 grant
   and CNPq/REBRATS 401366/2013 grant. SRLP is funded through CNPq
   311414/2013-3 grant. The sponsors were not involved in the design,
   sample collection and handling, analysis, data interpretation or
   conclusions.
CR [Anonymous], 2009, DENG DIAGN TREATM PR
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bossuyt PM, 2003, AM J CLIN PATHOL, V119, P18, DOI 10.1309/8EXCCM6YR1THUBAF
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Buonora SN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1368-7
   da Costa VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094655
   Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244
   FALCONAR AKI, 1990, J VIROL METHODS, V30, P323, DOI 10.1016/0166-0934(90)90075-Q
   Sea VRF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064056
   Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227
   Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lapphra K, 2008, DIAGN MICR INFEC DIS, V60, P387, DOI 10.1016/j.diagmicrobio.2007.11.010
   Lima MRQ, 2014, CLIN INSIGHTS DENGUE, P27
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Lima MDQ, 2014, J VIROL METHODS, V204, P105, DOI 10.1016/j.jviromet.2014.02.031
   Lima MDQ, 2011, CLIN VACCINE IMMUNOL, V18, P1031, DOI 10.1128/CVI.00024-11
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P179, DOI 10.1590/S0074-02762000000700030
   SCHUPBACH J, 1993, J VIROL METHODS, V43, P247, DOI 10.1016/0166-0934(93)90080-B
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06
NR 23
TC 3
Z9 3
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 11
PY 2017
VL 17
AR 204
DI 10.1186/s12879-017-2306-z
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA EP5BB
UT WOS:000397392900001
PM 28284209
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Oludele, J
   Lesko, B
   Gundane, IM
   de Bruycker-Nogueira, F
   Muianga, A
   Ali, S
   Mula, F
   Chelene, I
   Falk, KI
   dos Santos, FB
   Gudo, ES
AF Oludele, John
   Lesko, Birgitta
   Gundane, Isabel Mahumane
   de Bruycker-Nogueira, Fernanda
   Muianga, Argentina
   Ali, Sadia
   Mula, Flora
   Chelene, Imelda
   Falk, Kerstin I.
   dos Santos, Flavia Barreto
   Gudo, Eduardo Samo
TI Dengue Virus Serotype 2 Established in Northern Mozambique (2015-2016)
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID OUTBREAK; AFRICA
AB After the report of an outbreak of dengue virus serotype 2 in 2014 in Nampula and Pemba cities, northern Mozambique, a surveillance system was established by the National Institute of Health. A study was performed during 2015-2016 to monitor the trend of the outbreak and confirm the circulating serotype of dengue virus (DENV). After the inclusion of consenting patients who met the case definition, samples from 192 patients were tested for the presence of nonstructural protein 1 antigen, and 60/192 (31%) samples were positive. Further analysis included DENVIgM antibodies, with 39 (20%) IgM positive cases. Reverse transcriptase (RT) PCR was performed for identification of the prevailing DENV serotype; 21/23 tested samples were DENV-2 positive, with DENV-2 present in both affected cities. When sequencing DENV, phenotype Cosmopolitan was identified. The surveillance indicates ongoing spread of DENV-2 in northern Mozambique 2 years after the first report of the outbreak.
C1 [Oludele, John; Gundane, Isabel Mahumane; Muianga, Argentina; Ali, Sadia; Mula, Flora; Chelene, Imelda; Gudo, Eduardo Samo] Minist Hlth, NIH, Maputo, Mozambique.
   [Lesko, Birgitta; Falk, Kerstin I.] Publ Hlth Agcy Sweden, SE-17182 Solna, Sweden.
   [Lesko, Birgitta] Karolinska Inst, Dept Lab Med, Stockholm, Sweden.
   [de Bruycker-Nogueira, Fernanda; dos Santos, Flavia Barreto] Oswaldo Cruz Inst, Flavivirus Reference Lab, Rio De Janeiro, Brazil.
   [Falk, Kerstin I.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.
RP Lesko, B (corresponding author), Publ Hlth Agcy Sweden, SE-17182 Solna, Sweden.
EM firstjohnoludele@gmail.com; birgitta.lesko@ki.se;
   belinhamahumane@gmail.com; nandanog@ioc.fiocruz.br;
   valiosa.muianga@gmail.com; sadia.abdul.ali@gmail.com;
   flora.mula@gmail.com; ichelene@gmail.com;
   Kerstin.Falk@folkhalsomyndigheten.se; flaviab@ioc.fiocruz.br;
   esamogudojr@gmail.com
OI Santos, Flavia/0000-0002-1309-5366
CR Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Baba M, 2016, REV MED VIROL, V26, P183, DOI 10.1002/rmv.1877
   Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Caron M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078030
   CDC, 2013, CDC DENV 1 4 REAL TI
   Faria NRD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002095
   GUBLER DJ, 1986, AM J TROP MED HYG, V35, P1280, DOI 10.4269/ajtmh.1986.35.1280
   Nunes PCG, 2016, J MED VIROL, V88, P1130, DOI 10.1002/jmv.24464
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Massangaie M, 2016, AM J TROP MED HYG, V94, P413, DOI 10.4269/ajtmh.15-0543
   Vairo F, 2016, EMERG INFECT DIS, V22, P895, DOI 10.3201/eid2205.151462
NR 12
TC 3
Z9 4
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
BP 1418
EP 1422
DI 10.4269/ajtmh.17-0317
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5VW
UT WOS:000423222300022
PM 29016312
OA Green Published, Bronze
DA 2020-12-09
ER

PT J
AU Faria, NRD
   Solorzano, VEF
   de Souza, LJ
   Nogueira, RMR
   de Bruycker-Nogueira, F
   Chouin-Carneiro, T
   Simoes, JBS
   Lima, MDQ
   Pinto, LMD
   Kubelka, CF
   Heringer, M
   de Azeredo, EL
   dos Santos, FB
AF da Costa Faria, Nieli Rodrigues
   Fiestas Solorzano, Victor Edgar
   de Souza, Luiz Jose
   Ribeiro Nogueira, Rita Maria
   de Bruycker-Nogueira, Fernanda
   Chouin-Carneiro, Thais
   Santos Simoes, Jaqueline Bastos
   Queiroz Lima, Monique da Rocha
   de Oliveira Pinto, Luzia Maria
   Kubelka, Claire Fernandes
   Heringer, Manoela
   de Azeredo, Elzinandes Leal
   dos Santos, Flavia Barreto
TI Analysis of Clinical and Laboratory Alterations Related to Dengue Case
   Severity: Comparison between Serotypes 2 and 4 in Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID RIO-DE-JANEIRO; HEMORRHAGIC-FEVER; VIRUS-INFECTION; IN-VITRO;
   REEMERGENCE; DIAGNOSIS; TYPE-4; IMPACT
AB The increase in severe dengue (SD) cases has caused great impact on public health and has concerned authorities of countries where the disease is endemic and epidemics reach high proportions. The recognition of progression signs of this severe disease during the initial febrile phase can be difficult, since the symptoms are often indistinguishable from other febrile diseases. The aim of this study was to evaluate the clinical manifestations and laboratory findings in patients from two dengue outbreaks and their association with the disease. The study was conducted in patients (n = 153) with signs and symptoms consistent with dengue occurred during two distinct epidemics, 2010 and 2013, in the city of Campos dos Goytacazes, Rio de Janeiro, Brazil. According to the 2009 World Health Organization criteria, patients were classified as dengue without warning signs ([ DwoWS] 60.6%, 57/94), dengue with warning signs ([ DwWS] 30.9%, 29/94), and SD (4.25%, 4/94). Patients with DwWS/SD presented lower platelet and leukocyte counts and higher transaminase levels when compared with the DwoWS ones. Interestingly, patients from the epidemic of 2010 caused by dengue virus 2 (DENV-2) had lower platelet counts than patients of the 2013 epidemic caused by DENV-4. Furthermore, plasma leakage, gastrointestinal bleeding, and pleural effusion, hallmarks for a more severe disease, were also more frequently observed in those cases. Although previous studiesmayhave extensively reported the wide range of the clinical aspects of dengue, the characterization of DENV-4 is desirable considering the burden of the disease during epidemics, especially for the health units and hospitals performing patient's management.
C1 [da Costa Faria, Nieli Rodrigues; Fiestas Solorzano, Victor Edgar; de Bruycker-Nogueira, Fernanda; Chouin-Carneiro, Thais; Queiroz Lima, Monique da Rocha; de Oliveira Pinto, Luzia Maria; Kubelka, Claire Fernandes; Heringer, Manoela; de Azeredo, Elzinandes Leal; dos Santos, Flavia Barreto] Brazil Oswaldo Cruz Inst, Oswaldo Cruz Inst, Viral Immunol Lab, Rio De Janeiro, RJ, Brazil.
   [de Souza, Luiz Jose] Hosp Plantadores Cana, Campos Dos Goytacazes, RJ, Brazil.
   [Ribeiro Nogueira, Rita Maria; Santos Simoes, Jaqueline Bastos] Oswaldo Cruz Inst, Flavivirus Lab, Rio De Janeiro, RJ, Brazil.
RP dos Santos, FB (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Flavivirus Lab, Ave Brasil 4365, BR-21045360 Manguinho, RJ, Brazil.
EM nielircf@ioc.fiocruz.br; vicfiso@yahoo.es; luizjosedes@gmail.com;
   rita@ioc.fiocruz.br; nandanog@ioc.fiocruz.br; tatachouin@gmail.com;
   jbsantos@paho.org; moniqueq@ioc.fiocruz.br; lpinto@ioc.fiocruz.br;
   claire@ioc.fiocruz.br; manoela.heringer@ioc.fiocruz.br;
   elzinandes@ioc.fiocruz.br; flaviab@ioc.fiocruz.br
RI Fiestas, Victor/J-6894-2019; Kubelka, Claire F/C-5558-2009
OI Fiestas, Victor/0000-0002-5554-3542; Santos, Flavia/0000-0002-1309-5366
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPqNational Council for Scientific and Technological
   Development (CNPq) [305333/2012-7]; Programa Estrategico de Pesquisa em
   SaUde/PAPES VI-FIOCRUZ [407690/2012-3]; Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro/FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [210.026/2014];
   Oswaldo Cruz Foundation/FIOCRUZ; Brazilian Ministry of Health
FX This work was financially supported by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico/CNPq (grant no. 305333/2012-7),
   Programa Estrategico de Pesquisa em SaUde/PAPES VI-FIOCRUZ (grant no.
   407690/2012-3), Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro/FAPERJ (grant no. 210.026/2014 to Rita Maria Ribeiro Nogueira),
   Oswaldo Cruz Foundation/FIOCRUZ and Brazilian Ministry of Health. Nieli
   Rodrigues da Costa Faria, Thais Chouin-Carneiro, Manoela Heringer, and
   Monique da Rocha Queiroz Lima are fellows from the Coordenacabo de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fernanda de
   Bruycker-Nogueira is a fellow from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico/CNPq.
CR Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x
   Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P46, DOI 10.1111/j.1574-695X.2008.00399.x
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Faria NRD, 2016, T ROY SOC TROP MED H, V110, P228, DOI 10.1093/trstmh/trw013
   Dinh TT, 2010, AM J TROP MED HYG, V83, P774, DOI 10.4269/ajtmh.2010.10-0090
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Heringer M, 2015, T ROY SOC TROP MED H, V109, P268, DOI 10.1093/trstmh/trv006
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Hottz ED, 2013, J THROMB HAEMOST, V11, P951, DOI 10.1111/jth.12178
   Itha S, 2005, NATL MED J INDIA, V18, P127
   Jameel Tahir, 2012, J Ayub Med Coll Abbottabad, V24, P3
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee LK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001676
   Lin CF, 2006, VIRAL IMMUNOL, V19, P127, DOI 10.1089/vim.2006.19.127
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   Murgue B, 1997, J INFECT DIS, V175, P1497, DOI 10.1086/516486
   NAKAO S, 1989, BLOOD, V74, P1235
   Nguyen TL, 1997, RES VIROLOGY, V148, P273, DOI 10.1016/S0923-2516(97)88364-1
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Pan American Health Organization (PAHO), 2016, NUMB REP CAS DENG SE
   Lima MDQ, 2014, J VIROL METHODS, V204, P105, DOI 10.1016/j.jviromet.2014.02.031
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI 10.1172/JCI200421512
   Roy Amrita, 2013, N Am J Med Sci, V5, P480, DOI 10.4103/1947-2714.117313
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Secretaria de Vigilanciaem Saude/ Ministerio da Saude (SVS/ MS), 2014, CAS DENG BRAS GRAND
   SVS/MS - Secretaria de Vigilancia em Saude/Ministerio da Saude Brasil, 2011, DENG DIAGN MAN CLIN
   Tanner L, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000196
   Teixeira MG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4338
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Thomas L, 2008, AM J TROP MED HYG, V78, P990
   Tsai JJ, 2011, J INNATE IMMUN, V3, P530, DOI 10.1159/000322904
   WORLD HEALTH ORGANIZATION (WHO); Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
NR 37
TC 4
Z9 4
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 1
BP 137
EP 145
DI 10.4269/ajtmh.16-0227
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FG1AB
UT WOS:000409523900024
PM 28719315
OA Bronze, Green Published
DA 2020-12-09
ER

PT J
AU Ramos-Castaneda, J
   dos Santos, FB
   Martinez-Vega, R
   de Araujo, JMG
   Joint, G
   Sarti, E
AF Ramos-Castaneda, Jose
   dos Santos, Flavia Barreto
   Martinez-Vega, Ruth
   Galvao de Araujo, Josello Maria
   Joint, Graham
   Sarti, Elsa
TI Dengue in Latin America: Systematic Review of Molecular Epidemiological
   Trends
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID TYPE-3 GENOTYPE-III; VIRUS SEROTYPE 3; PHYLOGENETIC ANALYSIS;
   POPULATION-DYNAMICS; HEMORRHAGIC-FEVER; CO-CIRCULATION; BUENOS-AIRES;
   EVOLUTION; BRAZIL; LINEAGES
AB Dengue, the predominant arthropod-borne viral disease affecting humans, is caused by one of four distinct serotypes (DENV-1, -2, -3 or -4). A literature analysis and review was undertaken to describe the molecular epidemiological trends in dengue disease and the knowledge generated in specific molecular topics in Latin America, including the Caribbean islands, from 2000 to 2013 in the context of regional trends in order to identify gaps in molecular epidemiological knowledge and future research needs. Searches of literature published between 1 January 2000 and 30 November 2013 were conducted using specific search strategies for each electronic database that was reviewed. A total of 396 relevant citations were identified, 57 of which fulfilled the inclusion criteria. All four dengue virus serotypes were present and co-circulated in many countries over the review period (with the predominance of individual serotypes varying by country and year). The number of countries in which more than one serotype circulated steadily increased during the period under review. Molecular epidemiology data were found for Argentina, Bolivia, Brazil, the Caribbean region, Colombia, Ecuador, Mexico and Central America, Paraguay, Peru and Venezuela. Distinct lineages with different dynamics were found in each country, with co-existence, extinction and replacement of lineages occurring over the review period. Despite some gaps in the literature limiting the possibility for comparison, our review has described the molecular epidemiological trends of dengue infection. However, several gaps in molecular epidemiological information across Latin America and the Caribbean were identified that provide avenues for future research; in particular, sequence determination of the dengue virus genome is important for more precise phylogenetic classification and correlation with clinical outcome and disease severity.
C1 [Ramos-Castaneda, Jose] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.
   [dos Santos, Flavia Barreto] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Martinez-Vega, Ruth] Univ Santander, Escuela Med, Santander, Colombia.
   [Galvao de Araujo, Josello Maria] Univ Fed Rio Grande do Norte, Inst Med Trop Rio Grande Norte, Dept Microbiol & Parasitol, Lab Biol Mol Doencas Infecciosas & Canc, Natal, RN, Brazil.
   [Joint, Graham] Synercom Ltd, Macclesfield, Cheshire, England.
   [Sarti, Elsa] Sanofi Pasteur, LATAM, Mexico City, DF, Mexico.
RP Sarti, E (corresponding author), Sanofi Pasteur, LATAM, Mexico City, DF, Mexico.
EM elsa.sarti@sanofipasteur.com
RI Martinez-Vega, Ruth/AAD-3601-2019; Araujo, Joselio M G/B-5502-2013;
   Ramos-Castaneda, jose/V-6678-2019
OI Martinez-Vega, Ruth/0000-0002-6477-334X; Araujo, Joselio M
   G/0000-0003-3548-2786; Santos, Flavia/0000-0002-1309-5366
FU Sanofi Pasteur
FX Sanofi Pasteur sponsored this survey and analysis. The sponsors of this
   study formed part of the literature review group. The role of the
   sponsors in study design, data collection and analysis, decision to
   publish and preparation of the manuscript is detailed below. The
   Literature Review Group, which included members of the sponsor Sanofi
   Pasteur, were responsible for the conception of the literature analysis,
   development of the protocol, data collection, analysis and
   interpretation of data, provision of critical comments, writing the
   paper, and approving the final version to be published. All authors were
   involved in the decision to submit this paper for publication in PLOS
   NTD. All authors confirm that they had full access to all data
   identified during the literature search and analysis.
CR Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320
   Amaral R, 1983, SAUDE BRAS, V4, P236
   Anez G, 2012, AM J TROP MED HYG, V87, P548, DOI 10.4269/ajtmh.2012.12-0091
   Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459
   Anzai S, 2004, VIRUS GENES, V29, P219, DOI 10.1023/B:VIRU.0000036382.77987.84
   Aquino JDJD, 2008, VIRUS RES, V137, P266, DOI 10.1016/j.virusres.2008.07.011
   Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710
   Aquino VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007299
   Aviles G, 2003, VIRUS RES, V98, P75, DOI 10.1016/j.virusres.2003.08.018
   Aviles G, 2002, ARCH VIROL, V147, P2075, DOI 10.1007/s00705-002-0886-3
   Badii MH, 2007, DAENA INT J GOOD CON, V2, P248
   Barrero PR, 2004, VIRUS RES, V101, P135, DOI 10.1016/j.virusres.2003.12.033
   Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Brown MG, 2011, W INDIAN MED J, V60, P114
   Brown MG, 2011, W INDIAN MED J, V60, P120
   Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002
   Campos RD, 2013, J CLIN VIROL, V56, P86, DOI 10.1016/j.jcv.2012.10.006
   Carrillo-Valenzo E, 2010, ARCH VIROL, V155, P1401, DOI 10.1007/s00705-010-0721-1
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Chen WJ, 2003, INTERVIROLOGY, V46, P289, DOI 10.1159/000073208
   Cisneros A, 2006, ARCH VIROL, V151, P113, DOI 10.1007/s00705-005-0595-9
   Colijn Caroline, 2014, Evolution Medicine and Public Health, P96, DOI 10.1093/emph/eou018
   Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005
   Cruz CD, 2013, INFECT GENET EVOL, V18, P220, DOI 10.1016/j.meegid.2013.04.029
   Cruz CD, 2010, AM J TROP MED HYG, V83, P28
   Cruz CD, 2016, J VIROL METHODS, V235, P158, DOI 10.1016/j.jviromet.2016.06.001
   Faria NRD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002095
   de Castro MG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-3
   de Mora D, 2009, ARCH VIROL, V154, P699, DOI 10.1007/s00705-009-0343-7
   de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439
   Diaz FJ, 2006, ARCH MED RES, V37, P760, DOI 10.1016/j.arcmed.2006.02.004
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Dussart P, 2006, EMERG INFECT DIS, V12, P1748, DOI 10.3201/eid1211.060339
   Fansiri T, 2016, EVOL APPL, V9, P608, DOI 10.1111/eva.12360
   Forshey BM, 2009, EMERG INFECT DIS, V15, P1815, DOI 10.3201/eid1511.090663
   de Araujo JMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001784
   de Araujo JMG, 2009, MEM I OSWALDO CRUZ, V104, P526, DOI 10.1590/S0074-02762009000300021
   Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a
   Gotuzzo E, 2000, INFECT DIS CLIN N AM, V14, pXIII, DOI 10.1016/S0891-5520(05)70214-2
   Gubler DJ, 1992, DENGUE WORLDWIDE PRO, P19
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Gutierrez G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001394
   Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Guzman Tirado M G, 1999, Rev Cubana Med Trop, V51, P5
   Halstead Scott B., 2008, V5, P1
   Iovine NM, 2016, CLIN INFECT DIS
   Isturiz RE, 2000, INFECT DIS CLIN N AM, V14, P121, DOI 10.1016/S0891-5520(05)70221-X
   Villabona-Arenas CJ, 2009, TROP MED INT HEALTH, V14, P1241, DOI 10.1111/j.1365-3156.2009.02339.x
   Kochel T, 2008, INFECT GENET EVOL, V8, P682, DOI 10.1016/j.meegid.2008.06.008
   Kochel TJ, 2002, LANCET, V360, P310, DOI 10.1016/S0140-6736(02)09522-3
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Mamani Enrique, 2011, Rev. perú. med. exp. salud publica, V28, P72
   Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Nogueira ML, 2008, INT J INFECT DIS, V12, pE333, DOI 10.1016/j.ijid.2008.05.890
   Nogueira MB, 2008, MEM I OSWALDO CRUZ, V103, P483, DOI 10.1590/S0074-02762008000500013
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996
   Pan American Health Organization (PAHO), 2013, NUMBER OF REPORTED C
   Pan American Health Organization (PAHO), 2014, KEY FACTS ON VECTOR
   Pan American Health Organization (PAHO), 2015, DATA MAPS AND STATIS
   Peyrefitte CN, 2005, EMERG INFECT DIS, V11, P757, DOI 10.3201/eid1105.040959
   Peyrefitte CN, 2003, J CLIN MICROBIOL, V41, P5195, DOI 10.1128/JCM.41.11.5195-5198.2003
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Ramirez A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-329
   Regato M, 2008, VIRUS RES, V132, P197, DOI 10.1016/j.virusres.2007.10.012
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Roca Y, 2009, VECTOR-BORNE ZOONOT, V9, P337, DOI 10.1089/vbz.2008.0187
   Rodriguez-Roche R, 2005, EMERG INFECT DIS, V11, P773
   Rodriguez-Roche R, 2012, INFECT GENET EVOL, V12, P332, DOI 10.1016/j.meegid.2011.12.005
   Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811
   Barrero PR, 2008, VIRUS RES, V135, P83, DOI 10.1016/j.virusres.2008.02.013
   Santiago GA, 2012, J INFECT DIS, V206, P893, DOI 10.1093/infdis/jis426
   Schmidt DJ, 2011, INFECT GENET EVOL, V11, P2011, DOI 10.1016/j.meegid.2011.09.010
   Schneider J, 2001, TIME LINE FOR DENGUE
   Selck FW, 2014, VECTOR-BORNE ZOONOT, V14, P824, DOI 10.1089/vbz.2013.1528
   Sharp TM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002159
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Usme-Ciro JA, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-101
   Uzcategui NY, 2003, J GEN VIROL, V84, P1569, DOI 10.1099/vir.0.18807-0
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   World Health Organization, 2012, GLOB ACT PLAN CONTR, P1, DOI DOI 10.1016/S0968-8080(12)40660-7
NR 96
TC 30
Z9 31
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2017
VL 11
IS 1
AR e0005224
DI 10.1371/journal.pntd.0005224
PG 24
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EK8CR
UT WOS:000394152000026
PM 28068335
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU de Bruycker-Nogueira, F
   Mir, D
   dos Santos, FB
   Bello, G
AF de Bruycker-Nogueira, Fernanda
   Mir, Daiana
   dos Santos, Flavia Barreto
   Bello, Gonzalo
TI Evolutionary history and spatiotemporal dynamics of DENV-1 genotype V in
   the Americas
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE DENV-1; Genotype V; Lineages; Phylogeny; Evolution; Americas
ID DENGUE HEMORRHAGIC-FEVER; POPULATION-DYNAMICS; LINEAGE REPLACEMENT;
   CO-CIRCULATION; KEY-WEST; VIRUS; TYPE-1; BRAZIL; REVEALS; PHYLOGEOGRAPHY
AB The genotype V has been the most prevalent dengue virus type 1 (DENV-1) clade circulating in the Americas over the last 40 years. In this study, we investigate the spatiotemporal pattern of emergence and dissemination of DENV-1 lineages in the continent. We applied phylogenetic and phylogeographic approaches to a comprehensive data set of 836 DENV-1 E gene sequences of the genotype V isolated from 46 different countries around the world over a period of 50 years (1962 to 2014). Our study reveals that genetic diversity of DENV-1 genotype V in the Americas resulted from two independent introductions of this genotype from India. The first genotype V strain was most probably introduced into the Lesser Antilles at around the early 1970s and this Caribbean region becomes the source population of several DENV-1 lineages that spread in the Americas during the 1970s and 1980s. Most of those lineages appear to become extinct during the 1990s, except one that persisted in Venezuela and later spread to other American countries, dominating the DENV-1 epidemics in the region from the early 2000s onwards. The second genotype V strain of Indian origin was also most probably introduced into the Lesser Antilles at around the early 1980s. This lineage remained almost undetected for nearly 15 years, until it was introduced in Northern Brazil around the middle 1990s and later spread to other country regions. These results demonstrate that different geographic regions have played a role in maintaining and spreading the DENV-1 genotype V in the Americas over time. DENV-1 genotype V lineages have originated, spread and died out in the Americas with very different dynamics and the phenomenon of lineage replacement across successive DENV-1 epidemic outbreaks was a common characteristic in most American countries. (C) 2016 Elsevier B.V. All rights reserved.
C1 [de Bruycker-Nogueira, Fernanda; dos Santos, Flavia Barreto] Fiocruz MS, Oswaldo Cruz Inst, Lab Viral Immunol, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Mir, Daiana; Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Mol Immunol, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP dos Santos, FB (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Viral Immunol, Av Brasil 4365, BR-21045360 Rio De Janeiro, RJ, Brazil.
EM flaviab@ioc.fiocruz.br
RI , daiana/J-5515-2019; Bentancor, Gonzalo Jose Bello/N-7377-2019; Bello,
   Gonzalo/E-6842-2013
OI , daiana/0000-0002-3172-4867; Bentancor, Gonzalo Jose
   Bello/0000-0002-2724-2793; 
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPqNational Council for Scientific and Technological
   Development (CNPq) [303822/2015-5]; Programa Estrategico de Pesquisa em
   Saude/PAPES VI-FIOCRUZ [407690/2012-3]; "Agencia Nacional de
   Investigacion e Innovacion (ANII-Uruguay)"; "Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)"CAPES
FX To Postgraduate in Parasitary Biology at Oswaldo Cruz Institute/FIOCRUZ
   and Third International Bioinformatics Workshop on Molecular Biology and
   Evolution of Viruses for complementary training of FBN. This work was
   supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPq [grant number 303822/2015-5] and Programa Estrategico
   de Pesquisa em Saude/PAPES VI-FIOCRUZ [grant number 407690/2012-3]. DM
   is funded by a fellowship from "Agencia Nacional de Investigacion e
   Innovacion (ANII-Uruguay)". FBN and DM have fellowships from the
   "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)".
CR Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320
   Anez G, 2012, AM J TROP MED HYG, V87, P548, DOI 10.4269/ajtmh.2012.12-0091
   Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016
   Carrillo-Valenzo E, 2010, ARCH VIROL, V155, P1401, DOI 10.1007/s00705-010-0721-1
   Cunha MD, 2016, INFECT GENET EVOL, V43, P130, DOI 10.1016/j.meegid.2016.05.021
   de Bruycker-Nogueira F, 2015, INFECT GENET EVOL, V34, P126, DOI 10.1016/j.meegid.2015.07.007
   dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226
   Mir D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098519
   Munoz-Jordan JL, 2013, EMERG INFECT DIS, V19, P652, DOI 10.3201/eid1904.121295
   Piersen TC, 2013, FIELDS VIROLOGY, P747
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rambaut A., 2012, FIGTREE 1 4 0
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Tittarelli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111017
   Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649
   Villabona-Arenas CJ, 2011, INFECT GENET EVOL, V11, P878, DOI 10.1016/j.meegid.2011.02.007
   Walimbe AM, 2014, INFECT GENET EVOL, V22, P30, DOI 10.1016/j.meegid.2014.01.001
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
NR 35
TC 12
Z9 12
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD NOV
PY 2016
VL 45
BP 454
EP 460
DI 10.1016/j.meegid.2016.09.025
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA ED0ZY
UT WOS:000388574400060
PM 27713055
OA Bronze
DA 2020-12-09
ER

PT J
AU Calvet, GA
   dos Santos, FB
   Sequeira, PC
AF Calvet, Guilherme Amaral
   dos Santos, Flavia Barreto
   Sequeira, Patricia Carvalho
TI Zika virus infection: epidemiology, clinical manifestations and
   diagnosis
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review
DE Guillain-Barre syndrome; microcephaly; sexual transmission; Zika virus
ID RT-PCR
AB Purpose of reviewZika virus (ZIKV) is an arbovirus previously believed to cause only a mild and self-limiting illness. Recently, it has emerged as a new public health threat that caused a large outbreak in French Polynesia in 2013-2014 and since 2015 an explosive outbreak in Brazil, with an increase in severe congenital malformations (microcephaly) and neurological complications, mainly Guillain-Barre syndrome (GBS). Since then, it has spread through the Americas. On 1 February 2016, the WHO declared the ZIKV epidemic in Brazil a Public Health Emergency of International Concern. We reviewed the epidemiology of ZIKV infection, clinical presentations and diagnosis. We highlighted the clinical features and nonvector borne transmission of the virus.Recent findingsAssociation between ZIKV infection and severe foetal outcomes, including microcephaly and other birth defects; increased rate of GBS and other neurological complications due to the ongoing ZIKV outbreak; increased evidence to date of ZIKV being the only arbovirus linked to sexual transmission; the challenge of ZIKV diagnosis; and the need for a specific point-of care test in epidemic scenarios.SummaryThe findings illustrate the emergence of a viral disease with the identification of new associated disorders, new modes of transmission, including maternal-foetal and sexual transmission.
C1 [Calvet, Guilherme Amaral] Fundacao Oswaldo Cruz, Acute Febrile Illnesses Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [dos Santos, Flavia Barreto; Sequeira, Patricia Carvalho] Fundacao Oswaldo Cruz, Flavivirus Lab, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Calvet, GA (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, Ave Brasil 4365, BR-21045360 Rio De Janeiro, Brazil.
EM guilherme.calvet@ini.fiocruz.br
RI Calvet, GA/G-6959-2013
OI Calvet, GA/0000-0002-3545-5238
CR Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   CHOW VTK, 1993, ARCH VIROL, V133, P157, DOI 10.1007/BF01309751
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fang MY, 1997, MICROBIOL IMMUNOL, V41, P209, DOI 10.1111/j.1348-0421.1997.tb01192.x
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gaunt MW, 2005, J VIROL METHODS, V128, P113, DOI 10.1016/j.jviromet.2005.04.006
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
NR 21
TC 49
Z9 49
U1 0
U2 138
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD OCT
PY 2016
VL 29
IS 5
BP 459
EP 466
DI 10.1097/QCO.0000000000000301
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DW8QC
UT WOS:000383919600005
PM 27496713
DA 2020-12-09
ER

PT J
AU Nunes, PCG
   Paes, MV
   de Oliveira, CAB
   Soares, ACG
   de Filippis, AMB
   Lima, MDQ
   Alves, AMD
   da Silva, JFA
   Coelho, JMCD
   Rodrigues, FDD
   Nogueira, RMR
   dos Santos, FB
AF Guerra Nunes, Priscila Conrado
   Paes, Marciano Viana
   Basilio de Oliveira, Carlos Alberto
   Gomes Soares, Ana Carla
   Bispo de Filippis, Ana Maria
   Queiroz Lima, Monique da Rocha
   de Barcelos Alves, Ada Maria
   Amorim da Silva, Juliana Fernandes
   Chicarino de Oliveira Coelho, Janice Mery
   de Carvalho Rodrigues, Francisco das Chagas
   Ribeiro Nogueira, Rita Maria
   dos Santos, Flavia Barreto
TI Detection of Dengue NS1 and NS3 Proteins in Placenta and Umbilical Cord
   in Fetal and Maternal Death
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE dengue; NS1; NS3; maternal and fetal death; Brazil
AB In Brazil, dengue is a public health problem with the occurrence of explosive epidemics. This study reports maternal and fetal deaths due to dengue and which tissues of placenta and umbilical cord were analyzed by molecular methods and immunohistochemistry. The dengue NS3 and NS1 detection revealed the viral presence in different cells from placenta and umbilical cord. In the latter, DENV-2 was detected at a viral titer of 1,02 x 10(4) amounts of viral RNA. It was shown that the DENV markers analyzed here may be an alternative approach for dengue fatal cases investigation, especially involving maternal and fetal death. (C) 2016 Wiley Periodicals, Inc.
C1 [Guerra Nunes, Priscila Conrado; Bispo de Filippis, Ana Maria; Queiroz Lima, Monique da Rocha; Ribeiro Nogueira, Rita Maria; dos Santos, Flavia Barreto] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Paes, Marciano Viana; de Barcelos Alves, Ada Maria; Amorim da Silva, Juliana Fernandes] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, RJ, Brazil.
   [Basilio de Oliveira, Carlos Alberto] Univ Fed Estado Rio de Janeiro, Dept Anat Patol, Hosp Univ Gaffree Guinle, Rio De Janeiro, Brazil.
   [Gomes Soares, Ana Carla] Secretaria Municipal Saude Rio de Janeiro, Subsecretaria Atencao Primaria Vigilancia & Promo, Rio De Janeiro, RJ, Brazil.
   [Chicarino de Oliveira Coelho, Janice Mery; de Carvalho Rodrigues, Francisco das Chagas] Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol, Lab Anat Patol, Rio De Janeiro, RJ, Brazil.
RP dos Santos, FB (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
EM flaviab@ioc.fiocruz.br
OI Paes, Marciano/0000-0002-2266-2801
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Programa Estrategico de Pesquisa em Saude /PAPES VI-FIOCRUZ
   [407690/2012-3]; Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro /FAPERJCarlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [210.026/2014]; Oswaldo Cruz
   Foundation/FIOCRUZ; Brazilian Ministry of Health
FX Grant sponsor: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq); Grant sponsor: Programa Estrategico de Pesquisa em
   Saude /PAPES VI-FIOCRUZ; Grant number: 407690/2012-3; Grant sponsor:
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro /FAPERJ; Grant
   number: 210.026/2014; Grant sponsor: Oswaldo Cruz Foundation/FIOCRUZ;
   Grant sponsor: Brazilian Ministry of Health
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059
   Dalrymple NA, 2012, ADV VIROL, V2012, DOI 10.1155/2012/840654
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Figueiredo Luiz Tadeu Moraes, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P417, DOI 10.1590/S0036-46651994000500005
   Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   da Mota AKM, 2012, CAD SAUDE PUBLICA, V28, P1057, DOI 10.1590/S0102-311X2012000600005
   Maroun SLC, 2008, J PEDIAT-BRAZIL, V84, P556, DOI 10.1590/S0021-75572008000700014
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Miller N, 2010, CURR OPIN MOL THER, V12, P31
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Ribeiro CF, 2012, INT J INFECT DIS, V16, pE72, DOI 10.1016/j.ijid.2011.09.005
   SVS. (Secretaria de Vigilancia em Saude), 2014, OB HEM DENG
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06
NR 20
TC 6
Z9 6
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD AUG
PY 2016
VL 88
IS 8
BP 1448
EP 1452
DI 10.1002/jmv.24479
PG 5
WC Virology
SC Virology
GA DW5FU
UT WOS:000383669500023
PM 26792253
DA 2020-12-09
ER

PT J
AU Nunes, PCG
   Sampaio, SAF
   da Costa, NR
   de Mendonca, MCL
   Lima, MDQ
   Araujo, SEM
   dos Santos, FB
   Simoes, JBS
   Goncalves, BD
   Nogueira, RMR
   de Filippis, AMB
AF Guerra Nunes, Priscila Conrado
   Faria Sampaio, Simone Alves
   da Costa, Nieli Rodrigues
   Lima de Mendonca, Marcos Cesar
   Queiroz Lima, Monique da Rocha
   Araujo, Saraiva Eliane M.
   dos Santos, Flavia Barreto
   Santos Simoes, Jaqueline Basto
   Goncalves, Bianca de Santis
   Ribeiro Nogueira, Rita Maria
   Bispo de Filippis, Ana Maria
TI Dengue severity associated with age and a new lineage of dengue
   virus-type 2 during an outbreak in Rio De Janeiro, Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE viremia; qRT-PCR; genotype; dengue outbreaks
ID HEMORRHAGIC-FEVER; VIRAL LOAD; PATHOGENESIS; INFECTIONS; ANTIBODY;
   SEROTYPE
AB Dengue virus-type 2 (DENV-2) caused three outbreaks, in the years 1990, 1998, and 2008, in Rio de Janeiro, Brazil. The 2008 outbreak was the most severe in reported cases, hospitalizations, and deaths. To investigate virological and epidemiological factors that may have contributed to the pathogenic profile of 2008 epidemic, 102 patients sera obtained during the epidemic and inter-epidemic periods of three outbreaks were analysed by qRT-PCR to estimate viremia levels and their correlation with the clinical, immunological, and demographic patient characteristics. DENV-2 isolates from the outbreaks were sequenced. Two DENV-2 lineages (I and II) of the American/Asian genotype were confirmed, each exclusive for 1990-2002 and 2007-2011, respectively. The mean viremia level in the 2008 samples was two orders of magnitude higher than that of the 1990-2002 samples. Severe dengue cases increased from 31% in 1990-2002 to 69% in 2007-2011; in patients aged 15 years, from 3% in 1990-2002 to 37% in 2007-2011. The DENV-2 lineage II and younger age significantly contributed to the pathogenic profile of 2008 epidemic in Rio de Janeiro. J. Med. Virol. 88:1130-1136, 2016. (c) 2016 Wiley Periodicals, Inc.
C1 [Guerra Nunes, Priscila Conrado; Faria Sampaio, Simone Alves; da Costa, Nieli Rodrigues; Lima de Mendonca, Marcos Cesar; Queiroz Lima, Monique da Rocha; Araujo, Saraiva Eliane M.; dos Santos, Flavia Barreto; Santos Simoes, Jaqueline Basto; Goncalves, Bianca de Santis; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Inst Oswaldo Cruz, Oswaldo Cruz Fdn, Flavivirus Lab, BR-20001 Rio De Janeiro, Brazil.
RP de Filippis, AMB (corresponding author), FIOCRUZ IOC, Ave Brasil, BR-4365 Manguinho, RJ, Brazil.
EM abispo@ioc.fiocruz.br
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [304872/2011-3]; Fundacao de Amparo a Pesquisa no Estado do Rio de
   Janeiro-FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [E-26/110.663/2013, E/-26/103.149/2011]
FX Grant sponsor: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - CNPq; Grant number: 304872/2011-3; Grant sponsor: Fundacao
   de Amparo a Pesquisa no Estado do Rio de Janeiro-FAPERJ; Grant numbers:
   E-26/110.663/2013; E/-26/103.149/2011
CR Alvarez M, 2006, AM J TROP MED HYG, V75, P1113, DOI 10.4269/ajtmh.2006.75.1113
   Azevedo AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020528
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Faria NRD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002095
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Gibson G, 2013, CAD SAUDE PUBLICA, V29, P82, DOI 10.1590/S0102-311X2013000100010
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P261
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Macedo GA, 2013, T ROY SOC TROP MED H, V107, P141, DOI 10.1093/trstmh/trs091
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Ramos R, 2014, REV BRASILEIRA GEOGR, V10, P58
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811
   ROSEN L, 1986, S AFR MED J, P40
   Silva LK, 2010, EUR J HUM GENET, V18, P1221, DOI 10.1038/ejhg.2010.98
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Siqueira Jr JB, 2010, SAUDE BRASIL 2010 AN
   SVS (Secretaria de Vigilancia Sanit aria), 2012, GER PROGR NAC DENG
   SVS (Secretaria de Vigilancia Sanitaria), 2008, REL CAS DENG
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Thomas L, 2008, AM J TROP MED HYG, V78, P990
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vu TT, 2010, PLOS NEGLECT TROP D, V4, pe57
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   WORLD HEALTH ORGANIZATION, 2009, DENGUE: GUIDELINES FOR DIAGNOSIS, TREATMENT, PREVENTION AND CONTROL, P3
NR 32
TC 15
Z9 16
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JUL
PY 2016
VL 88
IS 7
BP 1130
EP 1136
DI 10.1002/jmv.24464
PG 7
WC Virology
SC Virology
GA DJ2UW
UT WOS:000374061600004
PM 27061403
DA 2020-12-09
ER

PT J
AU Calvet, G
   Aguiar, RS
   Melo, ASO
   Sampaio, SA
   de Filippis, I
   Fabri, A
   Araujo, ESM
   de Sequeira, PC
   de Mendonca, MCL
   de Oliveira, L
   Tschoeke, DA
   Schrago, CG
   Thompson, FL
   Brasil, P
   dos Santos, FB
   Nogueira, RMR
   Tanurit, A
   Filippis, AMB
AF Calvet, Guilherme
   Aguiar, Renato S.
   Melo, Adriana S. O.
   Sampaio, Simone A.
   de Filippis, Ivano
   Fabri, Allison
   Araujo, Eliane S. M.
   de Sequeira, Patricia C.
   de Mendonca, Marcos C. L.
   de Oliveira, Louisi
   Tschoeke, Diogo A.
   Schrago, Carlos G.
   Thompson, Fabiano L.
   Brasil, Patricia
   dos Santos, Flavia B.
   Nogueira, Rita M. R.
   Tanurit, Amilcar
   de Filippis, Ana M. B.
TI Detection and sequencing of Zika virus from amniotic fluid of fetuses
   with microcephaly in Brazil: a case study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID CHIKUNGUNYA-VIRUS; INFECTION; OUTBREAK; FEVER
AB Background The incidence of microcephaly in Brazil in 2015 was 20 times higher than in previous years. Congenital microcephaly is associated with genetic factors and several causative agents. Epidemiological data suggest that microcephaly cases in Brazil might be associated with the introduction of Zika virus. We aimed to detect and sequence the Zika virus genome in amniotic fluid samples of two pregnant women in Brazil whose fetuses were diagnosed with microcephaly.
   Methods In this case study, amniotic fluid samples from two pregnant women from the state of Paraiba in Brazil whose fetuses had been diagnosed with microcephaly were obtained, on the recommendation of the Brazilian health authorities, by ultrasound-guided transabdominal amniocentesis at 28 weeks' gestation. The women had presented at 18 weeks' and 10 weeks' gestation, respectively, with clinical manifestations that could have been symptoms of Zika virus infection, including fever, myalgia, and rash. After the amniotic fluid samples were centrifuged, DNA and RNA were extracted from the purified virus particles before the viral genome was identified by quantitative reverse transcription PCR and viral metagenomic next-generation sequencing. Phylogenetic reconstruction and investigation of recombination events were done by comparing the Brazilian Zika virus genome with sequences from other Zika strains and from flaviviruses that occur in similar regions in Brazil.
   Findings We detected the Zika virus genome in the amniotic fluid of both pregnant women. The virus was not detected in their urine or serum. Tests for dengue virus, chikungunya virus, Toxoplasma gondii, rubella virus, cytomegalovirus, herpes simplex virus, HIV, Treponema pallidum, and parvovirus B19 were all negative. After sequencing of the complete genome of the Brazilian Zika virus isolated from patient 1, phylogenetic analyses showed that the virus shares 97-100% of its genomic identity with lineages isolated during an outbreak in French Polynesia in 2013, and that in both envelope and NS 5 genomic regions, it clustered with sequences from North and South America, southeast Asia, and the Pacific. After assessing the possibility of recombination events between the Zika virus and other flaviviruses, we ruled out the hypothesis that the Brazilian Zika virus genome is a recombinant strain with other mosquito-borne flaviviruses.
   Interpretation These findings strengthen the putative association between Zika virus and cases of microcephaly in neonates in Brazil. Moreover, our results suggest that the virus can cross the placental barrier. As a result, Zika virus should be considered as a potential infectious agent for human fetuses. Pathogenesis studies that confirm the tropism of Zika virus for neuronal cells are warranted.
C1 [Calvet, Guilherme; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, BR-21040900 Rio De Janeiro, Brazil.
   [Sampaio, Simone A.; Fabri, Allison; Araujo, Eliane S. M.; de Sequeira, Patricia C.; de Mendonca, Marcos C. L.; dos Santos, Flavia B.; Nogueira, Rita M. R.; de Filippis, Ana M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
   [de Filippis, Ana M. B.] Fundacao Oswaldo Cruz, Inst Nacl Controle & Qualidade, BR-21040900 Rio De Janeiro, Brazil.
   [Aguiar, Renato S.; de Oliveira, Louisi; Schrago, Carlos G.; Tanurit, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.
   [Tschoeke, Diogo A.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.
   [Melo, Adriana S. O.] Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Campina Grande, Brazil.
   [Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Lab Sistemas Avancados Gestao Prod SAGE COPPE, Ctr Gestaotecnol CT2, Rio de Janeiro, Brazil.
RP Filippis, AMB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
EM abispo@ioc.fiocruz.br
RI Calvet, GA/G-6959-2013; de Filippis, Ivano/X-8759-2019; Schrago,
   Carlos/E-4612-2012; Melo, Adriana S O/H-5650-2016; amsalu,
   ribka/G-8780-2019; Aguiar, Renato S/G-3542-2015; Tschoeke, Diogo
   A/F-9913-2019
OI Calvet, GA/0000-0002-3545-5238; de Filippis, Ivano/0000-0003-0610-8648;
   Schrago, Carlos/0000-0001-6257-8906; Aguiar, Renato
   S/0000-0001-5180-3717; Tschoeke, Diogo A/0000-0001-8134-4259; Thompson,
   Fabiano/0000-0002-7562-1683
FU Consellho Nacional de Desenvolvimento e Pesquisa (CNPq)National Council
   for Scientific and Technological Development (CNPq); Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX Consellho Nacional de Desenvolvimento e Pesquisa (CNPq), Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brazilian Ministry of Health, 2016, MINIST SAFICLE INVES
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Onis M, 2008, LANCET, V371, P204, DOI 10.1016/S0140-6736(08)60131-2
   De Vries LS, 2004, NEUROPEDIATRICS, V35, P113, DOI 10.1055/s-2004-815833
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437
   Harris SR, 2013, DEV NEUROREHABIL, V16, P129, DOI 10.3109/17518423.2012.737040
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Lanari M, 2012, EARLY HUM DEV, V88, pS3, DOI 10.1016/S0378-3782(12)70003-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Sibley SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098569
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 30
TC 570
Z9 594
U1 7
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 653
EP 660
DI 10.1016/S1473-3099(16)00095-5
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500044
PM 26897108
OA Bronze, Green Published
DA 2020-12-09
ER

PT J
AU Faria, NRD
   Solorzano, VEF
   Nogueira, RMR
   Chouin-Carneiro, T
   Nunes, PCG
   Simoes, JBS
   Nogueira, FD
   Lima, MDQ
   Pinto, LMD
   Kubelka, CF
   da Cunhac, RV
   de Azeredo, EL
   dos Santos, FB
AF da Costa Faria, Nieli Rodrigues
   Fiestas Solorzano, Victor Edgar
   Ribeiro Nogueira, Rita Maria
   Chouin-Carneiro, Thais
   Guerra Nunes, Priscila Conrado
   Santos Simoes, Jaqueline Bastos
   Nogueira, Fernanda de Bruycker
   Queiroz Lima, Monique da Rocha
   de Oliveira Pinto, Luzia Maria
   Kubelka, Claire Fernandes
   da Cunhac, Rivaldo Venancio
   de Azeredo, Elzinandes Leal
   dos Santos, Flavia Barreto
TI Dengue epidemics in two distinct periods reveal distinct
   epidemiological, laboratorial and clinical aspects in a same scenario:
   analysis of the 2010 and 2013 epidemics in Mato Grosso do Sul, Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Brazil; Clinical aspects; Dengue virus; Diagnosis; Epidemics; NS1
ID DISEASE SEVERITY; VIRUS; SEROTYPES; CLASSIFICATION; CIRCULATION;
   INFECTIONS; ANTIGEN; BURDEN; STATE; NS1
AB Background: Dengue is a major problem in Brazil. Epidemiological and clinical aspects were characterized in patients from two epidemics which occurred in Mato Grosso do Sul, Brazil.
   Methods: Dengue cases were classified according to the 2009 WHO criteria, tested by serological and molecular biology tests and analysed for nonstructural protein 1 (NS1) antigenemia.
   Results: Dengue was confirmed in 78.7% (48/61) and 75.6% (118/156) of the cases studied in 2010 and 2013, respectively. DENV-1 and DENV-2 were the serotypes involved in the 2010 epidemic and DENV-4 in the 2013 one. Most of the cases were classified as dengue without warning; however, severe dengue was observed in 18.7% (9/48) of the cases in 2010 and less observed in DENV-4 cases. NS1 levels were higher in patients with dengue with warning signs and severe dengue in 2010. Circulating aspartate aminotransferase (AST) and alanine transferase (ALT) were altered in all groups, independently of the infecting serotype or epidemic. Patients with DENV-1 and DENV-2 presented significant lower monocyte counts when compared to patients with DENV-4. An inverse correlation was found between platelet count, leucocytes, monocytes and NS1 levels.
   Conclusions: Epidemics caused by the prevalence of distinct DENV serotypes had different impacts and clinical characteristics in a same scenario and, despite the occurrence of secondary infections, the DENV-4 emergence was not associated with severe cases.
C1 [da Costa Faria, Nieli Rodrigues; Ribeiro Nogueira, Rita Maria; Chouin-Carneiro, Thais; Guerra Nunes, Priscila Conrado; Santos Simoes, Jaqueline Bastos; Nogueira, Fernanda de Bruycker; Queiroz Lima, Monique da Rocha; dos Santos, Flavia Barreto] Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab, Av Brasil 4365, BR-21045360 Rio De Janeiro, RJ, Brazil.
   [da Costa Faria, Nieli Rodrigues; Fiestas Solorzano, Victor Edgar; de Oliveira Pinto, Luzia Maria; Kubelka, Claire Fernandes; de Azeredo, Elzinandes Leal] Inst Oswaldo Cruz, Imunnol Viral Lab, BR-20001 Rio De Janeiro, Brazil.
   [da Cunhac, Rivaldo Venancio] Univ Fed Mato Grosso do Sul, Med Clin Dept, Campo Grande, Brazil.
RP dos Santos, FB (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab, Av Brasil 4365, BR-21045360 Rio De Janeiro, RJ, Brazil.
EM flaviab@ioc.fiocruz.br
RI Fiestas, Victor/J-6894-2019; Kubelka, Claire F/C-5558-2009
OI Fiestas, Victor/0000-0002-5554-3542; 
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPqNational Council for Scientific and Technological
   Development (CNPq) [305333/2012-7]; Programa Estrategico de Pesquisa em
   Saude /PAPES VI-FIOCRUZ [407690/2012-3]; Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro /FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [210.026/2014];
   Oswaldo Cruz Foundation/FIOCRUZ; Brazilian Ministry of Health
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico/CNPq [grant number 305333/2012-7], Programa
   Estrategico de Pesquisa em Saude /PAPES VI-FIOCRUZ [grant number
   407690/2012-3], Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro /FAPERJ [grant number 210.026/2014 to RMR], Oswaldo Cruz
   Foundation/FIOCRUZ and Brazilian Ministry of Health. NRCF, TCC and MRQL
   and were fellows from the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) and PCGN and FBN were fellows from the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq.
CR Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x
   Allonso D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113634
   Amancio FF, 2014, REV INST MED TROP SP, V56, P267, DOI 10.1590/S0036-46652014000300014
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Azeredo EL, 2010, IMMUNOLOGY, V130, P202, DOI 10.1111/j.1365-2567.2009.03224.x
   Bastos MD, 2012, REV SOC BRAS MED TRO, V45, P393, DOI 10.1590/S0037-86822012000300022
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2015, EPIDEMICS-NETH, V11, P92, DOI 10.1016/j.epidem.2015.03.002
   Brasier AR, 2012, AM J TROP MED HYG, V86, P341, DOI 10.4269/ajtmh.2012.11-0469
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Chaturvedi UC, 2006, FEMS IMMUNOL MED MIC, V47, P155, DOI 10.1111/j.1574-695X.2006.00058.x
   de Azeredo EL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/313842
   Cavalcanti LPD, 2014, MEM I OSWALDO CRUZ, V109, P93, DOI 10.1590/0074-0276140384
   de la Cruz-Hernandez SI, 2013, AM J TROP MED HYG, V88, P446, DOI 10.4269/ajtmh.12-0023
   Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Heringer M, 2015, T ROY SOC TROP MED H, V109, P268, DOI 10.1093/trstmh/trv006
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   Pan American Health Organization, 2015, NUMB REP CAS DENG SE
   Paranavitane SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0570-8
   Lima MDQ, 2014, J VIROL METHODS, V204, P105, DOI 10.1016/j.jviromet.2014.02.031
   Rathakrishnan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092021
   Samanta J, 2015, WORLD J CLIN CASES, V3, P125, DOI 10.12998/wjcc.v3.i2.125
   Secretaria de Vigilancia em Saude, 1990, CAS DE DENG
   Secretaria de vigilancia em saude. Ministerio da Saude Brasil, MON CAS DENG FEBR CH
   SES/MS Secretaria de Estado de Saude Mato Grosso do Sul, 2013, B EP
   SES/MS Secretaria de Estado de Saude Mato Grosso do Sul, 2010, B EP
   Teixeira MG, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003812
   Torrentes-Carvalho A, 2009, MEM I OSWALDO CRUZ, V104, P1091, DOI 10.1590/S0074-02762009000800005
   WORLD HEALTH ORGANIZATION (WHO); Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
NR 33
TC 4
Z9 4
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD APR
PY 2016
VL 110
IS 4
BP 228
EP 236
DI 10.1093/trstmh/trw013
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DJ9ZV
UT WOS:000374573000005
PM 26956779
DA 2020-12-09
ER

PT J
AU Buonora, SN
   Passos, SRL
   do Carmo, CN
   Quintela, FM
   de Oliveira, DNR
   dos Santos, FB
   Hokerberg, YHM
   Nogueira, RMR
   Daumas, RP
AF Buonora, Sibelle Nogueira
   Lambert Passos, Sonia Regina
   do Carmo, Cleber Nascimento
   Quintela, Fernanda Moises
   Rodrigues de Oliveira, Diana Neves
   dos Santos, Flavia Barreto
   Marques Hoekerberg, Yara Hahr
   Ribeiro Nogueira, Rita Maria
   Daumas, Regina Paiva
TI Accuracy of clinical criteria and an immunochromatographic strip test
   for dengue diagnosis in a DENV-4 epidemic
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Accuracy; Sensitivity; Specificity; Diagnosis; Point-of-care
   systems; NS1
ID RIO-DE-JANEIRO; FEBRILE ILLNESSES; CASE DEFINITIONS; EMERGENCY-ROOM; NS1
   ANTIGEN; RAPID TEST; BRAZIL; CLASSIFICATION; SENSITIVITY; DISEASE
AB Background: Early diagnosis of dengue infection is important for decision-making and timely implementation of therapeutic measures. Although rapid NS1 assays have been used for dengue diagnosis since 2008, their performance in DENV-4 cases has not yet been fully assessed.
   Methods: We evaluated the accuracy of NS1 Bioeasy (TM) immunochromatographic strip test and of three clinical criteria for dengue diagnosis. Patients presenting at an emergency care center within 72 h of an acute febrile illness during the 2013 DENV-4 epidemic in Rio de Janeiro were consecutively enrolled for clinical and laboratory evaluation. We classified patients as suspected dengue or not according to three clinical criteria: WHO 2009, WHO 1997, and INI-FIOCRUZ. Dengue diagnosis was defined by RNA detection using RT-PCR and the negative cases were negative for all dengue serotypes and also Platelia (TM) NS1 ELISA. We obtained accuracy indices for NS1 Bioeasy (TM) alone and in combination with the clinical criteria.
   Results: RT-PCR for DENV-4 was positive in 148 out of 325 patients. Positive likelihood ratio, sensitivity, and specificity of NS1 Bioeasy (TM) with WHO 2009, WHO 1997, and INI-FIOCRUZ criteria were 22.6 (95 % CI 7.2-70.6), 40.6 % (95 % CI 32.3-49.3), and 98.2 % (95 % CI 94.9-99.6); 18.3 (95 % CI 6.8-49.2), 44.2 (95 % CI 35.8-52.9), 97.6 (95 % CI 94.0-99.3); 26.2 (95 % CI 6.5-106.5), 29.7 (95 % CI 22.4-37.8), 98.9 (95 % CI 96.0-99.9), respectively. WHO 1997 clinical criteria presented high sensitivity to rule out disease, but extremely low specificity. INI-FIOCRUZ had moderate sensitivity and specificity, and could target a group to a more specific test.
   Conclusions: Although the large rates of false negative results using NS1 Bioeasy (TM) rapid test advise against its use for triaging (rule out) purposes in DENV-4 epidemics, it could be used as a confirmatory tool in a bedside algorithm.
C1 [Buonora, Sibelle Nogueira; Lambert Passos, Sonia Regina; Quintela, Fernanda Moises; Rodrigues de Oliveira, Diana Neves; Marques Hoekerberg, Yara Hahr] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Epidemiol, Rio De Janeiro, Brazil.
   [do Carmo, Cleber Nascimento] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
   [Daumas, Regina Paiva] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Germano Sinval Faria Teaching Primary Care Ctr, Rio De Janeiro, Brazil.
   [dos Santos, Flavia Barreto; Ribeiro Nogueira, Rita Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Flavivirus Lab, Rio De Janeiro, Brazil.
RP Buonora, SN (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Epidemiol, Rio De Janeiro, Brazil.
EM sibellebuonora@gmail.com
RI DAUMAS, REGINA/M-9387-2013
OI DAUMAS, REGINA/0000-0002-8923-7711; Passos, Sonia/0000-0001-9947-2291;
   Buonora, Sibelle/0000-0002-0843-1783
CR Allonso D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113634
   [Anonymous], 2009, DENG DIAGN TREATM PR
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Bossuyt PM, 2003, AM J CLIN PATHOL, V119, P18, DOI 10.1309/8EXCCM6YR1THUBAF
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Diretoria Tecnica de Gestao, 2011, DENG DIAGN MAN CLIN
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316
   Colombo TE, 2013, J CLIN VIROL, V58, P710, DOI 10.1016/j.jcv.2013.10.021
   Conroy AL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-35
   da Costa VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094655
   Daumas RP, 2011, INFECTION, V39, P135, DOI 10.1007/s15010-011-0101-0
   Daumas RP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-77
   DIETZ VJ, 1990, AM J EPIDEMIOL, V131, P693
   Domingo C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0877-0
   Failace RR, 2009, HEMOGRAMA MANUAL INT
   Sea VRF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064056
   Ferraz FO, 2013, J CLIN VIROL, V58, P41, DOI 10.1016/j.jcv.2013.06.015
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gan VC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060946
   Gregory CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001400
   Gutierrez G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002385
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676
   Huang SY, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0623-z
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LAURITSEN JM, 2003, COMPREHENSIVE TOOL V
   Leo YS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-498
   Lima MRQ, 2014, CLIN INSIGHTS DENGUE, P27
   Low JGH, 2006, ANN ACAD MED SINGAP, V35, P783
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Macedo GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096314
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Nujum ZT, 2014, PATHOG GLOB HEALTH, V108, P103, DOI 10.1179/2047773214Y.0000000131
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Paranavitane SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0570-8
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Lima MDQ, 2014, J VIROL METHODS, V204, P105, DOI 10.1016/j.jviromet.2014.02.031
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Setiati TE, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-22
   Silva FG, 2011, BEPA, V8, P14
   Tan LK, 2014, PLOS ONE, V9
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 46
TC 12
Z9 13
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 29
PY 2016
VL 16
AR 37
DI 10.1186/s12879-016-1368-7
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA DC0BC
UT WOS:000368880600001
PM 26822788
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Ramos, J
   dos Santos, FB
   Martinez, R
   Araujo, J
   Sarti, E
AF Ramos, Jose
   dos Santos, Flavia Barreto
   Martinez, Ruth
   Araujo, Joselito
   Sarti, Elsa
TI MOLECULAR EPIDEMIOLOGY FOR DENGUE VIRUS IN THE LATIN AMERICAN REGION: A
   SYSTEMATIC REVIEW
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Ramos, Jose; Martinez, Ruth] Natl Inst Publ Hlth, Mexico City, DF, Mexico.
   [dos Santos, Flavia Barreto; Araujo, Joselito] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Sarti, Elsa] Sanofi Pasteur, Mexico City, DF, Mexico.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2015
VL 93
IS 4
SU S
MA 752
BP 228
EP 228
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA VB0ZJ
UT WOS:000412844102493
DA 2020-12-09
ER

PT J
AU de Bruycker-Nogueira, F
   Nogueira, RMR
   Faria, NRD
   Simoes, JBS
   Nunes, PCG
   de Filippis, AMB
   dos Santos, FB
AF de Bruycker-Nogueira, Fernanda
   Ribeiro Nogueira, Rita Maria
   da Costa Faria, Nieli Rodrigues
   Santos Simoes, Jaqueline Bastos
   Guerra Nunes, Priscila Conrado
   Bispo de Filippis, Ana Maria
   dos Santos, Flavia Barreto
TI Insights of the genetic diversity of DENV-1 detected in Brazil in 25
   years: Analysis of the envelope domain III allows lineages
   characterization
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE DENV-1; Genotype V; Lineages; Domain III; Phylogeny; Brazil
ID DENGUE VIRUS TYPE-1; NATURAL-POPULATIONS; REPLACEMENT; SEROTYPE-1;
   EVOLUTION; RECOMBINATION; CIRCULATION; EXPRESSION; EMERGENCE; REVEALS
AB Dengue virus type 1 (DENV-1) was first isolated in Brazil in 1986 in the state of Rio de Janeiro (RJ) and during 25 years, this serotype emerged and re-emerged causing explosive epidemics in the country. Here, we aimed to present the phylogeny and molecular characterization based on the envelope gene (E) of DENV-1 (n = 48) isolated during epidemics occurred from 1986 to 2011. Six full coding region genomes of DENV-1 were fully sequenced and possible genomic recombination events were analyzed. The results showed that the Brazilian DENV-1 isolates analyzed belong to genotype V (Americas/Africa), but grouping into distinct clades. Three groups were identified, one dating from 1986 to 2002 (lineage 1a), a second group isolated from 2009 to 2011 and a representative strain isolated in 2002 (lineage 2), and a group of strains isolated from 2010 to 2011 (lineage 1b). The lineages 1a and 1b were more closely related to the American strains, while lineage 2 to the Asian strains. Amino acids (aa) substitutions were observed in the domains I and III of the E protein and were associated to the lineages segregation. A substitution on E297 differentiated the lineage 1a from the lineages 1b and 2. Substitutions on E338, E394 (domain III), E428 and E436 (stem region) differentiated lineages 1a, 1b and 2. With the exception of the C gene, all the others genes analyzed allowed the DENV-1 classification into the distinct genotypes. Interestingly, the E gene's domain III and stem regions alone were able to characterize the distinct lineages, as observed by the analysis of the entire E gene and the complete coding region. No recombinant events were detected, but a strain belonging to lineage 1a was closely related to a known recombinant strain (AF513110/BR/2001). (C) 2015 Elsevier B.V. All rights reserved.
C1 [de Bruycker-Nogueira, Fernanda; Ribeiro Nogueira, Rita Maria; da Costa Faria, Nieli Rodrigues; Santos Simoes, Jaqueline Bastos; Guerra Nunes, Priscila Conrado; Bispo de Filippis, Ana Maria; dos Santos, Flavia Barreto] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP dos Santos, FB (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab, Av Brasil 4365, BR-21045360 Rio De Janeiro, RJ, Brazil.
EM flaviab@ioc.fiocruz.br
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [501564/03-9, 305333/2012-7]; Programa Estrategico de Pesquisa em
   Saude/PAPES VI-FIOCRUZ [407690/2012-3]; Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro/FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [210.026/2014]
FX To Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   Grant number 501564/03-9 for FBN's scholarship and Grant number
   305333/2012-7. To Programa Estrategico de Pesquisa em Saude/PAPES
   VI-FIOCRUZ Grant number 407690/2012-3, to Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro/FAPERJ Grant number 210.026/2014 to RMR, to
   Oswaldo Cruz Foundation/FIOCRUZ and to the Brazilian Ministry of Health.
   To Dr. Joselio de Araujo, for primer design, to Dr Tatsuya Nagata for
   support on the Recombination Software, to Aline dos Santos Moreira and
   Renata Almeida de Sa from the Sequencing Platform (PDTIS/FIOCRUZ), to
   Clarice Rodrigues dos Santos, Dinair Couto Lima, Simone Alves Sampaio,
   Bianca De Santis, Jose da Costa Farias Filho, Leda Maria dos Santos for
   technical support. To FOCEM (Fondo para la Convergencia Estructural del
   Mercosul) for providing the course on the "Introduction to Structural
   Biology and Bioinformatics'', at the Institute Pasteur-Montevideo. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030
   Aaskov J, 2007, J GEN VIROL, V88, P3334, DOI 10.1099/vir.0.83122-0
   Anez G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/678645
   Bordignon J, 2008, VIROLOGY, V377, P319, DOI 10.1016/j.virol.2008.04.033
   Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016
   Carrillo-Valenzo E, 2010, ARCH VIROL, V155, P1401, DOI 10.1007/s00705-010-0721-1
   Carvalho SES, 2010, VIRUS GENES, V40, P60, DOI 10.1007/s11262-009-0428-0
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen SP, 2008, ARCH VIROL, V153, P1175, DOI 10.1007/s00705-008-0090-1
   Chen YP, 1996, J VIROL, V70, P8765, DOI 10.1128/JVI.70.12.8765-8772.1996
   CHOUDHURY MA, 2014, PLOS ONE, V0009
   Chu PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074165
   Dash PK, 2015, VIRUS RES, V195, P124, DOI 10.1016/j.virusres.2014.08.018
   dos Santos CND, 2002, VIRUS RES, V90, P197, DOI 10.1016/S0168-1702(02)00180-6
   dos Santos FB, 2013, DENGUE B, V37, P61
   dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Duong V, 2013, INFECT GENET EVOL, V15, P59, DOI 10.1016/j.meegid.2011.06.019
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kukreti H, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-1
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226
   Miller S, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P35
   Munoz-Jordan JL, 2013, EMERG INFECT DIS, V19, P652, DOI 10.3201/eid1904.121295
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Shin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074582
   Shurtleff AC, 2001, VIROLOGY, V281, P75, DOI 10.1006/viro.2000.0748
   Silva Jr J., 2013, DENGUE SITUACAO PERS
   Suzuki R, 2007, VIROLOGY, V362, P374, DOI 10.1016/j.virol.2006.11.026
   SVS/MS, 2014, B EP, V44
   Thai KTD, 2012, J VIROL, V86, P835, DOI 10.1128/JVI.05985-11
   Thu HM, 2005, VIROLOGY, V336, P163, DOI 10.1016/j.virol.2005.03.018
   Tolou HJG, 2001, J GEN VIROL, V82, P1283, DOI 10.1099/0022-1317-82-6-1283
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Wang WK, 2002, J VIROL, V76, P4662, DOI 10.1128/JVI.76.9.4662-4665.2002
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   WORLD HEALTH ORGANIZATION (WHO); Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
   Yamanaka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027322
   Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005
   Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087630
NR 55
TC 4
Z9 4
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD AUG
PY 2015
VL 34
BP 126
EP 136
DI 10.1016/j.meegid.2015.07.007
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA CQ9AJ
UT WOS:000360902400017
PM 26160541
DA 2020-12-09
ER

PT J
AU Heringer, M
   Nogueira, RMR
   de Filippis, AMB
   Lima, MRQ
   Faria, NRC
   Nunes, PCG
   Nogueira, FB
   dos Santos, FB
AF Heringer, Manoela
   Nogueira, Rita Maria R.
   de Filippis, Ana Maria B.
   Lima, Monique R. Q.
   Faria, Nieli R. C.
   Nunes, Priscila C. G.
   Nogueira, Fernanda B.
   dos Santos, Flavia B.
TI Impact of the emergence and re-emergence of different dengue viruses'
   serotypes in Rio de Janeiro, Brazil, 2010 to 2012
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Brazil; Dengue; Fatal cases; Laboratorial diagnosis; Surveillance
ID LINKED-IMMUNOSORBENT-ASSAY; NONSTRUCTURAL PROTEIN NS1; RAPID DETECTION;
   STATE; SURVEILLANCE; EPIDEMIC; CIRCULATION; DIAGNOSIS; ANTIGEN; TYPE-3
AB Background: Rio de Janeiro (RJ) has been of major importance for the epidemiology of dengue viruses (DENVs) in Brazil. After the DENV 1-4 introductions in 1986, 1990, 2000 and 2011, respectively, the state has suffered explosive epidemics. We aimed to describe laboratorial, epidemiological and clinical aspects due to the emergence and re-emergence of distinct DENV in a 2-year period.
   Methods: Suspected dengue cases (n = 2833), including 190 fatal cases, were submitted to virus isolation, RT-PCR and non-structural 1 (NS1) antigen capture ELISA, IgM antibody-capture (MAC)-ELISA and IgG-ELISA.
   Results: Case confirmation was 47.5%. MAC-ELISA confirmed 32.6% of the cases, RT-PCR confirmed 56.3%; DENV was recovered in 33.1% of samples inoculated and NS1 ELISA confirmed 27.5% of the cases. DENV-2 was prevalent in 2010, DENV-1 in 2011 and DENV-4 in 2012. Individuals infected by DENV-3 and over 65 years-old, and children 15 years-old and under infected by DENV-2 had a significantly higher risk of developing a severe disease. Fatal cases confirmed (n=67) were due to DENV-1 (26.8%), DENV-2 (14.9%), DENV-3 (2.9%) and DENV-4 (7.4%).
   Conclusions: It has been shown here that viral emergences or re-emergences may play different roles in the disease epidemiology, especially when many serotypes co-circulate.
C1 [Heringer, Manoela; Nogueira, Rita Maria R.; de Filippis, Ana Maria B.; Lima, Monique R. Q.; Faria, Nieli R. C.; Nunes, Priscila C. G.; Nogueira, Fernanda B.; dos Santos, Flavia B.] Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab, BR-21045360 Rio De Janeiro, RJ, Brazil.
RP dos Santos, FB (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab, Brasil 4365, BR-21045360 Rio De Janeiro, RJ, Brazil.
EM flaviab@ioc.fiocruz.br
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPqNational Council for Scientific and Technological
   Development (CNPq) [305333/2012-7]; Programa Estrategico de Pesquisa em
   Saude/PAPES VI-FIOCRUZ [407690/2012-3]; Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro /FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [210.026/2014];
   Oswaldo Cruz Foundation/FIOCRUZ; Brazilian Ministry of Health
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico/CNPq [grant number 305333/2012-7], Programa
   Estrategico de Pesquisa em Saude/PAPES VI-FIOCRUZ [grant number
   407690/2012-3], Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro /FAPERJ [grant number 210.026/2014 to RMR], Oswaldo Cruz
   Foundation/FIOCRUZ and Brazilian Ministry of Health. MH, MRQL and NRCF
   were fellows from the Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) and PCGN and FBN were fellows from the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   Claro Lenita Barreto Lorena, 2004, Cad. Saúde Pública, V20, P1447, DOI 10.1590/S0102-311X2004000600002
   Teixeira TRD, 2008, CAD SAUDE PUBLICA, V24, P2160, DOI 10.1590/S0102-311X2008000900022
   De Paula SO, 2002, T ROY SOC TROP MED H, V96, P266, DOI 10.1016/S0035-9203(02)90094-5
   dos Santos FB, 2013, DENGUE B, V37, P61
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lindenbach BD, 2001, FIELDS VIROLOGY, VII, P991, DOI DOI 10.1016/J.JMB.2013.11.024
   Macedo GA, 2013, T ROY SOC TROP MED H, V107, P141, DOI 10.1093/trstmh/trs091
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   Miagostovich MP, 1997, MEM I OSWALDO CRUZ, V92, P595, DOI 10.1590/S0074-02761997000500006
   NOGUEIRA R M R, 1988, Memorias do Instituto Oswaldo Cruz, V83, P219, DOI 10.1590/S0074-02761988000200012
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Nogueira RMR, 1999, MEM I OSWALDO CRUZ, V94, P297, DOI 10.1590/S0074-02761999000300004
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Rigau-Perez JG, 2002, AM J TROP MED HYG, V67, P355, DOI 10.4269/ajtmh.2002.67.355
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P179, DOI 10.1590/S0074-02762000000700030
   SES/SINAN, 1990, CAS DE DENG
   SVS/MS, 2009, INF EP DENG SEM 1 52
   Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
   World Health Organization (WHO) Regional Office for South-East Asia, 2009, SPEC PROGRAM RES TRA, V147
   Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06
NR 32
TC 10
Z9 10
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD APR
PY 2015
VL 109
IS 4
BP 268
EP 274
DI 10.1093/trstmh/trv006
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CI5EJ
UT WOS:000354775900008
PM 25634640
DA 2020-12-09
ER

PT J
AU Lima, MDQ
   Nogueira, RMR
   de Filippis, AMB
   Nunes, PCG
   de Sousa, CS
   da Silva, MH
   dos Santos, FB
AF Queiroz Lima, Monique da Rocha
   Ribeiro Nogueira, Rita Maria
   Bispo de Filippis, Ana Maria
   Guerra Nunes, Priscila Conrado
   de Sousa, Carla Santos
   da Silva, Manoela Heringer
   dos Santos, Flavia Barreto
TI A simple heat dissociation method increases significantly the ELISA
   detection sensitivity of the nonstructural-1 glycoprotein in patients
   infected with DENV type-4
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Dengue diagnosis; NS1 ELISA; Immune-complex dissociation; DENV-4;
   secondary infections
ID LINKED-IMMUNOSORBENT-ASSAY; NS1 ANTIGEN-DETECTION; DENGUE VIRUS TYPE-4;
   DIAGNOSIS; SURVEILLANCE; SEROTYPE; DISEASE
AB The secreted form of the dengue virus (DENV) nonstructural-1 (NS1) glycoprotein has been shown to be useful for the diagnosis of DENV infections in patients' serum samples. In a number of studies, the sensitivity of the commercially available DENV NS1 glycoprotein detection assays was higher against some DENV serotypes (DENV-1 > DENV-3 > DENV-2 = DENV-4) than others and were also lower using patients' serum samples with secondary versus primary DENV infections. In this study, 471 DENV-4 positive acute phase patients' serum samples were selected from a large panel collected in Brazil from March 2011 to October 2012 by RT-PCR and/or virus isolation followed by serotype determination. The sera from primary (n = 228) and secondary (n = 238) DENV-4 infections were identified using IgM and IgG capture ELISAs. The sensitivity of a commercial DENV NS1 glycoprotein detection ELISA was then assessed when these serum samples were not pre-treated or pre-treated by acid or heat dissociation prior to being tested. Acid and heat dissociation of patients' serum samples with primary and secondary DENV-4 infections increased significantly the sensitivity of the DENV NS1 glycoprotein detection ELISA from 54.4% to 77.2% (p < 0.05) and 82% (p < 0.05) and from 39.1% to 63.9% (p < 0.05) and 73.1% (p < 0.05), respectively. Treatment of DENV infected patients' serum samples using simple and rapid heat dissociation step (100 C for 5 min) was, therefore, shown to be very useful for increasing the sensitivity of the DENV NS1 glycoprotein detection ELISA using serum samples from either primary or secondary DENV infected patients. (c) 2014 Elsevier B.V. All rights reserved.
C1 [Queiroz Lima, Monique da Rocha; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria; Guerra Nunes, Priscila Conrado; de Sousa, Carla Santos; da Silva, Manoela Heringer; dos Santos, Flavia Barreto] Inst Oswaldo Cruz, Flavivirus Lab, BR-21045360 Rio De Janeiro, RJ, Brazil.
RP dos Santos, FB (corresponding author), Inst Oswaldo Cruz, FIOCRUZ, Flavivirus Lab, Av Brasil 4365, BR-21045360 Rio De Janeiro, RJ, Brazil.
EM flaviab@ioc.fiocruz.br
FU Conselho Nacional de Desenvolvimento Cientifico Tecnologico -
   CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); FIOCRUZ; PAPES VI/FIOCRUZ; CAPES
   fellowshipCAPES
FX We are grateful to Eliane S.M. de Araujo, Simone Alves Sampaio,
   Jaqueline Bastos Santos, Nieli Rodrigues da Costa Faria, Fernanda de
   Bruycker Nogueira and Jose Farias Filho for technical support. This
   study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico Tecnologico - CNPq, FAPERJ, FIOCRUZ and PAPES VI/FIOCRUZ.
   MRQL is a CAPES fellowship recipient.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316
   Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   Dussart P, 2006, EMERG INFECT DIS, V12, P1748, DOI 10.3201/eid1211.060339
   FALCONAR AKI, 1990, J VIROL METHODS, V30, P323, DOI 10.1016/0166-0934(90)90075-Q
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811
   Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lapphra K, 2008, DIAGN MICR INFEC DIS, V60, P387, DOI 10.1016/j.diagmicrobio.2007.11.010
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Schupbach J, 1996, AIDS, V10, P1085
   Shu PY, 2003, CLIN DIAGN LAB IMMUN, V10, P622, DOI 10.1128/CDLI.10.4.622-630.2003
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
   WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
NR 19
TC 23
Z9 23
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD AUG
PY 2014
VL 204
BP 105
EP 108
DI 10.1016/j.jviromet.2014.02.031
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA AJ4LY
UT WOS:000337649100019
PM 24747585
DA 2020-12-09
ER

PT J
AU Maldaner, FR
   Aragao, FJL
   dos Santos, FB
   Franco, OL
   Lima, MDQ
   Resende, RD
   Vasques, RM
   Nagata, T
AF Maldaner, Franciele Roberta
   Lima Aragao, Francisco Jose
   dos Santos, Flavia Barreto
   Franco, Octavio Luiz
   Queiroz Lima, Monique da Rocha
   Resende, Renato de Oliveira
   Vasques, Raquel Medeiros
   Nagata, Tatsuya
TI Dengue virus tetra-epitope peptide expressed in lettuce chloroplasts for
   potential use in dengue diagnosis
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Dengue virus; Tetra-epitope antigen; Transplastomic plant; Dengue
   diagnostic
ID LOUIS ENCEPHALITIS-VIRUS; ENVELOPE DOMAIN-III; PROTEIN; ANTIBODY;
   DETERMINANTS; GLYCOPROTEIN; ANTIGEN; CHOLERA; ASSAYS; MICE
AB Dengue virus causes about 100 million cases of dengue disease per year in the world. Laboratory diagnosis is done mainly by serological techniques, which in many cases use crude virus extracts that may cause cross-reactions to other flaviviruses. These undesirable cross-reactions can be reduced or eliminated by using recombinant proteins based on restricted epitopes. Aiming to decrease flaviviral cross-reactions and non-specific interactions in dengue serological assays, a plant expression system was chosen for recombinant antigen production as a reliable and inexpensive dengue diagnostic tool. In the present report, the lettuce plastid transformation system was applied to achieve efficient and stable tetra-epitope peptide antigen production, and its reactivity was evaluated. For this purpose, one putative epitope at positions 34 to 57 of E protein within the junction site of domains I and II of dengue virus (DENV) 1 to 4 serotypes linked by glycine linkers was expressed in lettuce chloroplasts. The potential immunoreactivity for the four DENV serotypes was evaluated using sera from patients of positive and negative dengue cases. Results indicated an overall sensitivity of 71.7 % and specificity of 100 %. No cross-reactions with the sera of yellow fever-positive or healthy individuals vaccinated against yellow fever were observed. This novel approach may provide an alternative system for the large-scale production of dengue recombinant antigens useful for serodiagnosis.
C1 [Maldaner, Franciele Roberta; Nagata, Tatsuya] Univ Brasilia, Dept Patol Mol, BR-70910900 Brasilia, DF, Brazil.
   [Lima Aragao, Francisco Jose] Embrapa Recursos Genet & Biotecnol, BR-70770900 Brasilia, DF, Brazil.
   [dos Santos, Flavia Barreto; Queiroz Lima, Monique da Rocha] Inst Oswaldo Cruz, Lab Flavivirus, BR-21040360 Rio De Janeiro, Brazil.
   [Franco, Octavio Luiz; Vasques, Raquel Medeiros] Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, BR-70790160 Brasilia, DF, Brazil.
   [Resende, Renato de Oliveira; Nagata, Tatsuya] Univ Brasilia, Dept Biol Celular, BR-70910970 Brasilia, DF, Brazil.
RP Aragao, FJL (corresponding author), Embrapa Recursos Genet & Biotecnol, PqEB W5 Norte, BR-70770900 Brasilia, DF, Brazil.
EM francisco.aragao@embrapa.br; tatsuya@unb.br
RI Vasques, Raquel/AAI-8226-2020; Nagata, Tatsuya/I-4031-2013; Franco,
   Octavio L/T-3020-2017; Aragao, Francisco J.L./E-6962-2013
OI Nagata, Tatsuya/0000-0002-7114-017X; Franco, Octavio/0000-0001-9546-0525
FU Fundacao de Apoio a Pesquisa do Distrito Federal (Brazil); "Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq)
FX We thank Dr. Hirosuke Kanamoto (Research Institute of Innovative
   Technology for the Earth, Japan) for providing plasmid pRL1001. We also
   thank to Dr. Rita Maria Nogueira (Flavivirus Laboratory, IOC/Fiocruz,
   Brazil) for providing the samples. The work was funded by the Fundacao
   de Apoio a Pesquisa do Distrito Federal (Brazil) for a research grant
   and by the "Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico" (CNPq, Brazil) for the DSc scholarship to the first author.
CR AnandaRao R, 2006, CLIN VACCINE IMMUNOL, V13, P59, DOI 10.1128/CVI.13.1.59-67.2006
   Martinez CA, 2010, BIOTECHNOL LETT, V32, P867, DOI 10.1007/s10529-010-0236-6
   Aragao FJL, 1996, THEOR APPL GENET, V93, P142, DOI 10.1007/BF00225739
   Batra G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-64
   Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721
   Beaumier CM, 2008, J INFECT DIS, V197, P608, DOI 10.1086/526790
   Cuzzubbo AJ, 2001, CLIN DIAGN LAB IMMUN, V8, P1150, DOI 10.1128/CDLI.8.6.1150-1155.2001
   Daniell H, 2002, TRENDS PLANT SCI, V7, P84, DOI 10.1016/S1360-1385(01)02193-8
   Davoodi-Semiromi A, 2010, PLANT BIOTECHNOL J, V8, P223, DOI 10.1111/j.1467-7652.2009.00479.x
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   Dos Santos FB, 2004, AM J TROP MED HYG, V71, P144, DOI 10.4269/ajtmh.2004.71.144
   Doyle J. L. ., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796
   Falconar AKI, 1999, ARCH VIROL, V144, P2313, DOI 10.1007/s007050050646
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124
   Goncalvez AP, 2004, J VIROL, V78, P12919, DOI 10.1128/JVI.78.23.12919-12928.2004
   Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042
   Kanagaraj AP, 2011, PLANT MOL BIOL, V76, P323, DOI 10.1007/s11103-011-9766-0
   Kanamoto H, 2006, TRANSGENIC RES, V15, P205, DOI 10.1007/s11248-005-3997-2
   Kim TG, 2010, PROTEIN EXPRES PURIF, V74, P236, DOI 10.1016/j.pep.2010.07.013
   Kurane I, 2007, COMP IMMUNOL MICROB, V30, P329, DOI 10.1016/j.cimid.2007.05.010
   Lai CJ, 2007, J VIROL, V81, P12766, DOI 10.1128/JVI.01420-07
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lim S, 2011, PLANT MOL BIOL, V76, P335, DOI 10.1007/s11103-011-9745-5
   Lisova O, 2007, J GEN VIROL, V88, P2387, DOI 10.1099/vir.0.83028-0
   Lossl AG, 2011, PLANT BIOTECHNOL J, V9, P527, DOI 10.1111/j.1467-7652.2011.00615.x
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Rodrigues SG, 2010, J GEN VIROL, V91, P2420, DOI 10.1099/vir.0.019117-0
   Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200
   ROEHRIG JT, 1990, VIROLOGY, V177, P668, DOI 10.1016/0042-6822(90)90532-V
   Saejung W, 2007, VACCINE, V25, P6646, DOI 10.1016/j.vaccine.2007.06.029
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Sumathi K, 2006, NUCLEIC ACIDS RES, V34, pW128, DOI 10.1093/nar/gkl036
   van der Schaar HM, 2009, IMMUNOBIOLOGY, V214, P613, DOI 10.1016/j.imbio.2008.11.008
   Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Wilkins MR, 1999, METH MOL B, V112, P531
NR 40
TC 14
Z9 16
U1 0
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD JUL
PY 2013
VL 97
IS 13
BP 5721
EP 5729
DI 10.1007/s00253-013-4918-6
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 173ZE
UT WOS:000321121500007
PM 23615743
OA Green Published
DA 2020-12-09
ER

PT J
AU Faria, NRD
   Nogueira, RMR
   de Filippis, AMB
   Simoes, JBS
   Nogueira, FD
   Lima, MDQ
   dos Santos, FB
AF da Costa Faria, Nieli Rodrigues
   Ribeiro Nogueira, Rita Maria
   Bispo de Filippis, Ana Maria
   Santos Simoes, Jaqueline Bastos
   Nogueira, Fernanda de Bruycker
   Queiroz Lima, Monique da Rocha
   dos Santos, Flavia Barreto
TI Twenty Years of DENV-2 Activity in Brazil: Molecular Characterization
   and Phylogeny of Strains Isolated from 1990 to 2010
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUS TYPE-2; RIO-DE-JANEIRO; HEMORRHAGIC-FEVER; PUERTO-RICO;
   EPIDEMIOLOGY; ENVELOPE; NUCLEOTIDE; EVOLUTION; PATHOGENESIS; REEMERGENCE
AB In Brazil, dengue has been a major public health problem since its introduction in the 1980s. Phylogenetic studies constitute a valuable tool to monitor the introduction and spread of viruses as well as to predict the potential epidemiological consequences of such events. Aiming to perform the molecular characterization and phylogenetic analysis of DENV-2 during twenty years of viral activity in the country, viral strains isolated from patients presenting different disease manifestations (n = 34), representing six states of the country, from 1990 to 2010, were sequenced. Partial genome sequencing (genes C/prM/M/E) was performed in 25 DENV-2 strains and full-length genome sequencing (coding region) was performed in 9 strains. The percentage of similarity among the DENV-2 strains in this study and reference strains available in Genbank identified two groups epidemiologically distinct: one represented by strains isolated from 1990 to 2003 and one from strains isolated from 2007 to 2010. No consistent differences were observed on the E gene from strains isolated from cases with different clinical manifestations analyzed, suggesting that if the disease severity has a genetic origin, it is not only due to the differences observed on the E gene. The results obtained by the DENV-2 full-length genome sequencing did not point out consistent differences related to a more severe disease either. The analysis based on the partial and/or complete genome sequencing has characterized the Brazilian DENV-2 strains as belonging to the Southeast Asian genotype, however a distinction of two Lineages within this genotype has been identified. It was established that strains circulating prior DENV-2 emergence (1990-2003) belong to Southeast Asian genotype, Lineage I and strains isolated after DENV-2 emergence in 2007 belong to Southeast Asian genotype, Lineage II. Furthermore, all DENV-2 strains analyzed presented an asparagine (N) in E-390, previously identified as a probable genetic marker of virulence observed in DHF strains from Asian origin. The percentage of identity of the latter with the Dominican Republic strain isolated in 2001 combined to the percentage of divergence with the strains first introduced in the country in the 1990s suggests that those viruses did not evolve locally but were due to a new viral Lineage introduction in the country from the Caribbean.
C1 [da Costa Faria, Nieli Rodrigues; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria; Santos Simoes, Jaqueline Bastos; Nogueira, Fernanda de Bruycker; Queiroz Lima, Monique da Rocha; dos Santos, Flavia Barreto] Inst Oswaldo Cruz, Flavivirus Lab, BR-20001 Rio De Janeiro, Brazil.
RP Faria, NRD (corresponding author), Inst Oswaldo Cruz, Flavivirus Lab, BR-20001 Rio De Janeiro, Brazil.
EM flaviab@ioc.fiocruz.br
FU FIOCRUZ; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); CAPESCAPES
FX The authors want to thank FIOCRUZ, CNPq, FAPERJ and CAPES for the
   financial support. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ANDERSON CR, 1956, SCIENCE, V124, P224, DOI 10.1126/science.124.3214.224
   Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459
   Aquino JDJD, 2008, VIRUS RES, V137, P266, DOI 10.1016/j.virusres.2008.07.011
   Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0
   Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005
   Catteau A, 2003, J GEN VIROL, V84, P2781, DOI 10.1099/vir.0.19163-0
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Cordeiro M. T., 2008, VINTE ANOS EVOLUCAO
   dos Santos FB, 2002, MEM I OSWALDO CRUZ, V97, P991, DOI 10.1590/S0074-02762002000700011
   Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5
   GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   GUZMAN MG, 1995, AM J TROP MED HYG, V52, P241, DOI 10.4269/ajtmh.1995.52.241
   Heinz F, 2000, VIRUS TAXONOMY, P859
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   KOURI GP, 1987, T ROY SOC TROP MED H, V81, P821, DOI 10.1016/0035-9203(87)90042-3
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   LEWIS JA, 1993, VIROLOGY, V197, P216, DOI 10.1006/viro.1993.1582
   Li DS, 2010, EMERG INFECT DIS, V16, P123, DOI 10.3201/eid1601.091275
   Lin CW, 2003, J VIROL, V77, P2600, DOI 10.1128/JVI.77.4.2600-2606.2003
   Lindenbach BD, 2001, FIELDS VIROLOGY, VII, P991, DOI DOI 10.1016/J.JMB.2013.11.024
   Marianneau Philippe, 1998, Acta Cientifica Venezolana, V49, P13
   McElroy KL, 2011, EMERG INFECT DIS, V17, P64, DOI 10.3201/eid1701.100961
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Messer WB, 2002, AM J TROP MED HYG, V66, P765, DOI 10.4269/ajtmh.2002.66.765
   Miagostovich MP, 1998, MEM I OSWALDO CRUZ, V93, P625, DOI 10.1590/S0074-02761998000500011
   Neto RJP, 2005, BRAZ J MED BIOL RES, V38, P843, DOI 10.1590/S0100-879X2005000600005
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996
   Pandey B, 2003, P 10 AS C DIARRH DIS
   Pryor MJ, 2001, AM J TROP MED HYG, V65, P427, DOI 10.4269/ajtmh.2001.65.427
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   Rico-Hesse R, 2007, CLIN INFECT DIS, V44, P1462, DOI 10.1086/517587
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811
   ROSEN L, 1977, AM J TROP MED HYG, V26, P337, DOI 10.4269/ajtmh.1977.26.337
   Sanchez IJ, 1996, J GEN VIROL, V77, P2541, DOI 10.1099/0022-1317-77-10-2541
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   SVS/MS, 2009, INF EP DENG SEM 1 52
   SVS/MS, 2010, INF EP DENG AN SIT T
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447
   Varas CY, 2000, REV MED EXP, V18, P35
   Vasconcelos Pedro F. Da C., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P253
   WORLD HEALTH ORGANIZATION (WHO); Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
   Xiao SY, 2001, J INFECT DIS, V183, P1437, DOI 10.1086/320200
   Yamanaka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027322
   ZAGNE SMO, 1994, T ROY SOC TROP MED H, V88, P677, DOI 10.1016/0035-9203(94)90225-9
   Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005
NR 54
TC 23
Z9 24
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2013
VL 7
IS 3
AR e2095
DI 10.1371/journal.pntd.0002095
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 117HI
UT WOS:000316943800015
PM 23516646
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Macedo, GA
   de Araujo, JMG
   Schatzmayra, HG
   Costa, FAC
   de Filippis, AMB
   dos Santos, FB
   Nogueira, RM
AF Macedo, Gleicy Amorim
   Galvao de Araujo, Joselio Maria
   Schatzmayr, Hermann Goncalves
   Carvalho Costa, Filipe Anibal
   Bispo de Filippis, Ana Maria
   dos Santos, Flavia Barreto
   Ribeiro Nogueira, Rita Maria
TI Virological surveillance for early warning of dengue epidemics in the
   State of Rio de Janeiro, Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Dengue virus; Surveillance; Brazil
ID HEMORRHAGIC-FEVER; VIRUS TYPE-3; GENETIC-CHARACTERIZATION; DIAGNOSIS;
   AMERICA; SAMPLES
AB Background: The state of Rio de Janeiro has been important since 1986 as a portal for the introduction of dengue virus (DENV) into Brazil and dissemination of the virus throughout the country. This study describes an active surveillance of DENV in the state of Rio de Janeiro from 2004 to 2008.
   Method: A total of 14 408 samples from patients suspected to be infected with DENV were tested by virus isolation, and nested reverse transcriptase (RT)-PCR assay or anti-DENV dengue IgM antibody capture ELISA (MAC-ELISA), or both.
   Results: By the use of these different methods, a total of 2324(16.1%) cases were confirmed as dengue infection. The study covers an inter-epidemic period (2004-2005), the DENV-3 circulation in 2006, the re-emergence of DENV-2 in 2007 and the severe epidemic caused by DENV-2 in the summer of 2008. During the period, 69 dengue fatal cases were reported, 14 (20.2%) deaths being attributable to DENV-3 and 55 (79.7%) to DENV-2.
   Conclusion: Our results emphasize the role of the laboratory in the early detection of dengue virus transmission and provide information on the dynamics of DENV introduction and spread, important for the assessment of intervention strategies.
C1 [Macedo, Gleicy Amorim; Galvao de Araujo, Joselio Maria; Schatzmayr, Hermann Goncalves; Bispo de Filippis, Ana Maria; dos Santos, Flavia Barreto; Ribeiro Nogueira, Rita Maria] Inst Oswaldo Cruz, Flavivirus Lab, BR-20001 Rio De Janeiro, Brazil.
   [Galvao de Araujo, Joselio Maria] Univ Fed Rio Grande do Norte, Lab Mol Biol Infect Dis & Canc, BR-59072910 Natal, RN, Brazil.
   [Carvalho Costa, Filipe Anibal] Inst Oswaldo Cruz, Lab Biochem Systemat, BR-20001 Rio De Janeiro, Brazil.
RP de Araujo, JMG (corresponding author), Inst Oswaldo Cruz, Flavivirus Lab, BR-20001 Rio De Janeiro, Brazil.
EM joselio@cb.ufrn.br
RI Araujo, Joselio M G/B-5502-2013
OI Araujo, Joselio M G/0000-0003-3548-2786
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [501564/03-9]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/152.810/2006]
FX This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq [grant no. 501564/03-9]
   and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
   [grant no. E-26/152.810/2006]. The authors are grateful to the Program
   for Technological Development in Tools for Health-PDTIS-FIOCRUZ for the
   use of their facilities.
CR BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   BrisenoGarcia B, 1996, EMERG INFECT DIS, V2, P133, DOI 10.3201/eid0202.960210
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   De Paula SO, 2002, J VIROL METHODS, V102, P113, DOI 10.1016/S0166-0934(02)00005-8
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   dos Santos FB, 2002, MEM I OSWALDO CRUZ, V97, P991, DOI 10.1590/S0074-02762002000700011
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lindenbach BD, 2001, FIELDS VIROLOGY, VII, P991, DOI DOI 10.1016/J.JMB.2013.11.024
   Miagostovich MP, 2006, MEM I OSWALDO CRUZ, V101, P307, DOI 10.1590/S0074-02762006000300015
   Miagostovich MP, 2002, BRAZ J MED BIOL RES, V35, P869, DOI 10.1590/S0100-879X2002000800002
   Miagostovich MP, 1997, MEM I OSWALDO CRUZ, V92, P595, DOI 10.1590/S0074-02761997000500006
   Ministry of Health Goverrnment of Brazil, PORT SAUD
   NOGUEIRA R M R, 1988, Memorias do Instituto Oswaldo Cruz, V83, P219, DOI 10.1590/S0074-02761988000200012
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Pan American Health Organization, DENGUE
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Feres VCR, 2006, J CLIN VIROL, V37, P179, DOI 10.1016/j.jcv.2006.07.004
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   State Government of Rio de Janeiro, PORT SAUD RJ
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 29
TC 8
Z9 9
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAR
PY 2013
VL 107
IS 3
BP 141
EP 146
DI 10.1093/trstmh/trs091
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 102GI
UT WOS:000315832500001
PM 23322430
DA 2020-12-09
ER

PT J
AU de Castro, MG
   de Nogueira, FB
   Nogueira, RMR
   Lourenco-de-Oliveira, R
   dos Santos, FB
AF de Castro, Marcia Goncalves
   de Nogueira, Fernanda Bruycker
   Ribeiro Nogueira, Rita Maria
   Lourenco-de-Oliveira, Ricardo
   dos Santos, Flavia Barreto
TI Genetic variation in the 3 ' untranslated region of dengue virus
   serotype 3 strains isolated from mosquitoes and humans in Brazil
SO VIROLOGY JOURNAL
LA English
DT Article
DE Dengue virus type 3; Aedes aegypti; 3 ' UTR
ID RIO-DE-JANEIRO; POLYMERASE-CHAIN-REACTION; TYPE-3 GENOTYPE III;
   AEDES-AEGYPTI; MOLECULAR EPIDEMIOLOGY; HEMORRHAGIC-FEVER; PHYLOGENETIC
   ANALYSIS; 3'-NONCODING REGIONS; SECONDARY STRUCTURE; NONCODING REGION
AB Background: Dengue, a mosquito-borne viral infection caused by one of the four dengue virus (DENV) serotypes (DENV-1 to 4), replicate alternately on the mosquito vector and human host and are responsible for infections throughout tropical and subtropical regions of the world. In Brazil, the disease has become a major public health problem and the introduction of DENV-3 in 2000 in Rio de Janeiro (RJ) was associated with severe dengue epidemics. The potential emergence of strains associated with severe disease highlights the need for the surveillance of DENV in human host and vectors.
   Methods: Aiming to contribute for DENV phylogenetic and vector-virus-human host studies, we sequenced the entire genome of one DENV-3 isolated from naturally infected Aedes aegypti from RJ in 2001 and characterized the 3' UTR from strains isolated from mosquitoes and humans. Mosquitoes were pooled and submitted to virus isolation in Ae. albopictus C6/36 cells and the infecting serotype was identified by immunofluorescence using type-specific monoclonal antibody. Sequence analysis was performed using BioEdit software, the multiple alignments were performed using CLUSTAL W and the phylogenetic analysis by MEGA 5, using the Neighbor-joining method. Secondary structure prediction was performed by using the MFOLD program.
   Results: Exclusive substitutions and a substitution leading to a stop codon on the NS5 gene were observed in the DENV-3 isolated from a naturally infected Ae. aegypti and fully sequenced. As an 8-nucleotides deletion was observed within the 11-nucleotides (nts) insertion on the variable region (VR) from the 3' UTR in this isolate, we further sequenced other DENV-3 from both mosquitoes and humans. The majority of DENV-3 from RJ analyzed were characterized by the 11-nts insertion in the VR of the 3' UTR, despite the observation of strains carrying the 8-nts deletion. The latter presented similar secondary structures, however not all strains presenting the 11-nts insertion were similar in the predicted secondary structure.
   Conclusions: The phylogeny based on the analysis of the complete genome and 3' UTR characterized the DENV-3 isolated from both vector and human host as belonging to Genotype III (GIII), despite the differences observed on the 3' UTR. Further studies are needed to address the role of those mutations in the transmission of the different viral populations and vector competence.
C1 [de Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Lab Trasmissores Hematozoarios, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [de Nogueira, Fernanda Bruycker; Ribeiro Nogueira, Rita Maria; dos Santos, Flavia Barreto] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP dos Santos, FB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM flaviab@ioc.fiocruz.br
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FIOCRUZ; FIOCRUZ/PAPES V; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX CNPq, CAPES, FIOCRUZ, FIOCRUZ/PAPES V and FAPERJ. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Amarilla AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-113
   Aquino JDJD, 2008, VIRUS RES, V137, P266, DOI 10.1016/j.virusres.2008.07.011
   Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710
   Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7
   BrisenoGarcia B, 1996, EMERG INFECT DIS, V2, P133, DOI 10.3201/eid0202.960210
   Chao DY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-72
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005
   Cologna R, 2003, J VIROL, V77, P3929, DOI 10.1128/JVI.77.7.3929-3938.2003
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   Dash PK, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-55
   de Mora D, 2009, ARCH VIROL, V154, P699, DOI 10.1007/s00705-009-0343-7
   de Araujo JMG, 2009, MEM I OSWALDO CRUZ, V104, P526, DOI 10.1590/S0074-02762009000300021
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Harris E, 1999, VIROLOGY, V253, P86, DOI 10.1006/viro.1998.9481
   Honorio NA, 2001, REV SAUDE PUBL, V35, P385, DOI 10.1590/S0034-89102001000400009
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Iglesias NG, 2011, RNA BIOL, V8, P249, DOI 10.4161/rna.8.2.14992
   Isturiz RE, 2000, INFECT DIS CLIN N AM, V14, P121, DOI 10.1016/S0891-5520(05)70221-X
   King CC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-63
   Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021
   Kochel T, 2008, INFECT GENET EVOL, V8, P682, DOI 10.1016/j.meegid.2008.06.008
   Kow CY, 2001, J MED ENTOMOL, V38, P475, DOI 10.1603/0022-2585-38.4.475
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   Lindenbach BD, 2001, FIELDS VIROLOGY, VII, P991, DOI DOI 10.1016/J.JMB.2013.11.024
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009
   Mandl CW, 1998, J VIROL, V72, P2132, DOI 10.1128/JVI.72.3.2132-2140.1998
   Markoff L, 2003, ADV VIRUS RES, V59, P177, DOI 10.1016/S0065-3527(03)59006-6
   Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996
   Messer WB, 2002, AM J TROP MED HYG, V66, P765, DOI 10.4269/ajtmh.2002.66.765
   Miagostovich MP, 2006, MEM I OSWALDO CRUZ, V101, P307, DOI 10.1590/S0074-02762006000300015
   Miagostovich MP, 2002, BRAZ J MED BIOL RES, V35, P869, DOI 10.1590/S0100-879X2002000800002
   Moi ML, 2010, EMERG INFECT DIS, V16, P1770, DOI 10.3201/eid1611.101061
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Ocazionez RE, 2006, MEM I OSWALDO CRUZ, V101, P725, DOI 10.1590/S0074-02762006000700004
   Ospina MC, 2010, AM J TROP MED HYG, V83, P672, DOI 10.4269/ajtmh.2010.09-0766
   Pankhong P, 2009, DNA CELL BIOL, V28, P481, DOI 10.1089/dna.2008.0835
   Peyrefitte CN, 2005, EMERG INFECT DIS, V11, P757, DOI 10.3201/eid1105.040959
   Peyrefitte CN, 2003, J CLIN MICROBIOL, V41, P5195, DOI 10.1128/JCM.41.11.5195-5198.2003
   Podder G, 2006, AM J TROP MED HYG, V74, P263, DOI 10.4269/ajtmh.2006.74.263
   Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194
   Ramirez A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-329
   Rigau-Perez JG, 2002, AM J TROP MED HYG, V67, P355, DOI 10.4269/ajtmh.2002.67.355
   Roche C, 2007, MICROBES INFECT, V9, P63, DOI 10.1016/j.micinf.2006.10.010
   Rodriguez-Roche R, 2005, EMERG INFECT DIS, V11, P773
   Barrero PR, 2008, VIRUS RES, V135, P83, DOI 10.1016/j.virusres.2008.02.013
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Shurtleff AC, 2001, VIROLOGY, V281, P75, DOI 10.1006/viro.2000.0748
   Silva RLA, 2008, VIRUS RES, V135, P320, DOI 10.1016/j.virusres.2008.03.007
   Usuku S, 2001, ARCH VIROL, V146, P1381, DOI 10.1007/s007050170098
   Uzcategui NY, 2001, J GEN VIROL, V82, P2945, DOI 10.1099/0022-1317-82-12-2945
   Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6
   Villabona-Arenas C, 2009, TROP MED INT HLTH
   Wang WK, 2002, J VIROL, V76, P4662, DOI 10.1128/JVI.76.9.4662-4665.2002
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549
NR 65
TC 10
Z9 10
U1 0
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JAN 2
PY 2013
VL 10
AR 3
DI 10.1186/1743-422X-10-3
PG 11
WC Virology
SC Virology
GA 082RF
UT WOS:000314409300002
PM 23282086
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU de Araujo, JMG
   Gomes, GM
   Faria, NRD
   de Araujo, ESM
   de Filippis, AMB
   dos Santos, FB
   Schatzmayr, HG
   Nogueira, RMR
AF Galvao de Araujo, Joselio Maria
   Gomes, Gabriella Mello
   da Costa Faria, Nieli Rodrigues
   Machado de Araujo, Eliane Saraiva
   Bispo de Filippis, Ana Maria
   dos Santos, Flavia Barreto
   Schatzmayr, Hermann Goncalves
   Ribeiro Nogueira, Rita Maria
TI Evaluation of a generic RT-nested-PCR for detection of flaviviruses in
   suspected fatal cases of dengue infection, Rio de Janeiro, Brazil
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Dengue; Fatal cases; Generic RT-nested-PCR; Brazil
ID POLYMERASE CHAIN-REACTION; WEST-NILE-VIRUS; RAPID IDENTIFICATION;
   SEQUENCES; PRIMERS; ASSAY; AMPLIFICATION; SAMPLES
AB Flaviviruses are significant causes of disease worldwide and can be classified serologically into several antigenic complexes. The purpose of the present study was to evaluate the effectiveness of a generic RT-nested-PCR for detection of flavivirus during a dengue outbreak in Brazil in 2008. A total of 105 serum samples were collected from patients with fatal outcome and examined by generic RT-PCR, conventional RT-PCR, and IgM serology. The generic RT-PCR confirmed 19 of 105 (18%) cases. Conventional RT-PCR performed on 105 serum samples detected 45 (42.8%) dengue virus infections. The IgM serology confirmed 44 of 102 (43.1%) cases. The infecting serotype was identified by generic RT-PCR in 19 cases (18 DENV-2 and 1 DENV-3) and by conventional RT-PCR in 45 cases (40 DENV-2 and 5 DENV-3). In addition, we analyzed the performance of the generic and conventional RT-PCRs and IgM serology on serum samples stratified by the day of onset of symptoms. Our results indicate that different methods should be included in flavivirus surveillance programs, including virological and serological approaches. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Galvao de Araujo, Joselio Maria] Univ Fed Rio Grande do Norte, Lab Mol Biol Infect Dis & Canc, Dept Microbiol & Parasitol, BR-59072910 Natal, RN, Brazil.
   [Gomes, Gabriella Mello; da Costa Faria, Nieli Rodrigues; Machado de Araujo, Eliane Saraiva; Bispo de Filippis, Ana Maria; dos Santos, Flavia Barreto; Schatzmayr, Hermann Goncalves; Ribeiro Nogueira, Rita Maria] Oswaldo Cruz Inst FIOCRUZ, Lab Flavivirus, Rio De Janeiro, Brazil.
RP de Araujo, JMG (corresponding author), Univ Fed Rio Grande do Norte, Lab Mol Biol Infect Dis & Canc, Dept Microbiol & Parasitol, Campus Univ, BR-59072910 Natal, RN, Brazil.
EM joselio@cb.ufrn.br
RI Araujo, Joselio M G/B-5502-2013
OI Araujo, Joselio M G/0000-0003-3548-2786
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [501564/03-9]; FAPERJCarlos Chagas Filho Foundation for Research Support
   of the State of Rio de Janeiro (FAPERJ) [E-26/152.810/2006]
FX The research described in this article was made possible by support from
   the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq
   (grant no. 501564/03-9) and FAPERJ (grant no. E-26/152.810/2006). The
   authors thank the Program for Technological Development in Tools for
   Health-PDTIS-FIOCRUZ for use of its facilities.
CR Berrocal Luis, 2006, Rev. salud pública, V8, P218, DOI 10.1590/S0124-00642006000200010
   Bosch I, 2007, EMERG INFECT DIS, V13, P651, DOI 10.3201/eid1304.061383
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   CHANG GJJ, 1994, J CLIN MICROBIOL, V32, P477, DOI 10.1128/JCM.32.2.477-483.1994
   CHOW VTK, 1993, ARCH VIROL, V133, P157, DOI 10.1007/BF01309751
   ELDADAH ZA, 1991, J MED VIROL, V33, P260, DOI 10.1002/jmv.1890330410
   Fang MY, 1997, MICROBIOL IMMUNOL, V41, P209, DOI 10.1111/j.1348-0421.1997.tb01192.x
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   FULOP L, 1993, J VIROL METHODS, V44, P179, DOI 10.1016/0166-0934(93)90053-T
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Miagostovich Mariz P., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P149, DOI 10.1590/S0036-46651993000200006
   Monath TP, 1996, FIELDS VIROLOGY, P961
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   Rocco Iray M., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P281, DOI 10.1590/S0036-46652005000500008
   Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
NR 28
TC 2
Z9 2
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD DEC
PY 2012
VL 186
IS 1-2
BP 167
EP 170
DI 10.1016/j.jviromet.2012.08.010
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 060GD
UT WOS:000312763600030
PM 22960088
DA 2020-12-09
ER

PT J
AU de Castro, MG
   Nogueira, RMR
   de Filippis, AMB
   Ferreira, AA
   Lima, MDQ
   Faria, NRD
   Nogueira, FD
   Simoes, JBS
   Nunes, PCG
   Sampaio, SA
   Lourenco-de-Oliveira, R
   dos Santos, FB
AF de Castro, Marcia Goncaves
   Ribeiro Nogueira, Rita Maria
   Bispo de Filippis, Ana Maria
   Ferreira, Anielly Alves
   Queiroz Lima, Monique da Rocha
   da Costa Faria, Nieli Rodrigues
   Nogueira, Fernanda de Bruycker
   Santos Simoes, Jaqueline Bastos
   Guerra Nunes, Priscila Conrado
   Sampaio, Simone Alves
   Lourenco-de-Oliveira, Ricardo
   dos Santos, Flavia Barreto
TI Dengue virus type 4 in Niteroi, Rio de Janeiro: the role of molecular
   techniques in laboratory diagnosis and entomological surveillance
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue virus type 4; Aedes aegypti; RT-PCR; real-time RT-PCR; Simplexa
   (TM) Dengue real-time RT-PCR
ID POLYMERASE-CHAIN-REACTION; AEDES-AEGYPTI DIPTERA; RAPID DETECTION;
   BRAZIL; STATE; ANTIGEN; TRANSMISSION; CULICIDAE; NS1; MOSQUITOS
AB In Niteroi, state of Rio de Janeiro, dengue virus type 4 (DENV-4) was isolated for the first time in March 2011. We analysed the laboratory findings of the first cases and evaluated the use of molecular techniques for the detection of DENV-4 in Aedes aegypti that were field-caught. Conventional reverse transcriptase-polymerase chain reaction (RT-PCR) and Simplexa (TM) Dengue real-time RT-PCR confirmed DENV-4 infection in all cases. Additionally, DENV-4 was confirmed in a female Ae. aegypti with 1.08 x 10(3) copies/mL of virus, as determined by quantitative real-time RT-PCR. This is the first time the Simplexa (TM) Dengue real-time assay has been used for the classification of cases of infection and for entomological investigations. The use of these molecular techniques was shown to be important for the surveillance of dengue in humans and vectors.
C1 [de Castro, Marcia Goncaves; Ferreira, Anielly Alves; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Lab Trasmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria; Queiroz Lima, Monique da Rocha; da Costa Faria, Nieli Rodrigues; Nogueira, Fernanda de Bruycker; Santos Simoes, Jaqueline Bastos; Guerra Nunes, Priscila Conrado; Sampaio, Simone Alves; dos Santos, Flavia Barreto] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
RP dos Santos, FB (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Trasmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
EM flaviab@ioc.fiocruz.br
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FIOCRUZ; FIOCRUZ/PAPES V; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX CNPq, CAPES, FIOCRUZ, FIOCRUZ/PAPES V, FAPERJ
CR Chen CF, 2010, VECTOR-BORNE ZOONOT, V10, P1017, DOI 10.1089/vbz.2008.0069
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Garcia-Rejon JE, 2011, AM J TROP MED HYG, V84, P489, DOI 10.4269/ajtmh.2011.10-0654
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Guedes DRD, 2010, J VECTOR DIS, V47, P67
   Huang JL, 2001, J MED VIROL, V65, P553, DOI 10.1002/jmv.2072
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   KHIN MM, 1983, AM J TROP MED HYG, V32, P590, DOI 10.4269/ajtmh.1983.32.590
   Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009
   Mendez F, 2006, AM J TROP MED HYG, V74, P678, DOI 10.4269/ajtmh.2006.74.678
   MS/SVS - Ministerio de Saude/Secretaria de Vigilancia em Saude, 2011, BAL DENG SEM EP
   NOGUEIRA R M R, 1988, Memorias do Instituto Oswaldo Cruz, V83, P219, DOI 10.1590/S0074-02761988000200012
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   Nogueira RMR, 1999, MEM I OSWALDO CRUZ, V94, P297, DOI 10.1590/S0074-02761999000300004
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Pinheiro VCS, 2005, MEM I OSWALDO CRUZ, V100, P833, DOI 10.1590/S0074-02762005000800003
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P789, DOI 10.1089/vbz.2010.0028
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 30
TC 7
Z9 7
U1 0
U2 7
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD NOV
PY 2012
VL 107
IS 7
BP 940
EP 945
DI 10.1590/S0074-02762012000700017
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 083IT
UT WOS:000314457600017
PM 23147153
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU dos Santos, FB
   Nogueira, FB
   Castro, MG
   Nunes, PCG
   de Filippis, AMB
   Faria, NRC
   Simoes, JBS
   Sampaio, SA
   Santos, CR
   Nogueira, RMR
AF dos Santos, Flavia B.
   Nogueira, Fernanda B.
   Castro, Marcia G.
   Nunes, Priscila C. G.
   de Filippis, Ana Maria B.
   Faria, Nieli R. C.
   Simoes, Jaqueline B. S.
   Sampaio, Simone A.
   Santos, Clarice R.
   Nogueira, Rita Maria R.
TI First report of multiple lineages of dengue viruses type 1 in Rio de
   Janeiro, Brazil
SO VIROLOGY JOURNAL
LA English
DT Article
DE Dengue virus type 1; multiple lineages; phylogeny; Rio de Janeiro
ID REPLACEMENT; SELECTION; EVOLUTION
AB Background: In Brazil dengue has been a major public health problem since DENV-1 introduction and spread in 1986. After a low or silent co-circulation, DENV-1 re-emerged in 2009 causing a major epidemic in the country in 2010 and 2011. In this study, the phylogeny of DENV-1 strains isolated in RJ after its first introduction in 1986 and after its emergence in 2009 and 2010 was performed in order to document possible evolutionary patterns or introductions in a re-emergent virus.
   Findings: The analysis of the E gene sequences demonstrated that DENV-1 isolated during 2009/2010 still belong to genotype V (Americas/Africa) but grouping in a distinct clade (lineage II) of that represented by earlier DENV-1 (lineage I). However, strains isolated in 2011 grouped together forming another distinct clade (lineage III).
   Conclusions: The monitoring of DENV is important to observe the spread of potentially virulent strains as well to evaluate its impact over the population during an outbreak. Whether explosive epidemics reported in Brazil caused mainly by DENV-1 was due to lineage replacement, or due the population susceptibility to this serotype which has not circulated for almost a decade or even due to the occurrence of secondary infections in a hyperendemic country, is not clear. This is the first report of multiple lineages of DENV-1 detected in Brazil.
C1 [dos Santos, Flavia B.; Nogueira, Fernanda B.; Nunes, Priscila C. G.; de Filippis, Ana Maria B.; Faria, Nieli R. C.; Simoes, Jaqueline B. S.; Sampaio, Simone A.; Santos, Clarice R.; Nogueira, Rita Maria R.] Inst Oswaldo Cruz, Lab Flavivirus, BR-20001 Rio De Janeiro, Brazil.
   [Castro, Marcia G.] Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, BR-20001 Rio De Janeiro, Brazil.
RP dos Santos, FB (corresponding author), Inst Oswaldo Cruz, Lab Flavivirus, BR-20001 Rio De Janeiro, Brazil.
EM flaviab@ioc.fiocruz.br
RI Faria, Nuno Rodrigues/I-2975-2012
OI Faria, Nuno Rodrigues/0000-0001-8839-2798; Santos,
   Clarice/0000-0001-9910-0594
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [303546/2008-5]; CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E/26-102.936/2008]; FIOCRUZ
FX This work was supported by CNPq [303546/2008-5], CAPES, FAPERJ
   [E/26-102.936/2008] and FIOCRUZ.
CR Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182
   Carrillo-Valenzo E, 2010, ARCH VIROL, V155, P1401, DOI 10.1007/s00705-010-0721-1
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Kukreti H, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-1
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226
   *PDVI, GLOB BURD DENG
   Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   SVS/MS, 2009, INF EP DENG SEM 1 52
   SVS/MS, 2010, INF EP DENG AN SIT T
   Thu HM, 2005, VIROLOGY, V336, P163, DOI 10.1016/j.virol.2005.03.018
   Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005
NR 15
TC 21
Z9 22
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD AUG 3
PY 2011
VL 8
AR 387
DI 10.1186/1743-422X-8-387
PG 4
WC Virology
SC Virology
GA 817PF
UT WOS:000294685600001
PM 21813012
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Allonso, D
   Rosa, MD
   Coelho, DR
   da Costa, SM
   Nogueira, RMR
   Bozza, FA
   Dos Santos, FB
   Alves, AMD
   Mohana-Borges, R
AF Allonso, Diego
   Rosa, Marcela da Silva
   Coelho, Diego Rodrigues
   da Costa, Simone Morais
   Ribeiro Nogueira, Rita Maria
   Bozza, Fernando Augusto
   Dos Santos, Flavia Barreto
   de Barcelos Alves, Ada Maria
   Mohana-Borges, Ronaldo
TI Polyclonal antibodies against properly folded Dengue virus NS1 protein
   expressed in E-coli enable sensitive and early dengue diagnosis
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Dengue virus; NS1 protein; Dengue diagnosis; E. coli
ID NONSTRUCTURAL GLYCOPROTEIN NS1; SECONDARY STRUCTURE ANALYSES; ANTIGEN
   CAPTURE IMMUNOASSAY; LINKED-IMMUNOSORBENT-ASSAY; MONOCLONAL-ANTIBODIES;
   SIGNAL SEQUENCE; DNA VACCINE; TYPE-1; INFECTIONS; CELLS
AB The non-structural 1 (NS1) protein plays an important role in dengue diagnosis because it has been detected as a soluble serum antigen in both primary and secondary infections. The NS1 protein was expressed in Escherichia coli cells, and the efficiency of four different refolding protocols was tested. All of the protocols generated dimeric NS1 in a conformation similar to that of the protein expressed by eukaryotic cells. A polyclonal antibody produced from the properly folded E. coli recombinant NS1 (rNS1) protein proved to be a useful tool for the diagnosis of Dengue virus because it detected 100% of the Dengue virus 2 (DENV2) in infected patients' sera and 60% of the DENV IgM-positive sera not detected by commercial NS1-based diagnostic kits. These data suggest a high-efficiency method for correctly folding rNS1 that maintains its structural and immunogenic properties. In addition, a detection method using the polyclonal antibody against correctly folded rNS1 seemed to be more sensitive and efficient for NS1 detection in serum, highlighting its usefulness for developing a high-sensitivity diagnostic kit. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Allonso, Diego; Rosa, Marcela da Silva; Coelho, Diego Rodrigues; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estruct, BR-21941590 Rio De Janeiro, Brazil.
   [da Costa, Simone Morais; de Barcelos Alves, Ada Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria; Dos Santos, Flavia Barreto] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Bozza, Fernando Augusto] Fundacao Oswaldo Cruz, Inst Pesquisas Clin Evandro Chagas, Unidade Terapia Intens, Rio De Janeiro, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estruct, Edificio Ctr Ciencias Saude,Bloco C,Sala 36 Sub S, BR-21941902 Rio de Janeiro, Brazil.
EM mohana@biof.ufrj.br
RI Bozza, Fernando A/A-2618-2013; Borges, Ronaldo S Mohana/C-5575-2013;
   Allonso, Diego/Y-3446-2018
OI Bozza, Fernando A/0000-0003-4878-0256; Allonso,
   Diego/0000-0002-1410-480X; Mohana Borges, Ronaldo/0000-0002-1796-475X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); IMBEBB; FINEP (GENOPROT Dengue)Ciencia
   Tecnologia e Inovacao (FINEP); National Institutes of Science and
   Technology in Structural Biology and Bioimaging (INCT-INBEB);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX This work was supported by the following funding agencies: CNPq, FAPERJ,
   IMBEBB, and FINEP (GENOPROT Dengue), the National Institutes of Science
   and Technology in Structural Biology and Bioimaging (INCT-INBEB). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. We thank M.Sc.
   Iamara Andrade for her help with fluorescence microscopy and Ana
   Carolina Fonseca-Guimaraes for her technical assistance. Diego Allonso
   holds a Ph.D. fellowship from Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES). We would also like to thank the Genomic
   Platform for DNA sequencing of PDTIS/FIOCRUZ.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003
   Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022
   Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059
   Das D, 2009, PROTEIN EXPRES PURIF, V66, P66, DOI 10.1016/j.pep.2009.02.003
   Dos Santos FB, 2004, AM J TROP MED HYG, V71, P144, DOI 10.4269/ajtmh.2004.71.144
   Dos Santos FB, 2007, CLIN VACCINE IMMUNOL, V14, P641, DOI 10.1128/CVI.00474-06
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   FALCONAR AKI, 1991, J GEN VIROL, V72, P961, DOI 10.1099/0022-1317-72-4-961
   FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989
   FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Kao CL, 2001, J CLIN MICROBIOL, V39, P3672, DOI 10.1128/JCM.39.10.3672-3677.2001
   Lemes EMB, 2005, J CLIN VIROL, V32, P305, DOI 10.1016/j.jcv.2004.08.015
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   MASON PW, 1990, J GEN VIROL, V71, P2107, DOI 10.1099/0022-1317-71-9-2107
   Melo MN, 2009, J MOL BIOL, V392, P736, DOI 10.1016/j.jmb.2009.07.035
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   PRYOR MJ, 1993, VIROLOGY, V194, P769, DOI 10.1006/viro.1993.1318
   Qiu LW, 2009, CLIN VACCINE IMMUNOL, V16, P88, DOI 10.1128/CVI.00212-08
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Ramirez AH, 2009, DIAGN MICR INFEC DIS, V65, P247, DOI 10.1016/j.diagmicrobio.2009.07.022
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   SMITH GW, 1985, J GEN VIROL, V66, P559, DOI 10.1099/0022-1317-66-3-559
   Wallis TP, 2004, J BIOL CHEM, V279, P20729, DOI 10.1074/jbc.M312907200
   Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371
   Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
   Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06
   ZHAO B, 1987, J VIROL, V61, P4019, DOI 10.1128/JVI.61.12.4019-4022.1987
   Zhou JM, 2006, VIRUS GENES, V33, P27, DOI 10.1007/s11262-005-0036-6
NR 34
TC 16
Z9 17
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD JUL
PY 2011
VL 175
IS 1
BP 109
EP 116
DI 10.1016/j.jviromet.2011.04.029
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 791LG
UT WOS:000292666100016
PM 21569796
OA Green Published
DA 2020-12-09
ER

PT J
AU Lima, MDQ
   Nogueira, RMR
   de Filippis, AMB
   dos Santos, FB
AF Queiroz Lima, Monique da Rocha
   Ribeiro Nogueira, Rita Maria
   Bispo de Filippis, Ana Maria
   dos Santos, Flavia Barreto
TI Comparison of Two Generations of the Panbio Dengue NS1 Capture
   Enzyme-Linked Immunosorbent Assay
SO CLINICAL AND VACCINE IMMUNOLOGY
LA English
DT Article
ID VIRUS-INFECTION; PROTEIN NS1; DIAGNOSIS; ANTIGEN; ANTIBODIES; BRAZIL;
   LAOS
AB We compared two generations of Panbio (Brisbane, Australia) commercial kits for NS1 antigen capture for early diagnosis of dengue: the first-generation pan-E Dengue Early ELISA and the second-generation Dengue Early ELISA. The test improvement resulted in a highly sensitive and specific test suitable for use as a first-line test in the field.
C1 [Queiroz Lima, Monique da Rocha; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria; dos Santos, Flavia Barreto] Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab, BR-21045360 Rio De Janeiro, Brazil.
RP dos Santos, FB (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab, Av Brasil,4365 Manguinhos, BR-21045360 Rio De Janeiro, Brazil.
EM flaviab@ioc.fiocruz.br
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08
   Blacksell SD, 2008, DIAGN MICR INFEC DIS, V60, P43, DOI 10.1016/j.diagmicrobio.2007.07.011
   Blacksell SD, 2007, CLIN VACCINE IMMUNOL, V14, P1458, DOI 10.1128/CVI.00482-06
   Chuansumrit A, 2008, PEDIATR INFECT DIS J, V27, P43, DOI 10.1097/INF.0b013e318150666d
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   Kumarasamy V, 2007, J VIROL METHODS, V140, P75, DOI 10.1016/j.jviromet.2006.11.001
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   NOGUEIRA RMR, 1992, RES VIROLOGY, V143, P423, DOI 10.1016/S0923-2516(06)80136-6
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Ramirez AH, 2009, DIAGN MICR INFEC DIS, V65, P247, DOI 10.1016/j.diagmicrobio.2009.07.022
   Sekaran S. D., 2007, Journal of Infection in Developing Countries, V1, P182
   Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 19
TC 17
Z9 17
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1556-6811
J9 CLIN VACCINE IMMUNOL
JI Clin. Vaccine Immunol.
PD JUN
PY 2011
VL 18
IS 6
BP 1031
EP 1033
DI 10.1128/CVI.00024-11
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 771HH
UT WOS:000291147300020
PM 21525305
OA Bronze, Green Published
DA 2020-12-09
ER

PT J
AU Lima, MDQ
   Nogueira, RMR
   Schatzmayr, HG
   de Filippis, AMB
   Limonta, D
   dos Santos, FB
AF Queiroz Lima, Monique da Rocha
   Ribeiro Nogueira, Rita Maria
   Schatzmayr, Hermann Goncalves
   Bispo de Filippis, Ana Maria
   Limonta, Daniel
   dos Santos, Flavia Barreto
TI A New Approach to Dengue Fatal Cases Diagnosis: NS1 Antigen Capture in
   Tissues
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID NONSTRUCTURAL PROTEIN NS1; IMMUNOSORBENT-ASSAY; VIRUS-INFECTION; HUMAN
   LIVER; ENZYME; FEVER; IMMUNOASSAY; INVOLVEMENT; MICE
AB Background: Dengue is the most important arthropod borne viral disease worldwide in terms of morbidity and mortality and is caused by any of the four serotypes of dengue virus (DENV-1 to 4). Brazil is responsible for approximately 80% of dengue cases in the Americas, and since the introduction of dengue in 1986, a total of 5,944,270 cases have been reported including 21,596 dengue hemorrhagic fever and 874 fatal cases. DENV can infect many cell types and cause diverse clinical and pathological effects. The goal of the study was to investigate the usefulness of NS1 capture tests as an alternative tool to detect DENV in tissue specimens from previously confirmed dengue fatal cases (n = 23) that occurred in 2002 in Brazil.
   Methodology/Principal Findings: A total of 74 tissue specimens were available: liver (n = 23), lung (n = 14), kidney (n = 04), brain (n = 10), heart (n = 02), skin (n = 01), spleen (n = 15), thymus (n = 03) and lymph nodes (n = 02). We evaluated three tests for NS1 antigen capture: first generation Dengue Early ELISA (PanBio Diagnostics), Platelia NS1 (BioRad Laboratories) and the rapid test NS1 Ag Strip (BioRad Laboratories). The overall dengue fatal case diagnosis based on the tissues analyzed by Dengue Early ELISA, Platelia NS1 and the NS1 Ag Strip was 34.7% (08/23), 60.8% (14/23) and 91.3% (21/23), respectively. The Dengue Early ELISA detected NS1 in 22.9% (17/74) of the specimens analyzed and the Platelia NS1 in 45.9% (34/74). The highest sensitivity (78.3%; 58/74) was achieved by the NS1 Ag Strip, and the differences in the sensitivities were statistically significant (p < 0.05). The NS1 Ag Strip was the most sensitive in liver (91.3%; 21/23), lung (71.4%; 10/14), kidney (100%; 4/4), brain (80%; 8/10), spleen (66.6%, 10/15) and thymus (100%, 3/3) when compared to the other two ELISA assays.
   Conclusions/Significance: This study shows the DENV NS1 capture assay as a rapid and valuable approach to postmortem dengue confirmation. With an increasing number of DHF and fatal cases, the availability of new approaches useful for cases confirmation plays an important tool for the disease surveillance.
C1 [Queiroz Lima, Monique da Rocha; Ribeiro Nogueira, Rita Maria; Schatzmayr, Hermann Goncalves; Bispo de Filippis, Ana Maria; dos Santos, Flavia Barreto] Inst Oswaldo Cruz, Flavivirus Lab, BR-20001 Rio De Janeiro, Brazil.
   [Limonta, Daniel] Pedro Kouri Inst Trop Med, PAHO WHO Collaborating Ctr Study Dengue & Its Vec, Dept Virol, Natl Reference Lab Dengue, Havana, Cuba.
RP Lima, MDQ (corresponding author), Inst Oswaldo Cruz, Flavivirus Lab, BR-20001 Rio De Janeiro, Brazil.
EM flaviab@ioc.fiocruz.br
RI Limonta, Daniel/A-8644-2012
OI Limonta, Daniel/0000-0002-5128-6542
FU Conselho Nacional de Desenvolvimento Cientfico e
   Tecnologico-CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); PDTIS/FIOCRUZ; FIOCRUZ;
   CAPESCAPES
FX The study financing was from the Conselho Nacional de Desenvolvimento
   Cientfico e Tecnologico-CNPq, FAPERJ, PDTIS/FIOCRUZ and FIOCRUZ. MRQL
   and DL are CAPES and CNPq fellowship recipients, respectively. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Barreto DF, 2007, MEM I OSWALDO CRUZ, V102, P175, DOI 10.1590/S0074-02762007005000007
   Basílio-de-Oliveira C.A., 2005, Braz J Infect Dis, V9, P341, DOI 10.1590/S1413-86702005000400012
   Blacksell SD, 2008, DIAGN MICR INFEC DIS, V60, P43, DOI 10.1016/j.diagmicrobio.2007.07.011
   Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6
   CHUAH S K, 1987, SMJ Singapore Medical Journal, V28, P569
   Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7
   Donegani E, 1986, Minerva Cardioangiol, V34, P477
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Frolich K, 2003, J WILDLIFE DIS, V39, P121
   de Araujo JMG, 2009, J VIROL METHODS, V155, P34, DOI 10.1016/j.jviromet.2008.09.023
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman M G, 1999, Int J Infect Dis, V3, P130, DOI 10.1016/S1201-9712(99)90033-4
   HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   Huerre MR, 2001, VIRCHOWS ARCH, V438, P107
   Hunt AR, 2002, J CLIN MICROBIOL, V40, P2023, DOI 10.1128/JCM.40.6.2023-2030.2002
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   KANGWANPONG D, 1995, CLIN DIAGN VIROL, V3, P165, DOI 10.1016/0928-0197(94)00032-P
   Khongphatthallayothin A, 2000, Southeast Asian J Trop Med Public Health, V31, P642
   KILLEN H, 1993, J VIROL METHODS, V41, P135, DOI 10.1016/0166-0934(93)90121-7
   KSIAZEK TG, 1992, J CLIN MICROBIOL, V30, P947, DOI 10.1128/JCM.30.4.947-950.1992
   Kumarasamy V, 2007, J VIROL METHODS, V140, P75, DOI 10.1016/j.jviromet.2006.11.001
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Limonta D, 2007, J CLIN VIROL, V40, P50, DOI 10.1016/j.jcv.2007.04.024
   Limonta Daniel, 2009, Int J Infect Dis, V13, pe77, DOI 10.1016/j.ijid.2008.06.028
   Lin YL, 2000, VIROLOGY, V276, P114, DOI 10.1006/viro.2000.0524
   McBride WJH, 2009, DIAGN MICR INFEC DIS, V64, P31, DOI 10.1016/j.diagmicrobio.2009.01.002
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Wali JP, 1998, INT J CARDIOL, V64, P31, DOI 10.1016/S0167-5273(98)00008-4
   *WHO, 2009, 117 WHO
   Wiersinga WJ, 2006, CLIN INFECT DIS, V43, P800, DOI 10.1086/507111
   Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zainah S, 2009, J VIROL METHODS, V155, P157, DOI 10.1016/j.jviromet.2008.10.016
NR 44
TC 16
Z9 18
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2011
VL 5
IS 5
AR e1147
DI 10.1371/journal.pntd.0001147
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 770OZ
UT WOS:000291099100025
PM 21572520
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Lima, MDQ
   Nogueira, RMR
   Schatzmayr, HG
   dos Santos, FB
AF Queiroz Lima, Monique da Rocha
   Ribeiro Nogueira, Rita Maria
   Schatzmayr, Hermann Goncalves
   dos Santos, Flavia Barreto
TI Comparison of Three Commercially Available Dengue NS1 Antigen Capture
   Assays for Acute Diagnosis of Dengue in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID LINKED-IMMUNOSORBENT-ASSAY; NONSTRUCTURAL PROTEIN NS1; VIRUS-INFECTION;
   LABORATORY DIAGNOSIS; CELLS; IMMUNOASSAY; CIRCULATION; EXPRESSION;
   ANTIBODIES; MEMBRANE
AB Background: Dengue is associated with explosive urban epidemics and has become a major public health problem in many tropical developing countries, including Brazil. The laboratory diagnosis of dengue can be carried out using several approaches, however sensitive and specific assays useful to diagnose in the early stage of fever are desirable. The flavivirus non-structural protein NS1, a highly conserved and secreted glycoprotein, is a candidate protein for rapid diagnosis of dengue in endemic countries.
   Methodology/Principal Findings: We aimed to evaluate the potential use of 3 commercial kits in a panel of 450 serum samples for early diagnosis of dengue in Brazil. The PanBio Early ELISA (PanBio Diagnostics) showed a sensitivity of 72.3% (159/220) and a specificity of 100%, while the sensitivity of the Platelia (TM) NS1 assay (Biorad Laboratories) was 83.6% (184/ 220). However, the highest sensitivity (89.6%; 197/220) was obtained by using the NS1 Ag Strip (Biorad Laboratories). A lower sensitivity was observed in DENV-3 cases by all 3 kits. Serum positive by virus isolation were more often positive than cases positive by RT-PCR by all three assays and a higher detection rate was observed during the first four days after the onset of the symptoms. The presence or absence of IgM showed no influence in the confirmation by the pan-E Early ELISA (P = 0,6159). However, a higher confirmation by both Platelia (TM) NS1 (Biorad) and Dengue NS1 Ag Strip (Biorad) in the absence of IgM was statistically significant (P < 0,0001 and P = 0,0008, respectively). Only the Platelia (R) NS1 test showed a higher sensitivity in confirming primary infections than secondary ones.
   Conclusions/Significance: The results indicate that commercial kits of dengue NS1 antigen are useful for the laboratory diagnosis of acute primary and secondary dengue. It can be used in combination with the MAC-ELISA for case detection and as screening test to complement viral isolation.
C1 [Queiroz Lima, Monique da Rocha; Ribeiro Nogueira, Rita Maria; Schatzmayr, Hermann Goncalves; dos Santos, Flavia Barreto] Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab, BR-21045900 Rio De Janeiro, Brazil.
RP Lima, MDQ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab, BR-21045900 Rio De Janeiro, Brazil.
EM flaviab@ioc.fiocruz.br
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); PDTIS/FIOCRUZ; FIOCRUZ
FX This study was supported by CNPq, FAPERJ, PDTIS/FIOCRUZ and FIOCRUZ. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08
   Blacksell SD, 2008, DIAGN MICR INFEC DIS, V60, P43, DOI 10.1016/j.diagmicrobio.2007.07.011
   Blacksell SD, 2007, CLIN VACCINE IMMUNOL, V14, P1458, DOI 10.1128/CVI.00482-06
   CHAIYARATANA W, 2009, DIAGN MICROBIOL INFE, V64, P91
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chuansumrit A, 2008, PEDIATR INFECT DIS J, V27, P43, DOI 10.1097/INF.0b013e318150666d
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Huang JL, 2001, J MED VIROL, V65, P553, DOI 10.1002/jmv.2072
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003
   Kumarasamy V, 2007, J VIROL METHODS, V140, P75, DOI 10.1016/j.jviromet.2006.11.001
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lapphra K, 2008, DIAGN MICR INFEC DIS, V60, P387, DOI 10.1016/j.diagmicrobio.2007.11.010
   MASON PW, 1989, VIROLOGY, V169, P354, DOI 10.1016/0042-6822(89)90161-X
   McBride WJH, 2009, DIAGN MICR INFEC DIS, V64, P31, DOI 10.1016/j.diagmicrobio.2009.01.002
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   *PAHO, 1997, B EP, V18, P1
   PHUONG HL, 2009, DIAGN MICROBIOL INFE, V63, P373
   Ramirez AH, 2009, DIAGN MICROBIOL INFE
   Schilling S, 2004, J CLIN VIROL, V31, P179, DOI 10.1016/j.jcv.2004.03.020
   Sekaran S. D., 2007, Journal of Infection in Developing Countries, V1, P182
   Shu PY, 2004, J CLIN MICROBIOL, V42, P2489, DOI 10.1128/JCM.42.6.2489-2494.2004
   Shu PY, 2002, J CLIN MICROBIOL, V40, P1840, DOI 10.1128/JCM.40.5.1840-1844.2002
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   *WHO, 2002, 117 WHO
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zainah S, 2009, J VIROL METHODS, V155, P157, DOI 10.1016/j.jviromet.2008.10.016
NR 37
TC 92
Z9 92
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2010
VL 4
IS 7
AR e738
DI 10.1371/journal.pntd.0000738
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 632HC
UT WOS:000280412300009
PM 20625558
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Parameswaran, P
   Sklan, E
   Wilkins, C
   Burgon, T
   Samuel, MA
   Lu, R
   Ansel, KM
   Heissmeyer, V
   Einav, S
   Jackson, W
   Doukas, T
   Paranjape, S
   Polacek, C
   dos Santos, FB
   Jalili, R
   Babrzadeh, F
   Gharizadeh, B
   Grimm, D
   Kay, M
   Koike, S
   Sarnow, P
   Ronaghi, M
   Ding, SW
   Harris, E
   Chow, M
   Diamond, MS
   Kirkegaard, K
   Glenn, JS
   Fire, AZ
AF Parameswaran, Poornima
   Sklan, Ella
   Wilkins, Courtney
   Burgon, Trever
   Samuel, Melanie A.
   Lu, Rui
   Ansel, K. Mark
   Heissmeyer, Vigo
   Einav, Shirit
   Jackson, William
   Doukas, Tammy
   Paranjape, Suman
   Polacek, Charlotta
   dos Santos, Flavia Barreto
   Jalili, Roxana
   Babrzadeh, Farbod
   Gharizadeh, Baback
   Grimm, Dirk
   Kay, Mark
   Koike, Satoshi
   Sarnow, Peter
   Ronaghi, Mostafa
   Ding, Shou-Wei
   Harris, Eva
   Chow, Marie
   Diamond, Michael S.
   Kirkegaard, Karla
   Glenn, Jeffrey S.
   Fire, Andrew Z.
TI Six RNA Viruses and Forty-One Hosts: Viral Small RNAs and Modulation of
   Small RNA Repertoires in Vertebrate and Invertebrate Systems
SO PLOS PATHOGENS
LA English
DT Article
ID DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; VESICULAR STOMATITIS-VIRUS;
   INDUCED SILENCING COMPLEX; ANTIVIRAL IMMUNITY; CELLULAR MICRORNAS; CORE
   PROTEIN; DENGUE VIRUS; NS1 PROTEIN; LEADER RNA
AB We have used multiplexed high-throughput sequencing to characterize changes in small RNA populations that occur during viral infection in animal cells. Small RNA-based mechanisms such as RNA interference (RNAi) have been shown in plant and invertebrate systems to play a key role in host responses to viral infection. Although homologs of the key RNAi effector pathways are present in mammalian cells, and can launch an RNAi-mediated degradation of experimentally targeted mRNAs, any role for such responses in mammalian host-virus interactions remains to be characterized. Six different viruses were examined in 41 experimentally susceptible and resistant host systems. We identified virus-derived small RNAs (vsRNAs) from all six viruses, with total abundance varying from "vanishingly rare'' (less than 0.1% of cellular small RNA) to highly abundant (comparable to abundant micro-RNAs "miRNAs''). In addition to the appearance of vsRNAs during infection, we saw a number of specific changes in host miRNA profiles. For several infection models investigated in more detail, the RNAi and Interferon pathways modulated the abundance of vsRNAs. We also found evidence for populations of vsRNAs that exist as duplexed siRNAs with zero to three nucleotide 39 overhangs. Using populations of cells carrying a Hepatitis C replicon, we observed strand-selective loading of siRNAs onto Argonaute complexes. These experiments define vsRNAs as one possible component of the interplay between animal viruses and their hosts.
C1 [Parameswaran, Poornima; Burgon, Trever; Jackson, William; Doukas, Tammy; Sarnow, Peter; Kirkegaard, Karla] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
   [Sklan, Ella; Einav, Shirit; Glenn, Jeffrey S.] Stanford Univ, Sch Med, Dept Gastroenterol & Hepatol, Stanford, CA 94305 USA.
   [Wilkins, Courtney; Chow, Marie] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.
   [Samuel, Melanie A.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Lu, Rui; Ding, Shou-Wei] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.
   [Ansel, K. Mark] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.
   [Ansel, K. Mark] Univ Calif San Francisco, Strateg Asthma Basic Res Ctr, San Francisco, CA 94143 USA.
   [Heissmeyer, Vigo] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Mol Immunol, Munich, Germany.
   [Paranjape, Suman; Polacek, Charlotta; dos Santos, Flavia Barreto; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Jalili, Roxana; Babrzadeh, Farbod; Gharizadeh, Baback; Ronaghi, Mostafa] Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Stanford, CA 94305 USA.
   [Grimm, Dirk; Kay, Mark] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.
   [Grimm, Dirk; Kay, Mark; Fire, Andrew Z.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.
   [Koike, Satoshi] Tokyo Metropolitan Inst Med Sci, Tokyo Metropolitan Org Med Res, Tokyo 113, Japan.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Fire, Andrew Z.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.
RP Parameswaran, P (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
EM afire@stanford.edu
RI Diamond, Michael/AAH-1733-2019; Ding, Shou Wei/AAC-2533-2020
OI Diamond, Michael/0000-0002-8791-3165; Wilkins,
   Courtney/0000-0003-4001-7686; Heissmeyer, Vigo/0000-0002-2263-8545;
   Polacek, Charlotta/0000-0003-0297-5672
FU Burroughs Wellcome FundBurroughs Wellcome Fund [CABS1006173]; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB571]; Fritz
   Thyssen Foundation; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI071068,
   K08-AI079406-01, 1S10RR022982-01, AI069000, R01 AI052447, AI052324, U54
   AI057160, ROI GM37706]; UAMS Foundation; Burroughs Wellcome Fund
   Clinical Scientist Award in Translational ResearchBurroughs Wellcome
   Fund [RO1 DK066793, RO1 DK064223]; Pacific Southwest Regional Center of
   Excellence, PI Alan BarbourUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [NIAID-U54065359]; NATIONAL
   CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [S10RR022982, S10RR022982, S10RR022982,
   S10RR022982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U54AI057160, U54AI057160,
   U54AI057160, R01AI071068, U54AI057160, R01AI069000, U54AI057160,
   U54AI057160, U54AI057160, U54AI057160, U54AI057160, T32AI007328,
   T32AI007328, R01AI069000, U54AI057160, T32AI007328, U54AI057160,
   T32AI007328, U54AI057160, T32AI007328, T32AI007328, U54AI057160,
   K08AI079406, U54AI057160, U54AI057160, U54AI057160, U54AI057160,
   R01AI052447, U54AI057160, U54AI057160, R01AI071068, U54AI057160,
   U54AI057160, U54AI057160, R01AI052447, U54AI057160, K08AI079406,
   T32AI007328, U54AI057160, U54AI057160, U54AI057160, U54AI057160,
   U54AI057160, U54AI057160, U54AI057160, R01AI052324, R01AI071068,
   R01AI071068, U54AI057160, R01AI052447, U54AI057160, R01AI052447,
   U54AI057160, U54AI057160, U54AI057160, U54AI057160, R01AI052447,
   R01AI052324, U54AI057160, U54AI057160, U54AI057160, U54AI057160,
   U54AI057160, R01AI052447, U54AI057160, R01AI069000, U54AI057160,
   U54AI057160, U54AI057160, T32AI007328, U54AI057160, R01AI071068,
   U54AI057160, U54AI057160, U54AI057160, U54AI057160, R01AI052447,
   R01AI052324, U54AI057160, U54AI057160, T32AI007328, U54AI057160,
   U54AI057160, T32AI007328, U54AI057160, T32AI007328, U54AI057160,
   R01AI069000, U54AI057160, U54AI057160, R01AI069000, U54AI057160,
   U54AI057160, R01AI069000, U54AI057160, R01AI052447, U54AI057160,
   U54AI057160, T32AI007328, R01AI052447, U54AI057160, U54AI057160,
   T32AI007328, U54AI057160, U54AI057160, U54AI057160, U54AI057160,
   U54AI057160, U54AI057160, U54AI057160, U54AI057160, R01AI069000,
   U54AI057160, T32AI007328, U54AI057160, R01AI069000, T32AI007328,
   U54AI057160, R01AI052324, K08AI079406, R01AI052447, R01AI071068,
   U54AI057160, U54AI057160, U54AI057160, U54AI057160, R01AI071068,
   U54AI057160, U54AI057160, T32AI007328, T32AI007328, U54AI057160,
   R01AI071068, U54AI057160, R01AI052447, T32AI007328, U54AI057160,
   T32AI007328, R01AI071068, R01AI069000, U54AI057160, T32AI007328,
   U54AI057160, U54AI057160, U54AI057160, U54AI057160, T32AI007328,
   U54AI057160, U54AI057160, U54AI057160, U54AI057160, U54AI057160,
   U54AI057160, R01AI069000, T32AI007328, U54AI057160, U54AI057160,
   U54AI057160, R01AI069000, U54AI057160, T32AI007328, R01AI071068,
   U54AI057160, U54AI057160, T32AI007328, U54AI057160, R01AI069000,
   T32AI007328, U54AI057160, R01AI052447, U54AI057160, U54AI057160,
   U54AI057160, T32AI007328, U54AI057160, U54AI057160, K08AI079406,
   T32AI007328, T32AI007328, U54AI057160, T32AI007328, U54AI057160,
   K08AI079406, T32AI007328, U54AI057160, R01AI071068, U54AI057160,
   U54AI057160, U54AI057160, U54AI057160, U54AI057160, R01AI052324,
   T32AI007328, R01AI052324, T32AI007328, U54AI057160, R01AI052447,
   U54AI057160, T32AI007328, U54AI057160, U54AI057160, U54AI057160,
   U54AI057160, R01AI052447, U54AI057160, U54AI057160, R01AI071068,
   R01AI071068, R01AI071068, U54AI057160, U54AI057160, U54AI057160,
   U54AI057160, U54AI057160, U54AI057160, U54AI057160] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R01DK066793, R01DK064223,
   R01DK066793, R01DK064223, R01DK064223, R01DK064223, R01DK064223,
   R01DK066793, R01DK064223, R01DK066793] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM037706,
   R01GM037706, R01GM037706, R01GM037706, R01GM037706, R01GM037706,
   R01GM037706, R01GM037706, R01GM037706, R01GM037706, R01GM037706,
   R01GM037706, R01GM037706, R01GM037706, R01GM037706, R01GM037706,
   R01GM037706, R01GM037706, R01GM037706, R01GM037706, R01GM037706,
   R01GM037706, R01GM037706, R01GM037706, R01GM037706, R01GM037706,
   R01GM037706, R01GM037706, R01GM037706, R01GM037706, R01GM037706,
   R01GM037706, R01GM037706, R01GM037706] Funding Source: NIH RePORTER;
   Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [20590482] Funding Source: KAKEN
FX Funding sources: Burroughs Wellcome Fund (CABS1006173; to K. Mark
   Ansel), Deutsche Forschungsgemeinschaft SFB571 and the Fritz Thyssen
   Foundation (to Vigo Heissmeyer), NIH AI071068 (to Mark Kay), NIH
   K08-AI079406-01 (to Shirit Einav), 1S10RR022982-01 (to Mostafa Ronaghi),
   NIH AI069000 (to Peter Sarnow), NIH R01 AI052447 (to Shou-Wei Ding), NIH
   AI052324 (to Eva Harris), UAMS Foundation Chow research endowment fund
   (to Marie Chow), The Midwest Regional Center of Excellence for
   Biodefense and Emerging Infectious Diseases Research (NIH U54 AI057160;
   to Michael S. Diamond), NIH Director's Pioneer Award (to Karla
   Kirkegaard), Burroughs Wellcome Fund Clinical Scientist Award in
   Translational Research, RO1 DK066793, and RO1 DK064223 (to Jeffrey S.
   Glenn), NIH ROI GM37706, Stanford Dept. of Pathology funds, Bill &
   Melinda Gates Foundation (to Andrew Z. Fire), Stanford Graduate
   Fellowship (to Poornima Parameswaran), and for work in the Fire Lab from
   NIAID-U54065359 (Pacific Southwest Regional Center of Excellence, PI
   Alan Barbour). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001
   Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Ansel KM, 2008, NAT STRUCT MOL BIOL, V15, P523, DOI 10.1038/nsmb.1417
   BANERJEE AK, 1992, VIROLOGY, V188, P417, DOI 10.1016/0042-6822(92)90495-B
   Barik S, 2004, VIRUS RES, V102, P27, DOI 10.1016/j.virusres.2004.01.012
   Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   BRENNER S, 1974, GENETICS, V77, P71
   Burgyan Jozsef, 2008, V451, P69, DOI 10.1007/978-1-59745-102-4_5
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0
   CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825
   Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066
   Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005
   Chen WX, 2008, VIRUS RES, V133, P250, DOI 10.1016/j.virusres.2008.01.011
   CLEAVES GR, 1981, VIROLOGY, V111, P73, DOI 10.1016/0042-6822(81)90654-1
   Collins RE, 2005, FEBS LETT, V579, P5841, DOI 10.1016/j.febslet.2005.07.072
   Conzelmann KK, 1998, ANNU REV GENET, V32, P123, DOI 10.1146/annurev.genet.32.1.123
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   de Vries W, 2008, INT J BIOCHEM CELL B, V40, P2007, DOI 10.1016/j.biocel.2008.04.015
   Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877
   Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034
   Gitlin L, 2005, J VIROL, V79, P1027, DOI 10.1128/JVI.79.2.1027-1035.2005
   Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002
   Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023
   Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494
   Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0
   Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079
   Haussecker D, 2008, NAT STRUCT MOL BIOL, V15, P714, DOI 10.1038/nsmb.1440
   Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005
   Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06
   Ji J, 2008, J GEN VIROL, V89, P2761, DOI 10.1099/vir.0.2008/002923-0
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Joshua-Tor L, 2006, COLD SPRING HARB SYM, V71, P67, DOI 10.1101/sqb.2006.71.048
   Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]
   Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486
   Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005
   KURILLA MG, 1983, CELL, V34, P837, DOI 10.1016/0092-8674(83)90541-X
   Kwan WH, 2005, J VIROL, V79, P7291, DOI 10.1128/JVI.79.12.7291-7299.2005
   LANFORD RE, 1995, J VIROL, V69, P8079, DOI 10.1128/JVI.69.12.8079-8083.1995
   LANGLAND JO, 1994, J VIROL, V68, P3821, DOI 10.1128/JVI.68.6.3821-3829.1994
   Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290
   LEPPERT M, 1979, CELL, V18, P735, DOI 10.1016/0092-8674(79)90127-2
   Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027
   Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Lingel A, 2005, EMBO REP, V6, P1149, DOI 10.1038/sj.embor.7400583
   Lipardi C, 2009, P NATL ACAD SCI USA, V106, P15645, DOI 10.1073/pnas.0904984106
   Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513
   Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110
   Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103
   Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870
   Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007
   Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514
   Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283
   Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040
   Matskevich AA, 2007, J GEN VIROL, V88, P2627, DOI 10.1099/vir.0.83103-0
   Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007
   Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06
   Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005
   Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702
   Murakami Y, 2009, J HEPATOL, V50, P453, DOI 10.1016/j.jhep.2008.06.010
   Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792
   Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007
   NOVAK JE, 1991, J VIROL, V65, P3384, DOI 10.1128/JVI.65.6.3384-3387.1991
   Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5
   O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104
   O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677
   Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027
   OMALLEY RP, 1986, CELL, V44, P391, DOI 10.1016/0092-8674(86)90460-5
   Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839
   Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760
   Parrish S, 2001, RNA, V7, P1397
   Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578
   Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104
   Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918
   ROBERTSON HD, 1968, J BIOL CHEM, V243, P82
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06
   SAMUELS MLW, 2002, STAT LIFE SCI, P206
   Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001
   Severa M, 2007, CURR TOP MICROBIOL, V316, P167
   Seyhan AA, 2007, OLIGONUCLEOTIDES, V17, P473, DOI 10.1089/oli.2007.0079
   Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1
   Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699
   Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514
   Stein P, 2005, DEV BIOL, V286, P464, DOI 10.1016/j.ydbio.2005.08.015
   Svoboda P, 2000, DEVELOPMENT, V127, P4147
   Svoboda P, 2007, CURR OPIN MOL THER, V9, P248
   Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X
   Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6
   Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002
   Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082
   Ui-Tei K, 2000, FEBS LETT, V479, P79, DOI 10.1016/S0014-5793(00)01883-4
   Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028
   Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016
   Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957
   WILUSZ J, 1983, P NATL ACAD SCI-BIOL, V80, P5827, DOI 10.1073/pnas.80.19.5827
   Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020
   Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575
   Xu N, 2007, J VIROL, V81, P10540, DOI 10.1128/JVI.00885-07
   Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x
   Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017
NR 117
TC 177
Z9 181
U1 0
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD FEB
PY 2010
VL 6
IS 2
AR e1000764
DI 10.1371/journal.ppat.1000764
PG 21
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 565LZ
UT WOS:000275295900016
PM 20169186
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU de Araujo, JMG
   Bello, G
   Schatzmayr, HG
   dos Santos, FB
   Nogueira, RMR
AF Galvao de Araujo, Joselio Maria
   Bello, Gonzalo
   Schatzmayr, Hermann Goncalves
   dos Santos, Flavia Barreto
   Ribeiro Nogueira, Rita Maria
TI Dengue virus type 3 in Brazil: a phylogenetic perspective
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue virus type 3; genotypes; Brazil
ID HEMORRHAGIC-FEVER; MOLECULAR EPIDEMIOLOGY; CIRCULATION
AB Circulation of a new dengue virus (DENV)-3 genotype was recently described in Brazil and Colombia, but the precise classification of this genotype has been controversial. Here we perform phylogenetic and nucleotide-distance analyses of the envelope gene, which support the subdivision of DENV-3 strains into five distinct genotypes (GI to GV) and confirm the classification of the new South American genotype as GV. The extremely low genetic distances between Brazilian GV strains and the prototype Philippines/L11423 GV strain isolated in 1956 raise important questions regarding the origin of GV in South America.
C1 [Galvao de Araujo, Joselio Maria; Schatzmayr, Hermann Goncalves; dos Santos, Flavia Barreto; Ribeiro Nogueira, Rita Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, BR-21045900 Rio De Janeiro, Brazil.
   [Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil.
RP de Araujo, JMG (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM joselio@ioc.fiocruz.br
RI Bentancor, Gonzalo Jose Bello/N-7377-2019; Araujo, Joselio M
   G/B-5502-2013; Bello, Gonzalo/E-6842-2013
OI Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Araujo, Joselio M
   G/0000-0003-3548-2786; 
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [501564/03-9]; FAPERJCarlos Chagas Filho Foundation for Research Support
   of the State of Rio de Janeiro (FAPERJ) [E-26/152490/2002]
FX CNPq (501564/03-9), FAPERJ (E-26/152490/2002) JMG Ara jo and G Bello
   contributed equally to this article.
CR [Anonymous], 1995, Wkly Epidemiol Rec, V70, P41
   Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710
   ARAUJO JM, 2009, INFECT GENE IN PRESS
   Balmaseda A, 1999, AM J TROP MED HYG, V61, P893, DOI 10.4269/ajtmh.1999.61.893
   BrisenoGarcia B, 1996, EMERG INFECT DIS, V2, P133, DOI 10.3201/eid0202.960210
   BUKIN EK, 2006, DENGUE EPIDEMIC PARA
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   GUZMAN MG, 1998, ARCH VENEZ MED TROP, V2, P8
   Isturiz RE, 2000, INFECT DIS CLIN N AM, V14, P121, DOI 10.1016/S0891-5520(05)70221-X
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   Linderbach BD, 2001, FIELDS VIROLOGY, P991
   Nogueira MB, 2008, MEM I OSWALDO CRUZ, V103, P483, DOI 10.1590/S0074-02762008000500013
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Rosen L, 1999, Med Trop (Mars), V59, P495
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Usme-Ciro JA, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-101
   Usuku S, 2001, ARCH VIROL, V146, P1381, DOI 10.1007/s007050170098
   Uzcategui NY, 2003, J GEN VIROL, V84, P1569, DOI 10.1099/vir.0.18807-0
NR 19
TC 11
Z9 11
U1 0
U2 3
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2009
VL 104
IS 3
BP 526
EP 529
DI 10.1590/S0074-02762009000300021
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 462EX
UT WOS:000267332000021
PM 19547883
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU de Araujo, JMG
   Schatzmayr, HG
   de Filippis, AMB
   dos Santos, FB
   Cardoso, MA
   Britto, C
   Coelho, JMCO
   Nogueira, RMR
AF Galvao de Araujo, Joselio M.
   Schatzmayr, Hermann Goncalves
   Bispo de Filippis, Ana Maria
   dos Santos, Flavia Barreto
   Cardoso, Maria Angeica
   Britto, Constanca
   Oliveira Coelho, Janice M. C.
   Ribeiro Nogueira, Rita Maria
TI A retrospective survey of dengue virus infection in fatal cases from an
   epidemic in Brazil
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Dengue virus; Diagnosis; Surveillance; Tissues; Real-time; RT-PCR
ID HEMORRHAGIC-FEVER; BONE-MARROW; HUMAN LIVER; PATHOGENESIS; ANTIGENS;
   THAILAND; CELLS
AB Dengue virus can infect many cell types from the vascular, muscular and hematological systems causing diverse clinical and pathological signs. The purpose of the present study was to investigate by different diagnostic methods dengue virus in human tissue specimens obtained from fatal cases (n = 29) during a large-scale dengue fever epidemic in 2002 in the State of Rio de Janeiro, Brazil. The combination of four procedures provided diagnostic confirmation of DENV-3 infection in 26 (89.6%) out of the 29 suspected fatal cases. Dengue virus (DENV) was isolated from 2/74 (2.7%) tissue samples, inoculated into C6/36 cells and identified as DENV-3, nested RT-PCR accusing 22/72 (30.5%) samples as DENV-3. Real-time RT-PCR yielded the highest positivity rate, detecting viral RNA in 45/77 (58.4%) clinical specimens, including the liver (n = 18), lung (n = 8), spleen (n = 8), brain (n = 6), kidney (n = 3), bone marrow (n = 1) and heart (n = 1). Immunohistochemical tests recognized the DENV antigen in 26/59 (44%) specimens. Given the accuracy and effectiveness of real-time RT-PCR in this investigation, this approach may play an important role for rapid diagnosis of dengue infections. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Galvao de Araujo, Joselio M.; Schatzmayr, Hermann Goncalves; Bispo de Filippis, Ana Maria; dos Santos, Flavia Barreto; Ribeiro Nogueira, Rita Maria] Inst Oswaldo Cruz, Lab Flavivirus, BR-21045900 Rio De Janeiro, Brazil.
   [Britto, Constanca] Inst Oswaldo Cruz, Lab Mol Biol & Endem Dis, Rio De Janeiro, Brazil.
   [Oliveira Coelho, Janice M. C.] Evandro Chagas Clin Res Inst, Rio De Janeiro, Brazil.
RP de Araujo, JMG (corresponding author), Inst Oswaldo Cruz, Lab Flavivirus, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM joselio@ioc.fiocruz.br
RI Araujo, Joselio M G/B-5502-2013; Britto, Constanca/L-7658-2016
OI Araujo, Joselio M G/0000-0003-3548-2786; Britto,
   Constanca/0000-0003-0788-7030
FU Conselho Nacional cle Desenvolvimento Cientifico e
   Tecnologico-CNPqNational Council for Scientific and Technological
   Development (CNPq) [501564/03-9]; FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/152490/2002]
FX The research described in this publication was made possible by support
   from the Conselho Nacional cle Desenvolvimento Cientifico e
   Tecnologico-CNPq (grant no. 501564/03-9) and FAPERJ (grant no.
   E-26/152490/2002). The authors are grateful to the Program for
   Technological Development in Tools for Health-PDTIS-FIOCRUZ for the use
   of their facilities. J.M.G.A. received a fellowship frorn CNPq.
CR Basílio-de-Oliveira C.A., 2005, Braz J Infect Dis, V9, P341, DOI 10.1590/S1413-86702005000400012
   BHAMARAP.N, 1967, ANN TROP MED PARASIT, V61, P500, DOI 10.1080/00034983.1967.11686519
   Bhoopat L, 1996, ASIAN PAC J ALLERGY, V14, P107
   BOONPUCKNAVIG S, 1979, ARCH PATHOL LAB MED, V103, P463
   CHUAH S K, 1987, SMJ Singapore Medical Journal, V28, P569
   Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7
   DASILVA JB, 2002, EPIDEMIOL B, V23, P1
   Donegani E, 1986, Minerva Cardioangiol, V34, P477
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408
   HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102
   Veloso Henrique Horta, 2003, Braz J Infect Dis, V7, P418, DOI 10.1590/S1413-86702003000600010
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Khongphatthallayothin A, 2000, Southeast Asian J Trop Med Public Health, V31, P642
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LARUSSA VF, 1995, BAILLIERE CLIN HAEM, V8, P249, DOI 10.1016/S0950-3536(05)80240-9
   Leão Raimundo N.Q., 2002, Rev. Soc. Bras. Med. Trop., V35, P401, DOI 10.1590/S0037-86822002000400018
   Lin YL, 2000, J MED VIROL, V60, P425, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;425::AID-JMV10&gt;3.0.CO;2-A
   Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Nogueira R. M. R., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P68
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Rigau-Perez JG, 2002, AM J TROP MED HYG, V67, P355, DOI 10.4269/ajtmh.2002.67.355
   Rothwell SW, 1996, AM J TROP MED HYG, V54, P503, DOI 10.4269/ajtmh.1996.54.503
   Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007
   Wulur H, 1983, B WORLD HEALTH ORGAN, V61, P693
   YOSKAN S, 1983, P INT C DENG HAEM FE, P406
NR 32
TC 28
Z9 28
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
J9 J VIROL METHODS
JI J. Virol. Methods
PD JAN
PY 2009
VL 155
IS 1
BP 34
EP 38
DI 10.1016/j.jviromet.2008.09.023
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 396DW
UT WOS:000262573400005
PM 18951921
DA 2020-12-09
ER

PT J
AU Kwan, WH
   Navarro-Sanchez, E
   Dumortier, H
   Decossas, M
   Vachon, H
   dos Santos, FB
   Fridman, HW
   Rey, FA
   Harris, E
   Despres, P
   Mueller, CG
AF Kwan, Wing-Hong
   Navarro-Sanchez, Erika
   Dumortier, Helene
   Decossas, Marion
   Vachon, Hortense
   dos Santos, Flavia Barreto
   Fridman, Herve W.
   Rey, Felix A.
   Harris, Eva
   Despres, Philippe
   Mueller, Christopher G.
TI Dermal-Type Macrophages Expressing CD209/DC-SIGN Show Inherent
   Resistance to Dengue Virus Growth
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HUMAN DENDRITIC CELLS; HUMAN SKIN; INFECTION; SUBSETS
AB Background: An important question in dengue pathogenesis is the identity of immune cells involved in the control of dengue virus infection at the site of the mosquito bite. There is evidence that infection of immature myeloid dendritic cells plays a crucial role in dengue pathogenesis and that the interaction of the viral envelope E glycoprotein with CD209/DC-SIGN is a key element for their productive infection. Dermal macrophages express CD209, yet little is known about their role in dengue virus infection.
   Methods and Findings: Here, we showed that dermal macrophages bound recombinant envelope E glycoprotein fused to green fluorescent protein. Because dermal macrophages stain for IL-10 in situ, we generated dermal-type macrophages from monocytes in the presence of IL-10 to study their infection by dengue virus. The macrophages were able to internalize the virus, but progeny virus production was undetectable in the infected cells. In addition, no IFN-alpha was produced in response to the virus. The inability of dengue virus to grow in the macrophages was attributable to accumulation of internalized virus particles into poorly-acidified phagosomes.
   Conclusions: Aborting infection by viral sequestration in early phagosomes would present a novel means to curb infection of enveloped virus and may constitute a prime defense system to prevent dengue virus spread shortly after the bite of the infected mosquito.
C1 [Kwan, Wing-Hong; Dumortier, Helene; Decossas, Marion; Vachon, Hortense; Mueller, Christopher G.] Univ Strasbourg 1, IBMC, Lab Therapeut Immunol & Chem, CNRS, Strasbourg, France.
   [Kwan, Wing-Hong; Fridman, Herve W.] Ctr Rech Biomed Cordeliers, INSERM, U872, Paris UMRS 872 5, Paris, France.
   [Kwan, Wing-Hong; Fridman, Herve W.] Ctr Rech Biomed Cordeliers, INSERM, U872, Paris UMRS 872 6, Paris, France.
   [Navarro-Sanchez, Erika; Despres, Philippe] Inst Pasteur, Unite Interact Mol Flavivirus Hotes, Paris, France.
   [Navarro-Sanchez, Erika; Rey, Felix A.] Inst Pasteur, CNRS, URA 3015, Unite Rech Virol Struct, Paris, France.
   [dos Santos, Flavia Barreto; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA.
RP Kwan, WH (corresponding author), Univ Strasbourg 1, IBMC, Lab Therapeut Immunol & Chem, CNRS, Strasbourg, France.
EM pdespres@pasteur.fr; c.mueller@ibmc.u-strasbg.fr
RI Kwan, Wing-hong/C-6571-2016; Rey, Felix/B-6497-2012
OI Mueller, Christopher/0000-0002-4119-2729; fridman, wolf
   herman/0000-0002-1332-0973; decossas, marion/0000-0003-0810-4309; Rey,
   Felix/0000-0002-9953-7988
FU INSERMInstitut National de la Sante et de la Recherche Medicale
   (Inserm); CNRSCentre National de la Recherche Scientifique (CNRS);
   Fondation de la Recherche MedicaleFondation pour la Recherche Medicale;
   Agence Nationale de Recherche Microbiologie Immunologie Maladies
   EmergentesFrench National Research Agency (ANR) [ARBO-CELLGUARD];
   Pediatric Dengue Vaccine Initiative (PDVI); European CommissionEuropean
   CommissionEuropean Commission Joint Research Centre [51711]
FX This work was supported by INSERM, CNRS, the Fondation de la Recherche
   Medicale, the Agence Nationale de Recherche Microbiologie Immunologie
   Maladies Emergentes (contract ARBO-CELLGUARD), the Pediatric Dengue
   Vaccine Initiative (PDVI), and the European Commission (INCO-DEV,
   contract DENFRAME No. 51711). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Angel CE, 2007, IMMUNOL CELL BIOL, V85, P363, DOI 10.1038/sj.icb.7100047
   ANGEL CE, 2007, INT IMMUNOL, V5, P5
   Despres P, 1998, J VIROL, V72, P823
   Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499
   Kang KF, 1998, J INVEST DERMATOL, V111, P31, DOI 10.1046/j.1523-1747.1998.00121.x
   Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246
   Kwan WH, 2005, J VIROL, V79, P7291, DOI 10.1128/JVI.79.12.7291-7299.2005
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Morelli AE, 2005, J IMMUNOL, V175, P7905, DOI 10.4049/jimmunol.175.12.7905
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nestle FO, 2007, J CLIN INVEST, V117, P2382, DOI 10.1172/JCI33349
   Relloso M, 2002, J IMMUNOL, V168, P2634, DOI 10.4049/jimmunol.168.6.2634
   Rigden RC, 2002, IMMUNOLOGY, V106, P537, DOI 10.1046/j.1365-2567.2002.01460.x
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282
NR 20
TC 36
Z9 39
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2008
VL 2
IS 10
AR e311
DI 10.1371/journal.pntd.0000311
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 385IL
UT WOS:000261807800019
PM 18827881
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Dos Santos, FB
   Nogeira, RMR
   Lima, MRQ
   De Simone, TS
   Schatzmayr, HG
   Lemes, EAB
   Harris, E
   Miagostovich, MP
AF Dos Santos, Flavia B.
   Nogeira, Rita Maria R.
   Lima, Monique R. Q.
   De Simone, Thatiane S.
   Schatzmayr, Hermann G.
   Lemes, Elezer A. B.
   Harris, Eva
   Miagostovich, Marize P.
TI Recombinant polypeptide antigen-based immunoglobulin G enzyme-linked
   immunosorbent assay for serodiagnosis of dengue
SO CLINICAL AND VACCINE IMMUNOLOGY
LA English
DT Article
ID HEMAGGLUTINATION-INHIBITION; VIRUS-INFECTION; DIAGNOSIS; ANTIBODIES
AB We have developed an indirect enzyme-linked immunosorbent assay for detection of anti-dengue virus (DENV) immunoglobulin G antibodies using four recombinant DENV envelope polypeptides as antigens, which demonstrated a sensitivity of 89.4% and a specificity of 93.3%. These easily produced antigens are a feasible, cost-effective alternative for generating reagents for dengue serological tests.
C1 Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab, Dept Virol, BR-21045360 Rio De Janeiro, Brazil.
   Dept Technol Dev, BR-21045360 Rio De Janeiro, Brazil.
   Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA.
RP Dos Santos, FB (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Flavivirus Lab, Dept Virol, Av Brasil 4365, BR-21045360 Rio De Janeiro, Brazil.
EM flaviab@ioc.fiocruz.br
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW000905, TW 00905] Funding Source: Medline
CR AnandaRao R, 2006, CLIN VACCINE IMMUNOL, V13, P59, DOI 10.1128/CVI.13.1.59-67.2006
   Blacksell SD, 2006, CLIN INFECT DIS, V42, P1127, DOI 10.1086/501358
   CHUNGUE E, 1989, T ROY SOC TROP MED H, V83, P708, DOI 10.1016/0035-9203(89)90404-5
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Cuzzubbo AJ, 2001, CLIN DIAGN LAB IMMUN, V8, P1150, DOI 10.1128/CDLI.8.6.1150-1155.2001
   Dos Santos FB, 2004, AM J TROP MED HYG, V71, P144, DOI 10.4269/ajtmh.2004.71.144
   Groen J, 2000, CLIN DIAGN LAB IMMUN, V7, P867, DOI 10.1128/CDLI.7.6.867-871.2000
   Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   Innis Bruce L., 1997, P221
   Lam S K, 1993, Malays J Pathol, V15, P9
   LAM SK, 1995, ASIA-PAC J MOL BIOL, V3, P351
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Linderbach BD, 2001, FIELDS VIROLOGY, P991
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Ruechusatsawat K., 1994, Japanese Journal of Tropical Medicine and Hygiene, V22, P9
   Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004
   Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048
   Videa E, 2005, CLIN DIAGN LAB IMMUN, V12, P882, DOI 10.1128/CDLI.12.7.882-884.2005
   VORNDAM AV, 1997, DENGUE DENGUE HEMORR, P313
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 23
TC 5
Z9 5
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1556-6811
J9 CLIN VACCINE IMMUNOL
JI Clin. Vaccine Immunol.
PD MAY
PY 2007
VL 14
IS 5
BP 641
EP 643
DI 10.1128/CVI.00474-06
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 170RN
UT WOS:000246681800023
PM 17392435
OA Bronze, Green Published
DA 2020-12-09
ER

PT J
AU Pereira, E
   Faria, NRD
   Fialho, AM
   de Assis, RS
   Almeida, MMS
   Rocha, M
   Galvao, M
   dos Santos, FB
   Barreto, ML
   Leite, JPG
AF Pereira Filho, Edson
   da Costa Faria, Nieli R.
   Fialho, Alexandre M.
   de Assis, Rosane S.
   Almeida, Marilda Maria S.
   Rocha, Myrna
   Galvao, Marcia
   dos Santos, Flavia B.
   Barreto, Mauricio L.
   Leite, Jose Paulo G.
TI Adenoviruses associated with acute gastroententis in hospitalized and
   community children up to 5 years old in Rio de Janeiro and Salvador,
   Brazil
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID ENTERIC ADENOVIRUS-40; VIRAL AGENTS; FECAL SAMPLES; GENOME TYPES;
   DIARRHEA; IDENTIFICATION; PCR; ASTROVIRUS; ROTAVIRUS; PREVALENCE
AB Acute gastroenteritis is a major source of morbidity and mortality among young children in developed and developing countries. Human adenoviruses (HAdVs), and in particular species F, are related to childhood diarrhoea worldwide. This study presents the results obtained during an investigation of HAdVs causing acute gastroenteritis in children hospitalized in Rio de Janeiro, RJ, Brazil, from April 1996 to September 2003, as well as in children with diarrhoea living in the slums of Salvador, BA, Brazil, from October 2001 to September 2003. A total of 3060 stool samples was analysed by an enzyme immunoassay for rotavirus and adenovirus (EIARA) and 61 (2 %) were found to be positive. HAdV presented with low prevalence throughout the year, with a slight but not significant increase in incidence in late summer and early autumn. Children up to 2 years of age were the most frequently affected (79 % of all positive samples). All positive samples were analysed further by generic and species-specific HAdV PCR protocols, confirming 100 % specificity of this rapid and inexpensive EIARA. Species IF was the most prevalent (65 %), despite the occurrence of species A (112 %), C, ID and co-infection F/D (5 % each) and species B and co-infections F/A, F/C and B/D (2 % each). In order to type the species F strains as HAdV-40 or -41, generic IPCIR and a Hinfl restriction digest were performed. HAdV-40 and -41 were found to represent 62% (23/37) and 38% (14/37), respectively. These results demonstrated that a combination of generic and species-specific PCIRs is useful and reliable for HAdV species and type identification directly from faecal specimens. The results confirmed the enclemism of human adenoviruses, mainly species F, in children as aetiological agents of diarrhoea, although the limited sensitivity of EIARA as a screening method may have underestimated their prevalence.
C1 Fundacao Oswaldo Cruz, Dept Virol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   Inst Biol Exercito, Subdiv Pesquisa, BR-20911270 Rio De Janeiro, Brazil.
   Hosp Municipal Jesus, Setor Pediat, BR-20550200 Rio De Janeiro, Brazil.
   Hosp Municipal Salles Neto, Setor Pediat, BR-20260010 Rio De Janeiro, Brazil.
   Univ Fed Bahia, Inst Saude Colet, BR-40110170 Salvador, BA, Brazil.
RP Leite, JPG (corresponding author), Fundacao Oswaldo Cruz, Dept Virol, Inst Oswaldo Cruz, Ave Brasil 4365,Pavilhao Cardoso Fontes, BR-21045900 Rio De Janeiro, Brazil.
EM jpgleite@ioc.fiocruz.br
RI Barreto, Mauricio L/B-1752-2008
OI Barreto, Mauricio L/0000-0002-0215-4930; Fialho, Alexandre
   Madi/0000-0002-5412-3896
CR Adam E, 1996, ARCH VIROL, V141, P1891, DOI 10.1007/BF01718202
   Akalu A, 1998, J VIROL METHODS, V71, P187, DOI 10.1016/S0166-0934(97)00213-9
   Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001
   Amar CFL, 2004, EUR J CLIN MICROBIOL, V23, P529, DOI 10.1007/s10096-004-1149-x
   Barnes GL, 1998, J CLIN MICROBIOL, V36, P133, DOI 10.1128/JCM.36.1.133-138.1998
   Bereciartu A, 2002, J CLIN VIROL, V25, P197, DOI 10.1016/S1386-6532(02)00010-0
   Bon F, 1999, J CLIN MICROBIOL, V37, P3055, DOI 10.1128/JCM.37.9.3055-3058.1999
   BROWN M, 1990, J CLIN MICROBIOL, V28, P1525, DOI 10.1128/JCM.28.7.1525-1529.1990
   BROWN M, 1984, J CLIN MICROBIOL, V20, P334, DOI 10.1128/JCM.20.3.334-338.1984
   Chen KT, 2005, J INFECT DIS, V192, pS44, DOI 10.1086/431495
   De Jong JC, 1999, J CLIN MICROBIOL, V37, P3940, DOI 10.1128/JCM.37.12.3940-3945.1999
   DEJONG JC, 1993, J CLIN MICROBIOL, V31, P1562, DOI 10.1128/JCM.31.6.1562-1569.1993
   Dennehy PH, 2001, J INFECT DIS, V184, P10, DOI 10.1086/321007
   GOMES SA, 1989, J CLIN MICROBIOL, V27, P1022, DOI 10.1128/JCM.27.5.1022-1026.1989
   HALL TA, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.5598/IMAFUNGUS.2011.02.02.06
   HARSI CM, 1995, J MED VIROL, V45, P127, DOI 10.1002/jmv.1890450203
   HERRMANN JE, 1988, J CLIN MICROBIOL, V26, P1783, DOI 10.1128/JCM.26.9.1783-1786.1988
   HIERHOLZER JC, 1995, DIAGNOSTIC PROCEDURE, P169
   HORWITZ MS, 2001, FIELDS VIROLOGY, P2301
   JARECKIKHAN K, 1993, J CLIN MICROBIOL, V31, P484, DOI 10.1128/JCM.31.3.484-489.1993
   KIM KH, 1990, J CLIN MICROBIOL, V28, P2279, DOI 10.1128/JCM.28.10.2279-2284.1990
   Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197
   Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244
   LEITE JPG, 1985, J MED VIROL, V15, P203, DOI 10.1002/jmv.1890150213
   LEW JF, 1991, J INFECT DIS, V164, P673, DOI 10.1093/infdis/164.4.673
   LINHARES AL, 2002, VACINA ROTAVIRUS BEL, P199
   Liu CY, 2006, J CLIN VIROL, V35, P69, DOI 10.1016/j.jcv.2005.04.007
   Marie-Cardine A, 2002, CLIN INFECT DIS, V34, P1170, DOI 10.1086/339807
   McIver CJ, 2001, PATHOLOGY, V33, P353, DOI 10.1080/00313020120062983
   Oh DY, 2003, J MED VIROL, V71, P82, DOI 10.1002/jmv.10449
   Pereira H G, 1993, Bull Pan Am Health Organ, V27, P224
   PEREIRA HG, 1985, J VIROL METHODS, V10, P21, DOI 10.1016/0166-0934(85)90084-9
   Pring-Akerblom P, 1999, J MED VIROL, V58, P87, DOI 10.1002/(SICI)1096-9071(199905)58:1&lt;87::AID-JMV14&gt;3.0.CO;2-R
   Rohayem J, 2004, J VIROL METHODS, V118, P49, DOI 10.1016/j.jviromet.2004.01.016
   Saderi H, 2002, J CLIN VIROL, V24, P1, DOI 10.1016/S1386-6532(01)00206-2
   Scaletsky Isabel C. A., 1999, Arquivos de Gastroenterologia, V36, P54
   SCOTTTAYLOR T, 1990, J CLIN MICROBIOL, V28, P2797, DOI 10.1128/JCM.28.12.2797-2801.1990
   Soares CC, 2002, J CLIN VIROL, V23, P171, DOI 10.1016/S1386-6532(01)00220-7
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   UHNOO I, 1984, J CLIN MICROBIOL, V20, P365, DOI 10.1128/JCM.20.3.365-372.1984
   VENACCHIO L, 2006, PEDIAT INFECT DIS, V25, P2
   Wadell G, 1980, Ann N Y Acad Sci, V354, P16, DOI 10.1111/j.1749-6632.1980.tb27955.x
   Wood SR, 1997, J MED VIROL, V51, P198, DOI 10.1002/(SICI)1096-9071(199703)51:3&lt;198::AID-JMV9&gt;3.0.CO;2-1
   Xu WH, 2000, J CLIN MICROBIOL, V38, P4114, DOI 10.1128/JCM.38.11.4114-4120.2000
NR 44
TC 43
Z9 45
U1 0
U2 1
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-2615
EI 1473-5644
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD MAR
PY 2007
VL 56
IS 3
BP 313
EP 319
DI 10.1099/jmm.0.46685-0
PG 7
WC Microbiology
SC Microbiology
GA 146AS
UT WOS:000244907500004
PM 17314359
OA Bronze, Green Published
DA 2020-12-09
ER

PT J
AU Miagostovich, MP
   dos Santos, FB
   Fumian, TM
   Guimaraes, FR
   da Costa, EV
   Tavares, FN
   Coelho, JO
   Nogueira, RMR
AF Miagostovich, Marize Pereira
   Barreto dos Santos, Flavia
   Fumian, Tulio Machado
   Guimaraes, Flavia Ramos
   Veiga da Costa, Eliane
   Tavares, Fernando Neto
   Coelho, Janice Oliveira
   Ribeiro Nogueira, Rita Maria
TI Complete genetic characterization of a Brazilian dengue virus type 3
   strain isolated from a fatal outcome
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue virus type 3; complete genome; Brazil
ID LINKED-IMMUNOSORBENT-ASSAY; RIO-DE-JANEIRO; HEMORRHAGIC-FEVER;
   EPIDEMIOLOGY; EMERGENCE; SURVEILLANCE; VIRULENCE; AMERICA; REGION
AB We have determined the complete nucleotide and the deduced amino acid sequences of Brazilian dengue virus type 3 (DENV-3) from a dengue case with fatal outcome, which occurred during an epidemic in the state of Rio de Janeiro, Brazil, in 2002. This constitutes the first complete genetic characterization of a Brazilian DENV-3 strain since its introduction into the country in 2001. DENV-3 was responsible for the most severe dengue epidemic in the state, based on the highest number of reported cases and on the severity of clinical manifestations and deaths reported.
C1 Fiocruz MS, Inst Oswaldo Cruz, Dept Virol, BR-21040900 Rio De Janeiro, Brazil.
   Fiocruz MS, Fiocruz, RJ, Brazil.
RP Miagostovich, MP (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Dept Virol, Av Brasil 4365, BR-21040900 Rio De Janeiro, Brazil.
EM marizepm@ioc.fiocruz.br
CR Blaney JE, 2004, AM J TROP MED HYG, V71, P811, DOI 10.4269/ajtmh.2004.71.811
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   DASILVA JB, 2002, EPIDEMIOL B, V23, P1
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   dos Santos CND, 2002, VIRUS RES, V90, P197, DOI 10.1016/S0168-1702(02)00180-6
   dos Santos FB, 2002, MEM I OSWALDO CRUZ, V97, P991, DOI 10.1590/S0074-02762002000700011
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Fong MY, 2004, T ROY SOC TROP MED H, V98, P379, DOI 10.1016/j.trstmh.2003.11.004
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1
   Halstead Scott B, 2005, Vaccine, V23, P849, DOI 10.1016/j.vaccine.2004.03.069
   Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   KUMAR S, 2001, MOL EVOLUTIONARY GEN
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   Linderbach BD, 2001, FIELDS VIROLOGY, P991
   McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Messer WB, 2002, AM J TROP MED HYG, V66, P765, DOI 10.4269/ajtmh.2002.66.765
   Miagostovich MP, 2002, BRAZ J MED BIOL RES, V35, P869, DOI 10.1590/S0100-879X2002000800002
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   Nogueira R. M. R., 2002, Dengue Bulletin, V26, P77
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   OSATOMI K, 1990, VIROLOGY, V176, P643, DOI 10.1016/0042-6822(90)90037-R
   Passos Maíla Naves Pereira, 2004, Rev. Soc. Bras. Med. Trop., V37, P293, DOI 10.1590/S0037-86822004000400001
   Peyrefitte CN, 2003, J CLIN MICROBIOL, V41, P5195, DOI 10.1128/JCM.41.11.5195-5198.2003
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Pinheiro RP, 1998, INFECT MED, V15, P244
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rosen L, 1999, Med Trop (Mars), V59, P495
   Rosen L, 1996, B SOC PATHOL EXOT, V89, P91
   Shurtleff AC, 2001, VIROLOGY, V281, P75, DOI 10.1006/viro.2000.0748
   Usuku S, 2001, ARCH VIROL, V146, P1381, DOI 10.1007/s007050170098
   Uzcategui NY, 2003, J GEN VIROL, V84, P1569, DOI 10.1099/vir.0.18807-0
   1995, DENGUE 3 CENTRAL AM
NR 42
TC 18
Z9 19
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2006
VL 101
IS 3
BP 307
EP 313
DI 10.1590/S0074-02762006000300015
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 050VJ
UT WOS:000238116700015
PM 16862328
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU Nogueira, RMR
   Schatzmayr, HC
   de Filippis, AMB
   dos Santos, FB
   da Cunha, RV
   Coelho, JO
   de Souza, LJ
   Guimaraes, FR
   de Araujo, ESM
   De Simone, TS
   Baran, M
   Teixeira, G
   Miagostovich, MP
AF Nogueira, RMR
   Schatzmayr, HC
   de Filippis, AMB
   dos Santos, FB
   da Cunha, RV
   Coelho, JO
   de Souza, LJ
   Guimaraes, FR
   de Araujo, ESM
   De Simone, TS
   Baran, M
   Teixeira, G
   Miagostovich, MP
TI Dengue virus type 3, Brazil, 2002
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID RIO-DE-JANEIRO; LINKED-IMMUNOSORBENT-ASSAY; POLYMERASE CHAIN-REACTION;
   HEMORRHAGIC-FEVER; RURAL INDONESIA; EPIDEMIC; INFECTION; STATE;
   SURVEILLANCE
AB During the summer of 2002, Rio de Janeiro had a large epidemic of dengue fever; 288,245 cases were reported. A subset of 1,831 dengue hemorrhagic fever cases occurred. In this study, performed in the first half of 2002, samples from 1,559 patients with suspected cases of dengue infection were analyzed. From this total, 1,497 were obtained from patients with nonfatal cases, and 62 were obtained from patients with fatal cases. By the use of different methods, 831 (53.3%) cases, including 40 fatal cases, were confirmed as dengue infection. When virus identification was successful,. dengue virus type 3 (DENV-3) was obtained in 99% of cases. Neurologic involvement was shown in 1 patient with encephalitis, confirmed by the detection of DENV-3 RNA in the cerebrospinal fluid. This explosive epidemic of DENV-3 was the most severe dengue epidemic reported in Brazil since dengue viruses were introduced in 1986.
C1 Fiocruz MS, Lab Flavivirus Dept Virol, Inst Oswaldo Cruz, BR-21040190 Rio De Janeiro, Brazil.
   Fac Med Mato Grosso Sul, Campo Grande, Brazil.
   Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.
   Ctr Referencia Dengue, Goytacazes, Brazil.
   Secretaria Municpal Saude Rio de Janeiro, Rio De Janeiro, Brazil.
   Secretaria Saude Estado Rio de Janeiro, Rio De Janeiro, Brazil.
RP Nogueira, RMR (corresponding author), Fiocruz MS, Lab Flavivirus Dept Virol, Inst Oswaldo Cruz, Aveinda Brasil 4365, BR-21040190 Rio De Janeiro, Brazil.
EM rita@ioc.fiocruz.br
RI Cunha, Rivaldo Venancio/I-7737-2014
OI Cunha, Rivaldo Venancio/0000-0002-6622-7043
CR AZEVEDO MB, 2002, INFORME EPIDEMIOLOGI, V24, P65
   BrisenoGarcia B, 1996, EMERG INFECT DIS, V2, P133, DOI 10.3201/eid0202.960210
   *CDCP, 1995, DENG 3 CENTR AM DENG, P1
   CHUNGUE E, 1993, J GEN VIROL, V74, P2765, DOI 10.1099/0022-1317-74-12-2765
   Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7
   DASILVA JB, 2002, EPIDEMIOL B, V23, P1
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   ERAM S, 1979, AM J TROP MED HYG, V28, P711, DOI 10.4269/ajtmh.1979.28.711
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P701, DOI 10.4269/ajtmh.1979.28.701
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1
   Hanna JN, 2001, MED J AUSTRALIA, V174, P178, DOI 10.5694/j.1326-5377.2001.tb143213.x
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LAILLE M, 1991, J MED VIROL, V34, P51, DOI 10.1002/jmv.1890340109
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Leão Raimundo N.Q., 2002, Rev. Soc. Bras. Med. Trop., V35, P401, DOI 10.1590/S0037-86822002000400018
   Lin YL, 2000, J MED VIROL, V60, P425, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;425::AID-JMV10&gt;3.0.CO;2-A
   Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256
   Messer WB, 2002, AM J TROP MED HYG, V66, P765, DOI 10.4269/ajtmh.2002.66.765
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Miagostovich MP, 2002, BRAZ J MED BIOL RES, V35, P869, DOI 10.1590/S0100-879X2002000800002
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   Nogueira R. M. R., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P68
   Nogueira R. M. R., 2002, DENGUE B, V26, P1
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Nogueira RMR, 1999, T ROY SOC TROP MED H, V93, P418, DOI 10.1016/S0035-9203(99)90142-6
   Passos Maíla Naves Pereira, 2004, Rev. Soc. Bras. Med. Trop., V37, P293, DOI 10.1590/S0037-86822004000400001
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Rigau-Perez JG, 2002, AM J TROP MED HYG, V67, P355, DOI 10.4269/ajtmh.2002.67.355
   ROSEN L, 1977, AM J TROP MED HYG, V26, P337, DOI 10.4269/ajtmh.1977.26.337
   Rosen L, 1999, Med Trop (Mars), V59, P495
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   *SES RJ, 2002, QUADR DEM CAS NOT DE
   Souza Luiz José de, 2004, Braz J Infect Dis, V8, P156, DOI 10.1590/S1413-86702004000200006
   SUMARMO, 1983, B WORLD HEALTH ORGAN, V61, P693
   Wahid S. Fadilah S. Abdul, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P259
   ZAGNE SMO, 1994, T ROY SOC TROP MED H, V88, P677, DOI 10.1016/0035-9203(94)90225-9
NR 40
TC 79
Z9 83
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2005
VL 11
IS 9
BP 1376
EP 1381
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 960LG
UT WOS:000231591400007
PM 16229765
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU Videa, E
   Coloma, MJ
   dos Santos, FB
   Balmaseda, A
   Harris, E
AF Videa, E
   Coloma, MJ
   dos Santos, FB
   Balmaseda, A
   Harris, E
TI Immunoglobulin M enzyme-linked immunosorbent assay using recombinant
   polypeptides for diagnosis of dengue
SO CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
LA English
DT Article
ID VIRUS-INFECTION; ANTIBODIES; PROTEIN; ANTIGENS; LEVEL
AB We demonstrate that a mixture of four recombinant dengue virus E polypeptides corresponding to the N-terminal region of the envelope protein from all serotypes substitutes for standard antigens in two immunoglobulin:M enzyme-linked immunosorbent assay formats with 100% concordance, making these polypeptides a useful and accessible reagent for serological diagnosis of dengue in endemic countries.
C1 Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA.
   Ctr Nacl Diagnost & Referencia, Minist Hlth, Virol Lab, Managua, Nicaragua.
   Inst Oswaldo Cruz, Flavivirus Lab, Dept Virol, BR-20001 Rio De Janeiro, Brazil.
RP Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, 140 Warren Hall, Berkeley, CA 94720 USA.
EM eharris@socrates.berkeley.edu
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW000905] Funding Source: Medline
CR Balmaseda A, 2003, CLIN DIAGN LAB IMMUN, V10, P317, DOI 10.1128/CDLI.10.2.317-322.2003
   Cuzzubbo AJ, 2001, CLIN DIAGN LAB IMMUN, V8, P1150, DOI 10.1128/CDLI.8.6.1150-1155.2001
   Dos Santos FB, 2004, AM J TROP MED HYG, V71, P144, DOI 10.4269/ajtmh.2004.71.144
   Garcia G, 1997, AM J TROP MED HYG, V56, P466, DOI 10.4269/ajtmh.1997.56.466
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5
   Huang JL, 2001, J MED VIROL, V65, P553, DOI 10.1002/jmv.2072
   Linderbach BD, 2001, FIELDS VIROLOGY, P991
   Ludolfs D, 2002, J CLIN MICROBIOL, V40, P4317, DOI 10.1128/JCM.40.11.4317-4320.2002
   MANDL CW, 1989, J VIROL, V63, P564, DOI 10.1128/JVI.63.2.564-571.1989
   Simmons M, 1998, AM J TROP MED HYG, V58, P144, DOI 10.4269/ajtmh.1998.58.144
   Staropoli I, 1997, VACCINE, V15, P1946, DOI 10.1016/S0264-410X(97)00128-X
   Vorndam Vance, 1997, P313
   Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001
NR 14
TC 6
Z9 9
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1071-412X
J9 CLIN DIAGN LAB IMMUN
JI Clin. Diagn. Lab. Immunol.
PD JUL
PY 2005
VL 12
IS 7
BP 882
EP 884
DI 10.1128/CDLI.12.7.882-884.2005
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 957XU
UT WOS:000231407600015
PM 16002640
OA Green Published, Bronze
DA 2020-12-09
ER

PT J
AU Dos Santos, FB
   Miagostovich, MP
   Nogueira, RMR
   Schatzmayr, HG
   Riley, LW
   Harris, E
AF Dos Santos, FB
   Miagostovich, MP
   Nogueira, RMR
   Schatzmayr, HG
   Riley, LW
   Harris, E
TI Analysis of recombinant dengue virus polypeptides for dengue diagnosis
   and evaluation of the humoral immune response
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID RAPID IMMUNOCHROMATOGRAPHIC TEST; LINKED-IMMUNOSORBENT-ASSAY;
   ESCHERICHIA-COLI; MONOCLONAL-ANTIBODIES; ANTIGENIC STRUCTURE;
   IMMUNOGLOBULIN-M; CAPTURE ELISA; ENVELOPE; PROTEIN; INFECTION
AB Dengue is a serious cause of morbidity and mortality in tropical areas worldwide. We cloned and expressed recombinant polypeptides spanning the entire genome of a Brazilian dengue virus type 2 (DENV-2) strain in contiguous segments to generate antigens for dengue diagnosis and evaluation of the human humoral immune response. When analyzed by Western blot and an enzyme-linked immunosorbent assay (ELISA) using human sera, the most reactive polypeptide (pD2-3(E)) was located in the N-terminal portion of the envelope protein. The sensitivity of an IgG-ELISA using pD2-3(E) versus mouse brain antigen was 100% with convalescent sera and 79% with acute sera, with a specificity of 100%. Sera from patients infected with other DENV serotypes recognized pD2-3(E) equally well, whereas sera positive for yellow fever, rubella, and measles showed little or no reactivity. Using this novel approach, we identified a candidate antigen to facilitate diagnosis of DENV infections and observed a surprising variability in antibody patterns in the clinical response to DENV infections.
C1 Fiocruz MS, Dept Virol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA.
RP Dos Santos, FB (corresponding author), Fiocruz MS, Dept Virol, Inst Oswaldo Cruz, Av Brasil 4365,Manguinhos,Caixa Postal 926, BR-21045900 Rio De Janeiro, Brazil.
EM eharris@socrates.berkeley.edu
CR Barbosa da Silva Jarbas Jr, 2002, Epidemiol Bull, V23, P3
   BUKE DS, 2001, FIELDS VIROLOGY, P1043
   Burke D, 2001, FIELDS VIROLOGY, V4, P1043
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Cuzzubbo AJ, 2001, CLIN DIAGN LAB IMMUN, V8, P1150, DOI 10.1128/CDLI.8.6.1150-1155.2001
   dos Santos FB, 2002, MEM I OSWALDO CRUZ, V97, P991, DOI 10.1590/S0074-02762002000700011
   FONSECA BAL, 1991, AM J TROP MED HYG, V44, P500, DOI 10.4269/ajtmh.1991.44.500
   Garcia G, 1997, AM J TROP MED HYG, V56, P466, DOI 10.4269/ajtmh.1997.56.466
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Harris E, 1998, J CLIN MICROBIOL, V36, P2634, DOI 10.1128/JCM.36.9.2634-2639.1998
   Heinz F, 2000, VIRUS TAXONOMY, P859
   Huang JL, 2001, J MED VIROL, V65, P553, DOI 10.1002/jmv.2072
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Kelly EP, 2000, VACCINE, V18, P2549, DOI 10.1016/S0264-410X(00)00032-3
   Kuno G, 1998, AM J TROP MED HYG, V59, P757, DOI 10.4269/ajtmh.1998.59.757
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lam SK, 2000, CLIN DIAGN LAB IMMUN, V7, P850, DOI 10.1128/CDLI.7.5.850-852.2000
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Linderbach BD, 2001, FIELDS VIROLOGY, P991
   Ludolfs D, 2002, J CLIN MICROBIOL, V40, P4317, DOI 10.1128/JCM.40.11.4317-4320.2002
   MAKINO Y, 1994, MICROBIOL IMMUNOL, V38, P951, DOI 10.1111/j.1348-0421.1994.tb02152.x
   MANDL CW, 1989, J VIROL, V63, P564, DOI 10.1128/JVI.63.2.564-571.1989
   MASON PW, 1990, J GEN VIROL, V71, P2107, DOI 10.1099/0022-1317-71-9-2107
   MEGRET F, 1992, VIROLOGY, V187, P480, DOI 10.1016/0042-6822(92)90450-4
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Palmer CJ, 1999, J CLIN MICROBIOL, V37, P1600, DOI 10.1128/JCM.37.5.1600-1601.1999
   Sang CT, 1998, CLIN DIAGN LAB IMMUN, V5, P407, DOI 10.1128/CDLI.5.3.407-409.1998
   Se-Thoe SY, 1999, J MED VIROL, V57, P322, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;322::AID-JMV17&gt;3.0.CO;2-5
   Simmons M, 1998, AM J TROP MED HYG, V58, P144, DOI 10.4269/ajtmh.1998.58.144
   SRIVASTAVA AK, 1995, VACCINE, V13, P1251, DOI 10.1016/0264-410X(94)00059-V
   Staropoli I, 1997, VACCINE, V15, P1946, DOI 10.1016/S0264-410X(97)00128-X
   Sugrue RJ, 1997, J VIROL METHODS, V69, P159, DOI 10.1016/S0166-0934(97)00151-1
   TRIRAWATANAPONG T, 1992, GENE, V116, P139, DOI 10.1016/0378-1119(92)90509-N
   Valdes K, 2000, CLIN DIAGN LAB IMMUN, V7, P856, DOI 10.1128/CDLI.7.5.856-857.2000
   Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693
   VORNDAM AV, 1997, DENGUE DENGUE HEMORR, P313
   *WHO, 1997, DENG HAEM DEV DIAGN
   Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001
   Wu SJL, 2000, CLIN DIAGN LAB IMMUN, V7, P106, DOI 10.1128/CDLI.7.1.106-110.2000
NR 45
TC 17
Z9 17
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD AUG
PY 2004
VL 71
IS 2
BP 144
EP 152
DI 10.4269/ajtmh.2004.71.144
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 848AZ
UT WOS:000223440700004
PM 15306702
OA Green Published, Bronze
DA 2020-12-09
ER

PT J
AU dos Santos, FB
   Miagostovich, MP
   Nogueira, RMR
   Edgil, D
   Schatzmayr, HG
   Riley, LW
   Harris, E
AF dos Santos, FB
   Miagostovich, MP
   Nogueira, RMR
   Edgil, D
   Schatzmayr, HG
   Riley, LW
   Harris, E
TI Complete nucleotide sequence analysis of a Brazilian dengue virus type 2
   strain
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue virus type 2; complete genome; Brazil
ID RIO-DE-JANEIRO; MOLECULAR EVOLUTION; HEMORRHAGIC-FEVER; EPIDEMIOLOGY;
   STATE
AB In the last decade, dengue fever (DF) in Brazil has been recognized as an important public health problem, and an increasing number of dengue haemorrhagic fever (DHF) cases have been reported since the introduction of dengue virus type 2 (DEN-2) into the country in 1990. In order to analyze the complete genome sequence of a DEN-2 Brazilian strain (BR64022/98), we designed primers to amplify, contiguous segments of approximately 500 base pairs across the entire sequence of the viral genome. Twenty,fragments amplified by reverse transcriptase-PCR were cloned, and the complete nucleotide and the deduced ann. no acid sequences were determined. This constitutes the first complete genetic characterization of a DEN-2 strain from Brazil. All amino acid changes differentiating strains related to the Asian/American-Asian genotype were observed in BR64022/98, indicating the Asiatic origin of the strain.
C1 Fiocruz MS, Inst Oswaldo Cruz, Dept Virol, BR-21045900 Rio De Janeiro, Brazil.
   Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA.
RP dos Santos, FB (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Dept Virol, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
CR BLOK J, 1991, ARCH VIROL, V118, P209, DOI 10.1007/BF01314031
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   CHUNGUE E, 1995, J GEN VIROL, V76, P1877, DOI 10.1099/0022-1317-76-7-1877
   DEUBEL V, 1993, ARCH VIROL, V129, P197, DOI 10.1007/BF01316895
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Halstead Scott B., 1997, P23
   Harris E, 1998, J CLIN MICROBIOL, V36, P2634, DOI 10.1128/JCM.36.9.2634-2639.1998
   IGARASHI A, 1985, ADV VIRUS RES, V30, P21, DOI 10.1016/S0065-3527(08)60447-9
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   LEWIS JA, 1993, VIROLOGY, V197, P216, DOI 10.1006/viro.1993.1582
   Linderbach BD, 2001, FIELDS VIROLOGY, P991
   Messer WB, 2001, AM J TROP MED HYG, V65, P282
   Miagostovich MP, 1998, MEM I OSWALDO CRUZ, V93, P625, DOI 10.1590/S0074-02761998000500011
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Rico-Hesse R, 1998, AM J TROP MED HYG, V58, P96, DOI 10.4269/ajtmh.1998.58.96
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   ROSEN L, 1977, AM J TROP MED HYG, V26, P337, DOI 10.4269/ajtmh.1977.26.337
   Shurtleff AC, 2001, VIROLOGY, V281, P75, DOI 10.1006/viro.2000.0748
   Souza Rogerio Valls De, 1995, Memorias do Instituto Oswaldo Cruz Rio de Janeiro, V90, P345
   Tolou H, 2000, BIOCHEM BIOPH RES CO, V277, P89, DOI 10.1006/bbrc.2000.3640
   VASCONCELOS PFC, 1995, REV INST MED TROP SP, V37, P252
   Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5
   ZAGNE SMO, 1994, T ROY SOC TROP MED H, V88, P677, DOI 10.1016/0035-9203(94)90225-9
NR 28
TC 14
Z9 15
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD OCT
PY 2002
VL 97
IS 7
BP 991
EP 995
DI 10.1590/S0074-02762002000700011
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 614WY
UT WOS:000179215500011
PM 12471426
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU Miagostovich, MP
   dos Santos, FB
   de Simone, TS
   Costa, EV
   Filippis, AMB
   Schatzmayr, HG
   Nogueira, RMR
AF Miagostovich, MP
   dos Santos, FB
   de Simone, TS
   Costa, EV
   Filippis, AMB
   Schatzmayr, HG
   Nogueira, RMR
TI Genetic characterization of dengue virus type 3 isolates in the State of
   Rio de Janeiro, 2001
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE dengue viruses type 3; sequencing; RSS-PCR; Rio de Janeiro; Brazil
ID DE-JANEIRO; AMERICA; BRAZIL
AB The genetic characterization of dengue virus type 3 (DEN-3) strains isolated from autochthonous cases in the State of Rio de Janeiro, Brazil, in 2001 is presented. Restriction site-specific (RSS)-PCR performed on 22 strains classified the Brazilian DEN-3 viruses as subtype C, a subtype that contains viruses from Sri Lanka, India, Africa and recent isolates from Central America. Nucleic acid sequencing (positions 278 to 2550) of one DEN-3 strain confirmed the origin of these strains, since genotype III - classified by sequencing and RSS-PCR subtype C are correlated. This genetic subtype has been associated with hemorrhagic dengue epidemics and the information provided here could be useful to implement appropriate prevention and control measures.
C1 Fiocruz MS, Inst Oswaldo Cruz, Fdn Oswaldo Cruz,Pavilhao Cardoso Fontes, Dept Virol, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP Miagostovich, MP (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Fdn Oswaldo Cruz,Pavilhao Cardoso Fontes, Dept Virol, Avenida Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
CR Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Figueroa R, 2000, ARCH MED RES, V31, P429, DOI 10.1016/S0188-4409(00)00082-5
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P153
   Harris E, 1999, VIROLOGY, V253, P86, DOI 10.1006/viro.1998.9481
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   Nogueira RMR, 1999, MEM I OSWALDO CRUZ, V94, P297, DOI 10.1590/S0074-02761999000300004
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Rocco Iray Maria, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P55, DOI 10.1590/S0036-46652001000100011
   Schatzmayr HG, 1996, VIRUS REV RES, V1, P17
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   1995, DENGUE SURVEILLANCE, V70, P4
NR 14
TC 27
Z9 28
U1 0
U2 2
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD AUG
PY 2002
VL 35
IS 8
BP 869
EP 872
DI 10.1590/S0100-879X2002000800002
PG 4
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 612ME
UT WOS:000179079400002
PM 12185377
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU Miagostovich, MP
   Nogueira, RMR
   dos Santos, FB
   Schatzmayr, HG
   Araujo, ESM
   Vorndam, V
AF Miagostovich, MP
   Nogueira, RMR
   dos Santos, FB
   Schatzmayr, HG
   Araujo, ESM
   Vorndam, V
TI Evaluation of an IgG enzyme-linked immunosorbent assay for dengue
   diagnosis
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE diagnostic; dengue virus; HI; Mac-ELISA; IgG ELISA
ID RIO-DE-JANEIRO; ANTIBODIES; VIRUSES; BRAZIL; STATE
AB Background: The hemagglutination inhibition (HI) test has been one of the standards, with the IgM antibody capture ELISA (MAC-ELISA), for the diagnosis of dengue virus infections. The spread of dengue throughout the world and the increasing number of cases to be tested makes an ELISA-format test for IgG antibodies to replace the HI test highly desirable. Objectives: Evaluate the use of the IgG-ELISA as a substitute for the HI test in dengue diagnosis. Study design: Paired serum samples defined as being from primary or secondary dengue virus infections by HI, were tested by an ELISA that detects IgG antibodies. The correlations of titers and serologic interpretations between these two tests were examined. Results: The IgG-ELISA showed a low correlation with the HI in primary infections, and a higher correlation in secondary infections because of the influence of IgM antibodies in the HI test. Nevertheless, IgG ELISA titers could be reliably associated with primary or secondary infections when analyzed by days after onset of symptoms, and can be used to characterize the immune response after flavivirus infections. Conclusion: The combination of the IgM and IgG ELISAs may be used to serologically diagnose dengue virus infections, since the IgG ELISA can substitute for the HI test in characterizing the immune response to dengue virus infections. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Fiocruz MS, Inst Oswaldo Cruz, Dept Virol, Lab Flavivirus, BR-21045900 Rio De Janeiro, Brazil.
   Ctr Dis Control & Prevent, Publ Hlth Serv, Dept Hlth & Human Serv, San Juan, PR USA.
RP Miagostovich, MP (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Dept Virol, Lab Flavivirus, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM marizepm@gene.dbbm.fiocruz.br
CR CHUNGUE E, 1989, T ROY SOC TROP MED H, V83, P708, DOI 10.1016/0035-9203(89)90404-5
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   DESOUZA RV, 1995, MEM I OSWALDO CRUZ, V90, P345, DOI 10.1590/S0074-02761995000300006
   FIGUEIREDO LTM, 1989, T ROY SOC TROP MED H, V83, P702, DOI 10.1016/0035-9203(89)90403-3
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Halstead SB, 1997, DENGUE DENGUE HEMORR
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   INNIS BL, 1997, DENGUE DENGUE HEMORR
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   Lam S K, 1993, Malays J Pathol, V15, P9
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Schatzmayr HG, 1996, VIRUS REV RES, V1, P17
   Vasconcelos Pedro F. Da C., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P253
   Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693
   WHO, 1986, DENG HAEM FEV DIAGN
   ZAGNE SMO, 1994, T ROY SOC TROP MED H, V88, P677, DOI 10.1016/0035-9203(94)90225-9
NR 18
TC 103
Z9 108
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD DEC
PY 1999
VL 14
IS 3
BP 183
EP 189
DI 10.1016/S1386-6532(99)00059-1
PG 7
WC Virology
SC Virology
GA 265WQ
UT WOS:000084269500004
PM 10614855
DA 2020-12-09
ER

PT J
AU Nogueira, RMR
   Miagostovich, MP
   Schatzmayr, HG
   dos Santos, FB
   de Araujo, ESM
   de Filippis, AMB
   de Souza, RV
   Zagne, SMO
   Nicolai, C
   Baran, M
   Teixeira, G
AF Nogueira, RMR
   Miagostovich, MP
   Schatzmayr, HG
   dos Santos, FB
   de Araujo, ESM
   de Filippis, AMB
   de Souza, RV
   Zagne, SMO
   Nicolai, C
   Baran, M
   Teixeira, G
TI Dengue in the State of Rio de Janeiro, Brazil, 1986-1998
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue; epidemics; Rio de Janeiro; diagnosis
ID POLYMERASE CHAIN-REACTION; HEMORRHAGIC-FEVER; DE-JANEIRO; MOLECULAR
   EPIDEMIOLOGY; SHOCK SYNDROME; VIRUSES; ANTIBODIES; SEROTYPES; TYPE-2
AB This paper presents epidemiological, laboratory, and clinical data on 12 years of dengue virus activity in the Stare of Rio de Janeiro from the time the disease was first confirmed virologically in April 1986 through April 1998. DEN-1 and DEN-2 viruses are the serotypes circulating in the state and were responsible for the epidemics reported during the last 12 years. The results published here show both the impact of dengue virus infections on the population and laboratory advances that have improved dengue diagnosis.
C1 Hosp Evandro Chagas, Inst Oswaldo Cruz, Dept Virol, Lab Flavivirus, BR-21045900 Rio De Janeiro, Brazil.
   Univ Fed Fluminense, Fac Med, Dept Clin Med, Niteroi, RJ, Brazil.
   Secretaria Municipal Saude Rio De Janeiro, Rio De Janeiro, Brazil.
   Secretaria Estado Saude Rio De Janeiro, Rio De Janeiro, Brazil.
RP Nogueira, RMR (corresponding author), Hosp Evandro Chagas, Inst Oswaldo Cruz, Dept Virol, Lab Flavivirus, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM rita@gene.dbbm.fiocruz.br
CR CHIMELLI L, 1990, CLIN NEUROPATHOL, V9, P157
   Cunha Rivaldo Venancio Da, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P517, DOI 10.1590/S0036-46651995000600008
   DESOUZA RV, 1995, MEM I OSWALDO CRUZ, V90, P345, DOI 10.1590/S0074-02761995000300006
   DEUBEL V, 1993, ARCH VIROL, V129, P197, DOI 10.1007/BF01316895
   Dietz V, 1996, P R Health Sci J, V15, P201
   Figueiredo L T, 1990, Bull Pan Am Health Organ, V24, P217
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   GUBLER DJ, 1993, REGIONAL PUBLICATION, V22, P9
   Gubler DJ, 1988, ARBOVIRUSES EPIDEMIO, P223
   GUZMAN MG, 1986, ARTHROPOD BORNE VIRU, P172
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   HALSTEAD SB, 1967, JPN J MED SCI BIOL, VS 20, P96
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   KNUDSEN AB, 1996, INT SEM DENG RIO JAN, P27
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LEWIS JA, 1993, VIROLOGY, V197, P216, DOI 10.1006/viro.1993.1582
   Lum L. C. S., 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P467
   Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Miagostovich MP, 1997, MEM I OSWALDO CRUZ, V92, P595, DOI 10.1590/S0074-02761997000500006
   Miagostovich MP, 1998, MEM I OSWALDO CRUZ, V93, P625, DOI 10.1590/S0074-02761998000500011
   MORENS DM, 1986, AM J TROP MED HYG, V35, P197, DOI 10.4269/ajtmh.1986.35.197
   MORENS DM, 1978, J PEDIATR-US, V93, P1049, DOI 10.1016/S0022-3476(78)81258-X
   NASCIMENTO JP, 1992, INT SCI C OPT CONTR
   Nguyen TL, 1997, RES VIROLOGY, V148, P273, DOI 10.1016/S0923-2516(97)88364-1
   NOGUEIRA R M R, 1988, Memorias do Instituto Oswaldo Cruz, V83, P219, DOI 10.1590/S0074-02761988000200012
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   NOGUEIRA RMR, 1992, RES VIROLOGY, V143, P423, DOI 10.1016/S0923-2516(06)80136-6
   NOGUEIRA RMR, 1991, MEM I OSWALDO CRUZ, V86, P269, DOI 10.1590/S0074-02761991000200018
   PATEY O, 1993, AM J TROP MED HYG, V48, P793, DOI 10.4269/ajtmh.1993.48.793
   PEDRO Antonio, 1923, Brasil-Medico, V1, P173
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Row D, 1996, AM J TROP MED HYG, V54, P253, DOI 10.4269/ajtmh.1996.54.253
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   *SECR HLTH STAT RI, 1998, STAT REP DIS TRANSM
   Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566
   Vasconcelos Pedro F. Da C., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P253
   VORNDAM V, 1994, ARCH VIROL, V136, P191, DOI 10.1007/BF01538828
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   WHO, 1986, DENG HAEM FEV DIAGN
   ZAGNE SMO, 1994, T ROY SOC TROP MED H, V88, P677, DOI 10.1016/0035-9203(94)90225-9
   ZAGNE SMO, 1998, REV SOC BRAS MED S1, V31, P129
   1995, DENGUE 3 CENTRAL AM
NR 45
TC 37
Z9 48
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY-JUN
PY 1999
VL 94
IS 3
BP 297
EP 304
DI 10.1590/S0074-02761999000300004
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 196YB
UT WOS:000080336800004
PM 10419380
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU Cunha, RV
   Schatzmayr, HG
   Miagostovich, MP
   Barbosa, AMA
   Paiva, FG
   Miranda, RMO
   Ramos, CCF
   Coelho, JCO
   dos Santos, FB
   Nogueira, RMR
AF Cunha, RV
   Schatzmayr, HG
   Miagostovich, MP
   Barbosa, AMA
   Paiva, FG
   Miranda, RMO
   Ramos, CCF
   Coelho, JCO
   dos Santos, FB
   Nogueira, RMR
TI Dengue epidemic in the State of Rio Grande do Norte, Brazil, in 1997
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE dengue; DEN-1; DEN-2; dengue haemorrhagic fever; risk factors; Brazil
ID HEMORRHAGIC-FEVER; DE-JANEIRO; MONOCLONAL-ANTIBODIES; VIRUSES; CUBA;
   RISK
AB During 1997 a large dengue epidemic occurred in Rio Grande do Norte, a State in north-east Brazil. The cocirculation of dengue virus type 1 and dengue virus type 2 was demonstrated by virus isolation in Aedes albopictus clone C6/36 cell-line and by reverse transcriptase-polymerase chain reaction (RT-PCR). IgM capture enzyme-linked immunosorbent assay confirmed 52.3% of the 8105 studied cases and dengue antigen was demonstrated by immunohistochemical reaction on hepatocytes from 2 out of 5 fatal cases studied. Individual risk factors for development of dengue haemorrhagic fever/dengue shock syndrome, such as hypertension, diabetes mellitus and bronchial asthma, are discussed.
C1 Univ Fed Mato Grosso Sul, Disciplina Doencas Infecciosas & Parasitarias, Campo Grande, MS, Brazil.
   Inst Oswaldo Cruz FIOCRUZ, Rio De Janeiro, Brazil.
   Inst Oswaldo Cruz FIOCRUZ, Dept Virol, Lab Flavivirus, Rio De Janeiro, Brazil.
   IOC FIOCRUZ, Hosp Evandro Chagas, Manguinho, Brazil.
RP Cunha, RV (corresponding author), R Dr Armando Cunha 483, BR-79051040 Campo Grande, MS, Brazil.
RI Cunha, Rivaldo Venancio/I-7737-2014
OI Cunha, Rivaldo Venancio/0000-0002-6622-7043
CR ANDERSON W, 1994, ADV INTERNAL MED, P633
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   CHIMELLI L, 1990, CLIN NEUROPATHOL, V9, P157
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   CORDEIRO MT, 1997, VIRUS REV RES, V2, P112
   GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1094, DOI 10.4269/ajtmh.1981.30.1094
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   GUZMAN MG, 1984, T ROY SOC TROP MED H, V78, P239, DOI 10.1016/0035-9203(84)90286-4
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Innis B. L., 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P695
   KATZ MF, 1993, ADV INTERNAL MED, V38, P189
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   MARTINEZ E, 1988, ARTHROPOD BORNE VIRU, P157
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   NOGUEIRA RMR, 1992, RES VIROLOGY, V143, P423, DOI 10.1016/S0923-2516(06)80136-6
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   ROSEN L, 1977, AM J TROP MED HYG, V26, P337, DOI 10.4269/ajtmh.1977.26.337
   Souza Rogerio Valls De, 1995, Memorias do Instituto Oswaldo Cruz Rio de Janeiro, V90, P345
   WHO, 1986, DENG HAEM FEV DIAGN
   ZAGNE SMO, 1994, T ROY SOC TROP MED H, V88, P677, DOI 10.1016/0035-9203(94)90225-9
NR 24
TC 26
Z9 27
U1 1
U2 4
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON, ENGLAND W1N 4EY
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAY-JUN
PY 1999
VL 93
IS 3
BP 247
EP 249
DI 10.1016/S0035-9203(99)90008-1
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 216TT
UT WOS:000081460500007
PM 10492750
DA 2020-12-09
ER

PT J
AU Miagostovich, MP
   dosSantos, FB
   deAraujo, ESM
   Dias, J
   Schatzmayr, HG
   Nogueira, RMR
AF Miagostovich, MP
   dosSantos, FB
   deAraujo, ESM
   Dias, J
   Schatzmayr, HG
   Nogueira, RMR
TI Diagnosis of dengue by using reverse transcriptase-polymerase chain
   reaction
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue; diagnosis; virological surveillance; polymerase chain reaction
ID RIO-DE-JANEIRO; HEMORRHAGIC-FEVER; VIRUS SEROTYPES; RAPID DETECTION;
   VIRAL-RNA; BRAZIL; IDENTIFICATION; AMPLIFICATION; ANTIBODIES; TYPE-2
AB A rapid identification of dengue viruses from clinical samples by using a nested reverse transcriptase-polymerase chain reaction (RT-PCR) procedure was carried out for diagnostic and epidemiological purposes. RT-PCR identified DEN-1 and DEN-2 viruses in 41% (41/100) of previously confirmed cases and provided an accurate confirmation of DHF in four fatal cases. RT-PCR was also useful for detecting and typing dengue viruses in suspected cases, allowing a rapid identification of new serotypes in endemic areas.
C1 SECRETARIA SAUDE ESTADO BAHIA,DIV VIGILANCIA EPIDEMIOL,SALVADOR,BA,BRAZIL.
RP Miagostovich, MP (corresponding author), INST OSWALDO CRUZ,DEPT VIROL,LAB FLAVIVIRUS,AV BRASIL 4365,BR-21045900 RIO JANEIRO,BRAZIL.
CR BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   *CDC, 1995, MMWR-MORBID MORTAL W, V44, P21
   CHAN SY, 1994, J VIROL METHODS, V49, P315, DOI 10.1016/0166-0934(94)90146-5
   CHUNGUE E, 1993, J MED VIROL, V40, P142, DOI 10.1002/jmv.1890400211
   DEUBEL V, 1990, J VIROL METHODS, V30, P41, DOI 10.1016/0166-0934(90)90042-E
   FIGUEIREDO LTM, 1992, REV INST MED TROP SP, V34, P121, DOI 10.1590/S0036-46651992000200007
   FIGUEIREDO LTM, 1996, VIRUS REV RES, V1, P9
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   LAILLE M, 1991, J MED VIROL, V34, P51, DOI 10.1002/jmv.1890340109
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Miagostovich Mariz P., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P149, DOI 10.1590/S0036-46651993000200006
   MORITA K, 1991, J CLIN MICROBIOL, V29, P2107, DOI 10.1128/JCM.29.10.2107-2110.1991
   MORITA K, 1994, J MED VIROL, V44, P54, DOI 10.1002/jmv.1890440111
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   NOGUEIRA RMR, 1992, RES VIROLOGY, V143, P423, DOI 10.1016/S0923-2516(06)80136-6
   PAO CC, 1992, J INFECTION, V24, P23, DOI 10.1016/0163-4453(92)90842-T
   Pearse A.G.E., 1980, HISTOCHEMISTRY THEOR
   ROSEN L, 1989, RES VIROLOGY, V140, P361
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   SEAH CLK, 1995, J VIROL METHODS, V51, P193, DOI 10.1016/0166-0934(94)00104-O
   Souza Rogerio Valls De, 1995, Memorias do Instituto Oswaldo Cruz Rio de Janeiro, V90, P345
   Vasconcelos Pedro Fernando Da Costa, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P141, DOI 10.1590/S0036-46651993000200005
   VASCONCELOS PF, 1994, REV INST MED TROP SP, V37, P253
   ZAGNE SMO, 1994, T ROY SOC TROP MED H, V88, P677, DOI 10.1016/0035-9203(94)90225-9
NR 26
TC 23
Z9 23
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP-OCT
PY 1997
VL 92
IS 5
BP 595
EP 599
DI 10.1590/S0074-02761997000500006
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA XU937
UT WOS:A1997XU93700006
PM 9566225
OA DOAJ Gold
DA 2020-12-09
ER

EF